BindingDB Reactant_set_id	Ligand SMILES	Ligand InChI	Ligand InChI Key	BindingDB MonomerID	BindingDB Ligand Name	Target Name	Target Source Organism According to Curator or DataSource	Ki (nM)	IC50 (nM)	Kd (nM)	EC50 (nM)	kon (M-1-s-1)	koff (s-1)	pH	Temp (C)	Curation/DataSource	Article DOI	BindingDB Entry DOI	PMID	PubChem AID	Patent Number	Authors	Date of publication	Date in BindingDB	Institution	Link to Ligand in BindingDB	Link to Target in BindingDB	Link to Ligand-Target Pair in BindingDB	Ligand HET ID in PDB	PDB ID(s) for Ligand-Target Complex	PubChem CID	PubChem SID	ChEBI ID of Ligand	ChEMBL ID of Ligand	DrugBank ID of Ligand	IUPHAR_GRAC ID of Ligand	KEGG ID of Ligand	ZINC ID of Ligand	Number of Protein Chains in Target (>1 implies a multichain complex)	BindingDB Target Chain Sequence 1	PDB ID(s) of Target Chain 1	UniProt (SwissProt) Recommended Name of Target Chain 1	UniProt (SwissProt) Entry Name of Target Chain 1	UniProt (SwissProt) Primary ID of Target Chain 1	UniProt (SwissProt) Secondary ID(s) of Target Chain 1	UniProt (SwissProt) Alternative ID(s) of Target Chain 1	UniProt (TrEMBL) Submitted Name of Target Chain 1	UniProt (TrEMBL) Entry Name of Target Chain 1	UniProt (TrEMBL) Primary ID of Target Chain 1	UniProt (TrEMBL) Secondary ID(s) of Target Chain 1	UniProt (TrEMBL) Alternative ID(s) of Target Chain 1	BindingDB Target Chain Sequence 2	PDB ID(s) of Target Chain 2	UniProt (SwissProt) Recommended Name of Target Chain 2	UniProt (SwissProt) Entry Name of Target Chain 2	UniProt (SwissProt) Primary ID of Target Chain 2	UniProt (SwissProt) Secondary ID(s) of Target Chain 2	UniProt (SwissProt) Alternative ID(s) of Target Chain 2	UniProt (TrEMBL) Submitted Name of Target Chain 2	UniProt (TrEMBL) Entry Name of Target Chain 2	UniProt (TrEMBL) Primary ID of Target Chain 2	UniProt (TrEMBL) Secondary ID(s) of Target Chain 2	UniProt (TrEMBL) Alternative ID(s) of Target Chain 2	BindingDB Target Chain Sequence 3	PDB ID(s) of Target Chain 3	UniProt (SwissProt) Recommended Name of Target Chain 3	UniProt (SwissProt) Entry Name of Target Chain 3	UniProt (SwissProt) Primary ID of Target Chain 3	UniProt (SwissProt) Secondary ID(s) of Target Chain 3	UniProt (SwissProt) Alternative ID(s) of Target Chain 3	UniProt (TrEMBL) Submitted Name of Target Chain 3	UniProt (TrEMBL) Entry Name of Target Chain 3	UniProt (TrEMBL) Primary ID of Target Chain 3	UniProt (TrEMBL) Secondary ID(s) of Target Chain 3	UniProt (TrEMBL) Alternative ID(s) of Target Chain 3	BindingDB Target Chain Sequence 4	PDB ID(s) of Target Chain 4	UniProt (SwissProt) Recommended Name of Target Chain 4	UniProt (SwissProt) Entry Name of Target Chain 4	UniProt (SwissProt) Primary ID of Target Chain 4	UniProt (SwissProt) Secondary ID(s) of Target Chain 4	UniProt (SwissProt) Alternative ID(s) of Target Chain 4	UniProt (TrEMBL) Submitted Name of Target Chain 4	UniProt (TrEMBL) Entry Name of Target Chain 4	UniProt (TrEMBL) Primary ID of Target Chain 4	UniProt (TrEMBL) Secondary ID(s) of Target Chain 4	UniProt (TrEMBL) Alternative ID(s) of Target Chain 4	BindingDB Target Chain Sequence 5	PDB ID(s) of Target Chain 5	UniProt (SwissProt) Recommended Name of Target Chain 5	UniProt (SwissProt) Entry Name of Target Chain 5	UniProt (SwissProt) Primary ID of Target Chain 5	UniProt (SwissProt) Secondary ID(s) of Target Chain 5	UniProt (SwissProt) Alternative ID(s) of Target Chain 5	UniProt (TrEMBL) Submitted Name of Target Chain 5	UniProt (TrEMBL) Entry Name of Target Chain 5	UniProt (TrEMBL) Primary ID of Target Chain 5	UniProt (TrEMBL) Secondary ID(s) of Target Chain 5	UniProt (TrEMBL) Alternative ID(s) of Target Chain 5	BindingDB Target Chain Sequence 6	PDB ID(s) of Target Chain 6	UniProt (SwissProt) Recommended Name of Target Chain 6	UniProt (SwissProt) Entry Name of Target Chain 6	UniProt (SwissProt) Primary ID of Target Chain 6	UniProt (SwissProt) Secondary ID(s) of Target Chain 6	UniProt (SwissProt) Alternative ID(s) of Target Chain 6	UniProt (TrEMBL) Submitted Name of Target Chain 6	UniProt (TrEMBL) Entry Name of Target Chain 6	UniProt (TrEMBL) Primary ID of Target Chain 6	UniProt (TrEMBL) Secondary ID(s) of Target Chain 6	UniProt (TrEMBL) Alternative ID(s) of Target Chain 6	BindingDB Target Chain Sequence 7	PDB ID(s) of Target Chain 7	UniProt (SwissProt) Recommended Name of Target Chain 7	UniProt (SwissProt) Entry Name of Target Chain 7	UniProt (SwissProt) Primary ID of Target Chain 7	UniProt (SwissProt) Secondary ID(s) of Target Chain 7	UniProt (SwissProt) Alternative ID(s) of Target Chain 7	UniProt (TrEMBL) Submitted Name of Target Chain 7	UniProt (TrEMBL) Entry Name of Target Chain 7	UniProt (TrEMBL) Primary ID of Target Chain 7	UniProt (TrEMBL) Secondary ID(s) of Target Chain 7	UniProt (TrEMBL) Alternative ID(s) of Target Chain 7	BindingDB Target Chain Sequence 8	PDB ID(s) of Target Chain 8	UniProt (SwissProt) Recommended Name of Target Chain 8	UniProt (SwissProt) Entry Name of Target Chain 8	UniProt (SwissProt) Primary ID of Target Chain 8	UniProt (SwissProt) Secondary ID(s) of Target Chain 8	UniProt (SwissProt) Alternative ID(s) of Target Chain 8	UniProt (TrEMBL) Submitted Name of Target Chain 8	UniProt (TrEMBL) Entry Name of Target Chain 8	UniProt (TrEMBL) Primary ID of Target Chain 8	UniProt (TrEMBL) Secondary ID(s) of Target Chain 8	UniProt (TrEMBL) Alternative ID(s) of Target Chain 8	BindingDB Target Chain Sequence 9	PDB ID(s) of Target Chain 9	UniProt (SwissProt) Recommended Name of Target Chain 9	UniProt (SwissProt) Entry Name of Target Chain 9	UniProt (SwissProt) Primary ID of Target Chain 9	UniProt (SwissProt) Secondary ID(s) of Target Chain 9	UniProt (SwissProt) Alternative ID(s) of Target Chain 9	UniProt (TrEMBL) Submitted Name of Target Chain 9	UniProt (TrEMBL) Entry Name of Target Chain 9	UniProt (TrEMBL) Primary ID of Target Chain 9	UniProt (TrEMBL) Secondary ID(s) of Target Chain 9	UniProt (TrEMBL) Alternative ID(s) of Target Chain 9	BindingDB Target Chain Sequence 10	PDB ID(s) of Target Chain 10	UniProt (SwissProt) Recommended Name of Target Chain 10	UniProt (SwissProt) Entry Name of Target Chain 10	UniProt (SwissProt) Primary ID of Target Chain 10	UniProt (SwissProt) Secondary ID(s) of Target Chain 10	UniProt (SwissProt) Alternative ID(s) of Target Chain 10	UniProt (TrEMBL) Submitted Name of Target Chain 10	UniProt (TrEMBL) Entry Name of Target Chain 10	UniProt (TrEMBL) Primary ID of Target Chain 10	UniProt (TrEMBL) Secondary ID(s) of Target Chain 10	UniProt (TrEMBL) Alternative ID(s) of Target Chain 10	BindingDB Target Chain Sequence 11	PDB ID(s) of Target Chain 11	UniProt (SwissProt) Recommended Name of Target Chain 11	UniProt (SwissProt) Entry Name of Target Chain 11	UniProt (SwissProt) Primary ID of Target Chain 11	UniProt (SwissProt) Secondary ID(s) of Target Chain 11	UniProt (SwissProt) Alternative ID(s) of Target Chain 11	UniProt (TrEMBL) Submitted Name of Target Chain 11	UniProt (TrEMBL) Entry Name of Target Chain 11	UniProt (TrEMBL) Primary ID of Target Chain 11	UniProt (TrEMBL) Secondary ID(s) of Target Chain 11	UniProt (TrEMBL) Alternative ID(s) of Target Chain 11	BindingDB Target Chain Sequence 12	PDB ID(s) of Target Chain 12	UniProt (SwissProt) Recommended Name of Target Chain 12	UniProt (SwissProt) Entry Name of Target Chain 12	UniProt (SwissProt) Primary ID of Target Chain 12	UniProt (SwissProt) Secondary ID(s) of Target Chain 12	UniProt (SwissProt) Alternative ID(s) of Target Chain 12	UniProt (TrEMBL) Submitted Name of Target Chain 12	UniProt (TrEMBL) Entry Name of Target Chain 12	UniProt (TrEMBL) Primary ID of Target Chain 12	UniProt (TrEMBL) Secondary ID(s) of Target Chain 12	UniProt (TrEMBL) Alternative ID(s) of Target Chain 12	BindingDB Target Chain Sequence 13	PDB ID(s) of Target Chain 13	UniProt (SwissProt) Recommended Name of Target Chain 13	UniProt (SwissProt) Entry Name of Target Chain 13	UniProt (SwissProt) Primary ID of Target Chain 13	UniProt (SwissProt) Secondary ID(s) of Target Chain 13	UniProt (SwissProt) Alternative ID(s) of Target Chain 13	UniProt (TrEMBL) Submitted Name of Target Chain 13	UniProt (TrEMBL) Entry Name of Target Chain 13	UniProt (TrEMBL) Primary ID of Target Chain 13	UniProt (TrEMBL) Secondary ID(s) of Target Chain 13	UniProt (TrEMBL) Alternative ID(s) of Target Chain 13	BindingDB Target Chain Sequence 14	PDB ID(s) of Target Chain 14	UniProt (SwissProt) Recommended Name of Target Chain 14	UniProt (SwissProt) Entry Name of Target Chain 14	UniProt (SwissProt) Primary ID of Target Chain 14	UniProt (SwissProt) Secondary ID(s) of Target Chain 14	UniProt (SwissProt) Alternative ID(s) of Target Chain 14	UniProt (TrEMBL) Submitted Name of Target Chain 14	UniProt (TrEMBL) Entry Name of Target Chain 14	UniProt (TrEMBL) Primary ID of Target Chain 14	UniProt (TrEMBL) Secondary ID(s) of Target Chain 14	UniProt (TrEMBL) Alternative ID(s) of Target Chain 14	BindingDB Target Chain Sequence 15	PDB ID(s) of Target Chain 15	UniProt (SwissProt) Recommended Name of Target Chain 15	UniProt (SwissProt) Entry Name of Target Chain 15	UniProt (SwissProt) Primary ID of Target Chain 15	UniProt (SwissProt) Secondary ID(s) of Target Chain 15	UniProt (SwissProt) Alternative ID(s) of Target Chain 15	UniProt (TrEMBL) Submitted Name of Target Chain 15	UniProt (TrEMBL) Entry Name of Target Chain 15	UniProt (TrEMBL) Primary ID of Target Chain 15	UniProt (TrEMBL) Secondary ID(s) of Target Chain 15	UniProt (TrEMBL) Alternative ID(s) of Target Chain 15	BindingDB Target Chain Sequence 16	PDB ID(s) of Target Chain 16	UniProt (SwissProt) Recommended Name of Target Chain 16	UniProt (SwissProt) Entry Name of Target Chain 16	UniProt (SwissProt) Primary ID of Target Chain 16	UniProt (SwissProt) Secondary ID(s) of Target Chain 16	UniProt (SwissProt) Alternative ID(s) of Target Chain 16	UniProt (TrEMBL) Submitted Name of Target Chain 16	UniProt (TrEMBL) Entry Name of Target Chain 16	UniProt (TrEMBL) Primary ID of Target Chain 16	UniProt (TrEMBL) Secondary ID(s) of Target Chain 16	UniProt (TrEMBL) Alternative ID(s) of Target Chain 16	BindingDB Target Chain Sequence 17	PDB ID(s) of Target Chain 17	UniProt (SwissProt) Recommended Name of Target Chain 17	UniProt (SwissProt) Entry Name of Target Chain 17	UniProt (SwissProt) Primary ID of Target Chain 17	UniProt (SwissProt) Secondary ID(s) of Target Chain 17	UniProt (SwissProt) Alternative ID(s) of Target Chain 17	UniProt (TrEMBL) Submitted Name of Target Chain 17	UniProt (TrEMBL) Entry Name of Target Chain 17	UniProt (TrEMBL) Primary ID of Target Chain 17	UniProt (TrEMBL) Secondary ID(s) of Target Chain 17	UniProt (TrEMBL) Alternative ID(s) of Target Chain 17	BindingDB Target Chain Sequence 18	PDB ID(s) of Target Chain 18	UniProt (SwissProt) Recommended Name of Target Chain 18	UniProt (SwissProt) Entry Name of Target Chain 18	UniProt (SwissProt) Primary ID of Target Chain 18	UniProt (SwissProt) Secondary ID(s) of Target Chain 18	UniProt (SwissProt) Alternative ID(s) of Target Chain 18	UniProt (TrEMBL) Submitted Name of Target Chain 18	UniProt (TrEMBL) Entry Name of Target Chain 18	UniProt (TrEMBL) Primary ID of Target Chain 18	UniProt (TrEMBL) Secondary ID(s) of Target Chain 18	UniProt (TrEMBL) Alternative ID(s) of Target Chain 18	BindingDB Target Chain Sequence 19	PDB ID(s) of Target Chain 19	UniProt (SwissProt) Recommended Name of Target Chain 19	UniProt (SwissProt) Entry Name of Target Chain 19	UniProt (SwissProt) Primary ID of Target Chain 19	UniProt (SwissProt) Secondary ID(s) of Target Chain 19	UniProt (SwissProt) Alternative ID(s) of Target Chain 19	UniProt (TrEMBL) Submitted Name of Target Chain 19	UniProt (TrEMBL) Entry Name of Target Chain 19	UniProt (TrEMBL) Primary ID of Target Chain 19	UniProt (TrEMBL) Secondary ID(s) of Target Chain 19	UniProt (TrEMBL) Alternative ID(s) of Target Chain 19	BindingDB Target Chain Sequence 20	PDB ID(s) of Target Chain 20	UniProt (SwissProt) Recommended Name of Target Chain 20	UniProt (SwissProt) Entry Name of Target Chain 20	UniProt (SwissProt) Primary ID of Target Chain 20	UniProt (SwissProt) Secondary ID(s) of Target Chain 20	UniProt (SwissProt) Alternative ID(s) of Target Chain 20	UniProt (TrEMBL) Submitted Name of Target Chain 20	UniProt (TrEMBL) Entry Name of Target Chain 20	UniProt (TrEMBL) Primary ID of Target Chain 20	UniProt (TrEMBL) Secondary ID(s) of Target Chain 20	UniProt (TrEMBL) Alternative ID(s) of Target Chain 20	BindingDB Target Chain Sequence 21	PDB ID(s) of Target Chain 21	UniProt (SwissProt) Recommended Name of Target Chain 21	UniProt (SwissProt) Entry Name of Target Chain 21	UniProt (SwissProt) Primary ID of Target Chain 21	UniProt (SwissProt) Secondary ID(s) of Target Chain 21	UniProt (SwissProt) Alternative ID(s) of Target Chain 21	UniProt (TrEMBL) Submitted Name of Target Chain 21	UniProt (TrEMBL) Entry Name of Target Chain 21	UniProt (TrEMBL) Primary ID of Target Chain 21	UniProt (TrEMBL) Secondary ID(s) of Target Chain 21	UniProt (TrEMBL) Alternative ID(s) of Target Chain 21	BindingDB Target Chain Sequence 22	PDB ID(s) of Target Chain 22	UniProt (SwissProt) Recommended Name of Target Chain 22	UniProt (SwissProt) Entry Name of Target Chain 22	UniProt (SwissProt) Primary ID of Target Chain 22	UniProt (SwissProt) Secondary ID(s) of Target Chain 22	UniProt (SwissProt) Alternative ID(s) of Target Chain 22	UniProt (TrEMBL) Submitted Name of Target Chain 22	UniProt (TrEMBL) Entry Name of Target Chain 22	UniProt (TrEMBL) Primary ID of Target Chain 22	UniProt (TrEMBL) Secondary ID(s) of Target Chain 22	UniProt (TrEMBL) Alternative ID(s) of Target Chain 22	BindingDB Target Chain Sequence 23	PDB ID(s) of Target Chain 23	UniProt (SwissProt) Recommended Name of Target Chain 23	UniProt (SwissProt) Entry Name of Target Chain 23	UniProt (SwissProt) Primary ID of Target Chain 23	UniProt (SwissProt) Secondary ID(s) of Target Chain 23	UniProt (SwissProt) Alternative ID(s) of Target Chain 23	UniProt (TrEMBL) Submitted Name of Target Chain 23	UniProt (TrEMBL) Entry Name of Target Chain 23	UniProt (TrEMBL) Primary ID of Target Chain 23	UniProt (TrEMBL) Secondary ID(s) of Target Chain 23	UniProt (TrEMBL) Alternative ID(s) of Target Chain 23	BindingDB Target Chain Sequence 24	PDB ID(s) of Target Chain 24	UniProt (SwissProt) Recommended Name of Target Chain 24	UniProt (SwissProt) Entry Name of Target Chain 24	UniProt (SwissProt) Primary ID of Target Chain 24	UniProt (SwissProt) Secondary ID(s) of Target Chain 24	UniProt (SwissProt) Alternative ID(s) of Target Chain 24	UniProt (TrEMBL) Submitted Name of Target Chain 24	UniProt (TrEMBL) Entry Name of Target Chain 24	UniProt (TrEMBL) Primary ID of Target Chain 24	UniProt (TrEMBL) Secondary ID(s) of Target Chain 24	UniProt (TrEMBL) Alternative ID(s) of Target Chain 24	BindingDB Target Chain Sequence 25	PDB ID(s) of Target Chain 25	UniProt (SwissProt) Recommended Name of Target Chain 25	UniProt (SwissProt) Entry Name of Target Chain 25	UniProt (SwissProt) Primary ID of Target Chain 25	UniProt (SwissProt) Secondary ID(s) of Target Chain 25	UniProt (SwissProt) Alternative ID(s) of Target Chain 25	UniProt (TrEMBL) Submitted Name of Target Chain 25	UniProt (TrEMBL) Entry Name of Target Chain 25	UniProt (TrEMBL) Primary ID of Target Chain 25	UniProt (TrEMBL) Secondary ID(s) of Target Chain 25	UniProt (TrEMBL) Alternative ID(s) of Target Chain 25	BindingDB Target Chain Sequence 26	PDB ID(s) of Target Chain 26	UniProt (SwissProt) Recommended Name of Target Chain 26	UniProt (SwissProt) Entry Name of Target Chain 26	UniProt (SwissProt) Primary ID of Target Chain 26	UniProt (SwissProt) Secondary ID(s) of Target Chain 26	UniProt (SwissProt) Alternative ID(s) of Target Chain 26	UniProt (TrEMBL) Submitted Name of Target Chain 26	UniProt (TrEMBL) Entry Name of Target Chain 26	UniProt (TrEMBL) Primary ID of Target Chain 26	UniProt (TrEMBL) Secondary ID(s) of Target Chain 26	UniProt (TrEMBL) Alternative ID(s) of Target Chain 26	BindingDB Target Chain Sequence 27	PDB ID(s) of Target Chain 27	UniProt (SwissProt) Recommended Name of Target Chain 27	UniProt (SwissProt) Entry Name of Target Chain 27	UniProt (SwissProt) Primary ID of Target Chain 27	UniProt (SwissProt) Secondary ID(s) of Target Chain 27	UniProt (SwissProt) Alternative ID(s) of Target Chain 27	UniProt (TrEMBL) Submitted Name of Target Chain 27	UniProt (TrEMBL) Entry Name of Target Chain 27	UniProt (TrEMBL) Primary ID of Target Chain 27	UniProt (TrEMBL) Secondary ID(s) of Target Chain 27	UniProt (TrEMBL) Alternative ID(s) of Target Chain 27	BindingDB Target Chain Sequence 28	PDB ID(s) of Target Chain 28	UniProt (SwissProt) Recommended Name of Target Chain 28	UniProt (SwissProt) Entry Name of Target Chain 28	UniProt (SwissProt) Primary ID of Target Chain 28	UniProt (SwissProt) Secondary ID(s) of Target Chain 28	UniProt (SwissProt) Alternative ID(s) of Target Chain 28	UniProt (TrEMBL) Submitted Name of Target Chain 28	UniProt (TrEMBL) Entry Name of Target Chain 28	UniProt (TrEMBL) Primary ID of Target Chain 28	UniProt (TrEMBL) Secondary ID(s) of Target Chain 28	UniProt (TrEMBL) Alternative ID(s) of Target Chain 28	BindingDB Target Chain Sequence 29	PDB ID(s) of Target Chain 29	UniProt (SwissProt) Recommended Name of Target Chain 29	UniProt (SwissProt) Entry Name of Target Chain 29	UniProt (SwissProt) Primary ID of Target Chain 29	UniProt (SwissProt) Secondary ID(s) of Target Chain 29	UniProt (SwissProt) Alternative ID(s) of Target Chain 29	UniProt (TrEMBL) Submitted Name of Target Chain 29	UniProt (TrEMBL) Entry Name of Target Chain 29	UniProt (TrEMBL) Primary ID of Target Chain 29	UniProt (TrEMBL) Secondary ID(s) of Target Chain 29	UniProt (TrEMBL) Alternative ID(s) of Target Chain 29	BindingDB Target Chain Sequence 30	PDB ID(s) of Target Chain 30	UniProt (SwissProt) Recommended Name of Target Chain 30	UniProt (SwissProt) Entry Name of Target Chain 30	UniProt (SwissProt) Primary ID of Target Chain 30	UniProt (SwissProt) Secondary ID(s) of Target Chain 30	UniProt (SwissProt) Alternative ID(s) of Target Chain 30	UniProt (TrEMBL) Submitted Name of Target Chain 30	UniProt (TrEMBL) Entry Name of Target Chain 30	UniProt (TrEMBL) Primary ID of Target Chain 30	UniProt (TrEMBL) Secondary ID(s) of Target Chain 30	UniProt (TrEMBL) Alternative ID(s) of Target Chain 30	BindingDB Target Chain Sequence 31	PDB ID(s) of Target Chain 31	UniProt (SwissProt) Recommended Name of Target Chain 31	UniProt (SwissProt) Entry Name of Target Chain 31	UniProt (SwissProt) Primary ID of Target Chain 31	UniProt (SwissProt) Secondary ID(s) of Target Chain 31	UniProt (SwissProt) Alternative ID(s) of Target Chain 31	UniProt (TrEMBL) Submitted Name of Target Chain 31	UniProt (TrEMBL) Entry Name of Target Chain 31	UniProt (TrEMBL) Primary ID of Target Chain 31	UniProt (TrEMBL) Secondary ID(s) of Target Chain 31	UniProt (TrEMBL) Alternative ID(s) of Target Chain 31	BindingDB Target Chain Sequence 32	PDB ID(s) of Target Chain 32	UniProt (SwissProt) Recommended Name of Target Chain 32	UniProt (SwissProt) Entry Name of Target Chain 32	UniProt (SwissProt) Primary ID of Target Chain 32	UniProt (SwissProt) Secondary ID(s) of Target Chain 32	UniProt (SwissProt) Alternative ID(s) of Target Chain 32	UniProt (TrEMBL) Submitted Name of Target Chain 32	UniProt (TrEMBL) Entry Name of Target Chain 32	UniProt (TrEMBL) Primary ID of Target Chain 32	UniProt (TrEMBL) Secondary ID(s) of Target Chain 32	UniProt (TrEMBL) Alternative ID(s) of Target Chain 32	BindingDB Target Chain Sequence 33	PDB ID(s) of Target Chain 33	UniProt (SwissProt) Recommended Name of Target Chain 33	UniProt (SwissProt) Entry Name of Target Chain 33	UniProt (SwissProt) Primary ID of Target Chain 33	UniProt (SwissProt) Secondary ID(s) of Target Chain 33	UniProt (SwissProt) Alternative ID(s) of Target Chain 33	UniProt (TrEMBL) Submitted Name of Target Chain 33	UniProt (TrEMBL) Entry Name of Target Chain 33	UniProt (TrEMBL) Primary ID of Target Chain 33	UniProt (TrEMBL) Secondary ID(s) of Target Chain 33	UniProt (TrEMBL) Alternative ID(s) of Target Chain 33	BindingDB Target Chain Sequence 34	PDB ID(s) of Target Chain 34	UniProt (SwissProt) Recommended Name of Target Chain 34	UniProt (SwissProt) Entry Name of Target Chain 34	UniProt (SwissProt) Primary ID of Target Chain 34	UniProt (SwissProt) Secondary ID(s) of Target Chain 34	UniProt (SwissProt) Alternative ID(s) of Target Chain 34	UniProt (TrEMBL) Submitted Name of Target Chain 34	UniProt (TrEMBL) Entry Name of Target Chain 34	UniProt (TrEMBL) Primary ID of Target Chain 34	UniProt (TrEMBL) Secondary ID(s) of Target Chain 34	UniProt (TrEMBL) Alternative ID(s) of Target Chain 34	BindingDB Target Chain Sequence 35	PDB ID(s) of Target Chain 35	UniProt (SwissProt) Recommended Name of Target Chain 35	UniProt (SwissProt) Entry Name of Target Chain 35	UniProt (SwissProt) Primary ID of Target Chain 35	UniProt (SwissProt) Secondary ID(s) of Target Chain 35	UniProt (SwissProt) Alternative ID(s) of Target Chain 35	UniProt (TrEMBL) Submitted Name of Target Chain 35	UniProt (TrEMBL) Entry Name of Target Chain 35	UniProt (TrEMBL) Primary ID of Target Chain 35	UniProt (TrEMBL) Secondary ID(s) of Target Chain 35	UniProt (TrEMBL) Alternative ID(s) of Target Chain 35	BindingDB Target Chain Sequence 36	PDB ID(s) of Target Chain 36	UniProt (SwissProt) Recommended Name of Target Chain 36	UniProt (SwissProt) Entry Name of Target Chain 36	UniProt (SwissProt) Primary ID of Target Chain 36	UniProt (SwissProt) Secondary ID(s) of Target Chain 36	UniProt (SwissProt) Alternative ID(s) of Target Chain 36	UniProt (TrEMBL) Submitted Name of Target Chain 36	UniProt (TrEMBL) Entry Name of Target Chain 36	UniProt (TrEMBL) Primary ID of Target Chain 36	UniProt (TrEMBL) Secondary ID(s) of Target Chain 36	UniProt (TrEMBL) Alternative ID(s) of Target Chain 36	BindingDB Target Chain Sequence 37	PDB ID(s) of Target Chain 37	UniProt (SwissProt) Recommended Name of Target Chain 37	UniProt (SwissProt) Entry Name of Target Chain 37	UniProt (SwissProt) Primary ID of Target Chain 37	UniProt (SwissProt) Secondary ID(s) of Target Chain 37	UniProt (SwissProt) Alternative ID(s) of Target Chain 37	UniProt (TrEMBL) Submitted Name of Target Chain 37	UniProt (TrEMBL) Entry Name of Target Chain 37	UniProt (TrEMBL) Primary ID of Target Chain 37	UniProt (TrEMBL) Secondary ID(s) of Target Chain 37	UniProt (TrEMBL) Alternative ID(s) of Target Chain 37	BindingDB Target Chain Sequence 38	PDB ID(s) of Target Chain 38	UniProt (SwissProt) Recommended Name of Target Chain 38	UniProt (SwissProt) Entry Name of Target Chain 38	UniProt (SwissProt) Primary ID of Target Chain 38	UniProt (SwissProt) Secondary ID(s) of Target Chain 38	UniProt (SwissProt) Alternative ID(s) of Target Chain 38	UniProt (TrEMBL) Submitted Name of Target Chain 38	UniProt (TrEMBL) Entry Name of Target Chain 38	UniProt (TrEMBL) Primary ID of Target Chain 38	UniProt (TrEMBL) Secondary ID(s) of Target Chain 38	UniProt (TrEMBL) Alternative ID(s) of Target Chain 38	BindingDB Target Chain Sequence 39	PDB ID(s) of Target Chain 39	UniProt (SwissProt) Recommended Name of Target Chain 39	UniProt (SwissProt) Entry Name of Target Chain 39	UniProt (SwissProt) Primary ID of Target Chain 39	UniProt (SwissProt) Secondary ID(s) of Target Chain 39	UniProt (SwissProt) Alternative ID(s) of Target Chain 39	UniProt (TrEMBL) Submitted Name of Target Chain 39	UniProt (TrEMBL) Entry Name of Target Chain 39	UniProt (TrEMBL) Primary ID of Target Chain 39	UniProt (TrEMBL) Secondary ID(s) of Target Chain 39	UniProt (TrEMBL) Alternative ID(s) of Target Chain 39	BindingDB Target Chain Sequence 40	PDB ID(s) of Target Chain 40	UniProt (SwissProt) Recommended Name of Target Chain 40	UniProt (SwissProt) Entry Name of Target Chain 40	UniProt (SwissProt) Primary ID of Target Chain 40	UniProt (SwissProt) Secondary ID(s) of Target Chain 40	UniProt (SwissProt) Alternative ID(s) of Target Chain 40	UniProt (TrEMBL) Submitted Name of Target Chain 40	UniProt (TrEMBL) Entry Name of Target Chain 40	UniProt (TrEMBL) Primary ID of Target Chain 40	UniProt (TrEMBL) Secondary ID(s) of Target Chain 40	UniProt (TrEMBL) Alternative ID(s) of Target Chain 40	BindingDB Target Chain Sequence 41	PDB ID(s) of Target Chain 41	UniProt (SwissProt) Recommended Name of Target Chain 41	UniProt (SwissProt) Entry Name of Target Chain 41	UniProt (SwissProt) Primary ID of Target Chain 41	UniProt (SwissProt) Secondary ID(s) of Target Chain 41	UniProt (SwissProt) Alternative ID(s) of Target Chain 41	UniProt (TrEMBL) Submitted Name of Target Chain 41	UniProt (TrEMBL) Entry Name of Target Chain 41	UniProt (TrEMBL) Primary ID of Target Chain 41	UniProt (TrEMBL) Secondary ID(s) of Target Chain 41	UniProt (TrEMBL) Alternative ID(s) of Target Chain 41	BindingDB Target Chain Sequence 42	PDB ID(s) of Target Chain 42	UniProt (SwissProt) Recommended Name of Target Chain 42	UniProt (SwissProt) Entry Name of Target Chain 42	UniProt (SwissProt) Primary ID of Target Chain 42	UniProt (SwissProt) Secondary ID(s) of Target Chain 42	UniProt (SwissProt) Alternative ID(s) of Target Chain 42	UniProt (TrEMBL) Submitted Name of Target Chain 42	UniProt (TrEMBL) Entry Name of Target Chain 42	UniProt (TrEMBL) Primary ID of Target Chain 42	UniProt (TrEMBL) Secondary ID(s) of Target Chain 42	UniProt (TrEMBL) Alternative ID(s) of Target Chain 42	BindingDB Target Chain Sequence 43	PDB ID(s) of Target Chain 43	UniProt (SwissProt) Recommended Name of Target Chain 43	UniProt (SwissProt) Entry Name of Target Chain 43	UniProt (SwissProt) Primary ID of Target Chain 43	UniProt (SwissProt) Secondary ID(s) of Target Chain 43	UniProt (SwissProt) Alternative ID(s) of Target Chain 43	UniProt (TrEMBL) Submitted Name of Target Chain 43	UniProt (TrEMBL) Entry Name of Target Chain 43	UniProt (TrEMBL) Primary ID of Target Chain 43	UniProt (TrEMBL) Secondary ID(s) of Target Chain 43	UniProt (TrEMBL) Alternative ID(s) of Target Chain 43	BindingDB Target Chain Sequence 44	PDB ID(s) of Target Chain 44	UniProt (SwissProt) Recommended Name of Target Chain 44	UniProt (SwissProt) Entry Name of Target Chain 44	UniProt (SwissProt) Primary ID of Target Chain 44	UniProt (SwissProt) Secondary ID(s) of Target Chain 44	UniProt (SwissProt) Alternative ID(s) of Target Chain 44	UniProt (TrEMBL) Submitted Name of Target Chain 44	UniProt (TrEMBL) Entry Name of Target Chain 44	UniProt (TrEMBL) Primary ID of Target Chain 44	UniProt (TrEMBL) Secondary ID(s) of Target Chain 44	UniProt (TrEMBL) Alternative ID(s) of Target Chain 44	BindingDB Target Chain Sequence 45	PDB ID(s) of Target Chain 45	UniProt (SwissProt) Recommended Name of Target Chain 45	UniProt (SwissProt) Entry Name of Target Chain 45	UniProt (SwissProt) Primary ID of Target Chain 45	UniProt (SwissProt) Secondary ID(s) of Target Chain 45	UniProt (SwissProt) Alternative ID(s) of Target Chain 45	UniProt (TrEMBL) Submitted Name of Target Chain 45	UniProt (TrEMBL) Entry Name of Target Chain 45	UniProt (TrEMBL) Primary ID of Target Chain 45	UniProt (TrEMBL) Secondary ID(s) of Target Chain 45	UniProt (TrEMBL) Alternative ID(s) of Target Chain 45	BindingDB Target Chain Sequence 46	PDB ID(s) of Target Chain 46	UniProt (SwissProt) Recommended Name of Target Chain 46	UniProt (SwissProt) Entry Name of Target Chain 46	UniProt (SwissProt) Primary ID of Target Chain 46	UniProt (SwissProt) Secondary ID(s) of Target Chain 46	UniProt (SwissProt) Alternative ID(s) of Target Chain 46	UniProt (TrEMBL) Submitted Name of Target Chain 46	UniProt (TrEMBL) Entry Name of Target Chain 46	UniProt (TrEMBL) Primary ID of Target Chain 46	UniProt (TrEMBL) Secondary ID(s) of Target Chain 46	UniProt (TrEMBL) Alternative ID(s) of Target Chain 46	BindingDB Target Chain Sequence 47	PDB ID(s) of Target Chain 47	UniProt (SwissProt) Recommended Name of Target Chain 47	UniProt (SwissProt) Entry Name of Target Chain 47	UniProt (SwissProt) Primary ID of Target Chain 47	UniProt (SwissProt) Secondary ID(s) of Target Chain 47	UniProt (SwissProt) Alternative ID(s) of Target Chain 47	UniProt (TrEMBL) Submitted Name of Target Chain 47	UniProt (TrEMBL) Entry Name of Target Chain 47	UniProt (TrEMBL) Primary ID of Target Chain 47	UniProt (TrEMBL) Secondary ID(s) of Target Chain 47	UniProt (TrEMBL) Alternative ID(s) of Target Chain 47	BindingDB Target Chain Sequence 48	PDB ID(s) of Target Chain 48	UniProt (SwissProt) Recommended Name of Target Chain 48	UniProt (SwissProt) Entry Name of Target Chain 48	UniProt (SwissProt) Primary ID of Target Chain 48	UniProt (SwissProt) Secondary ID(s) of Target Chain 48	UniProt (SwissProt) Alternative ID(s) of Target Chain 48	UniProt (TrEMBL) Submitted Name of Target Chain 48	UniProt (TrEMBL) Entry Name of Target Chain 48	UniProt (TrEMBL) Primary ID of Target Chain 48	UniProt (TrEMBL) Secondary ID(s) of Target Chain 48	UniProt (TrEMBL) Alternative ID(s) of Target Chain 48	BindingDB Target Chain Sequence 49	PDB ID(s) of Target Chain 49	UniProt (SwissProt) Recommended Name of Target Chain 49	UniProt (SwissProt) Entry Name of Target Chain 49	UniProt (SwissProt) Primary ID of Target Chain 49	UniProt (SwissProt) Secondary ID(s) of Target Chain 49	UniProt (SwissProt) Alternative ID(s) of Target Chain 49	UniProt (TrEMBL) Submitted Name of Target Chain 49	UniProt (TrEMBL) Entry Name of Target Chain 49	UniProt (TrEMBL) Primary ID of Target Chain 49	UniProt (TrEMBL) Secondary ID(s) of Target Chain 49	UniProt (TrEMBL) Alternative ID(s) of Target Chain 49	BindingDB Target Chain Sequence 50	PDB ID(s) of Target Chain 50	UniProt (SwissProt) Recommended Name of Target Chain 50	UniProt (SwissProt) Entry Name of Target Chain 50	UniProt (SwissProt) Primary ID of Target Chain 50	UniProt (SwissProt) Secondary ID(s) of Target Chain 50	UniProt (SwissProt) Alternative ID(s) of Target Chain 50	UniProt (TrEMBL) Submitted Name of Target Chain 50	UniProt (TrEMBL) Entry Name of Target Chain 50	UniProt (TrEMBL) Primary ID of Target Chain 50	UniProt (TrEMBL) Secondary ID(s) of Target Chain 50	UniProt (TrEMBL) Alternative ID(s) of Target Chain 50
913478	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H13ClN4O/c17-12-6-4-11(5-7-12)15-14(16(22)20-9-2-10-20)19-13-3-1-8-18-21(13)15/h1,3-8H,2,9-10H2	OUXBYUBGWJQGHZ-UHFFFAOYSA-N	285528	Azetidin-1-yl[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone (1)::US10077269, Example 1::US10669279, Example 1	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 38.6							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285528	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285528&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118863076	378169167							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913479	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H13ClN4O/c17-12-6-4-11(5-7-12)15-14(16(22)20-9-2-10-20)19-13-3-1-8-18-21(13)15/h1,3-8H,2,9-10H2	OUXBYUBGWJQGHZ-UHFFFAOYSA-N	285528	Azetidin-1-yl[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone (1)::US10077269, Example 1::US10669279, Example 1	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 35.5							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285528	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285528&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118863076	378169167							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913480	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H13ClN4O/c17-12-6-4-11(5-7-12)15-14(16(22)20-9-2-10-20)19-13-3-1-8-18-21(13)15/h1,3-8H,2,9-10H2	OUXBYUBGWJQGHZ-UHFFFAOYSA-N	285528	Azetidin-1-yl[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone (1)::US10077269, Example 1::US10669279, Example 1	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 130							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285528	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285528&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118863076	378169167							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913481	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H13ClN4O/c17-12-6-4-11(5-7-12)15-14(16(22)20-9-2-10-20)19-13-3-1-8-18-21(13)15/h1,3-8H,2,9-10H2	OUXBYUBGWJQGHZ-UHFFFAOYSA-N	285528	Azetidin-1-yl[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone (1)::US10077269, Example 1::US10669279, Example 1	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 10300							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285528	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285528&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118863076	378169167							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913482	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H13ClN4O/c17-11-5-3-10(4-6-11)15-14(16(22)19-12-7-8-12)20-13-2-1-9-18-21(13)15/h1-6,9,12H,7-8H2,(H,19,22)	YOCIPGYKDZCTFU-UHFFFAOYSA-N	285529	3-(4-Chlorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide (2)::US10077269, Example 2::US10669279, Example 2::US9598421, Example 2	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 10.7							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285529	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285529&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118863067	378169168							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913483	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H13ClN4O/c17-11-5-3-10(4-6-11)15-14(16(22)19-12-7-8-12)20-13-2-1-9-18-21(13)15/h1-6,9,12H,7-8H2,(H,19,22)	YOCIPGYKDZCTFU-UHFFFAOYSA-N	285529	3-(4-Chlorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide (2)::US10077269, Example 2::US10669279, Example 2::US9598421, Example 2	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 17.7							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285529	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285529&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118863067	378169168							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913484	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H13ClN4O/c17-11-5-3-10(4-6-11)15-14(16(22)19-12-7-8-12)20-13-2-1-9-18-21(13)15/h1-6,9,12H,7-8H2,(H,19,22)	YOCIPGYKDZCTFU-UHFFFAOYSA-N	285529	3-(4-Chlorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide (2)::US10077269, Example 2::US10669279, Example 2::US9598421, Example 2	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 27.9							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285529	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285529&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118863067	378169168							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913485	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H13ClN4O/c17-11-5-3-10(4-6-11)15-14(16(22)19-12-7-8-12)20-13-2-1-9-18-21(13)15/h1-6,9,12H,7-8H2,(H,19,22)	YOCIPGYKDZCTFU-UHFFFAOYSA-N	285529	3-(4-Chlorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide (2)::US10077269, Example 2::US10669279, Example 2::US9598421, Example 2	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 4340							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285529	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285529&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118863067	378169168							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913486	COc1c(F)cc(cc1F)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H14F2N4O2/c1-25-16-11(18)8-10(9-12(16)19)15-14(17(24)22-6-3-7-22)21-13-4-2-5-20-23(13)15/h2,4-5,8-9H,3,6-7H2,1H3	SCHCQOLPISHKOS-UHFFFAOYSA-N	285530	Azetidin-1-yl[3-(3,5-difluoro-4-methoxyphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone (3)::US10077269, Example 3::US10669279, Example 3::US9598421, Example 3	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 12.7							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285530	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285530&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118863063	378169169							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913487	COc1c(F)cc(cc1F)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H14F2N4O2/c1-25-16-11(18)8-10(9-12(16)19)15-14(17(24)22-6-3-7-22)21-13-4-2-5-20-23(13)15/h2,4-5,8-9H,3,6-7H2,1H3	SCHCQOLPISHKOS-UHFFFAOYSA-N	285530	Azetidin-1-yl[3-(3,5-difluoro-4-methoxyphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone (3)::US10077269, Example 3::US10669279, Example 3::US9598421, Example 3	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 29.1							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285530	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285530&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118863063	378169169							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913488	COc1c(F)cc(cc1F)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H14F2N4O2/c1-25-16-11(18)8-10(9-12(16)19)15-14(17(24)22-6-3-7-22)21-13-4-2-5-20-23(13)15/h2,4-5,8-9H,3,6-7H2,1H3	SCHCQOLPISHKOS-UHFFFAOYSA-N	285530	Azetidin-1-yl[3-(3,5-difluoro-4-methoxyphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone (3)::US10077269, Example 3::US10669279, Example 3::US9598421, Example 3	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 51.9							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285530	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285530&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118863063	378169169							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913489	COc1c(F)cc(cc1F)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H14F2N4O2/c1-25-16-11(18)8-10(9-12(16)19)15-14(17(24)22-6-3-7-22)21-13-4-2-5-20-23(13)15/h2,4-5,8-9H,3,6-7H2,1H3	SCHCQOLPISHKOS-UHFFFAOYSA-N	285530	Azetidin-1-yl[3-(3,5-difluoro-4-methoxyphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone (3)::US10077269, Example 3::US10669279, Example 3::US9598421, Example 3	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 2410							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285530	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285530&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118863063	378169169							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913490	COc1ncc(cn1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C15H14N6O2/c1-23-15-16-7-9(8-17-15)13-12(14(22)19-10-4-5-10)20-11-3-2-6-18-21(11)13/h2-3,6-8,10H,4-5H2,1H3,(H,19,22)	SDZFOFNADNADKA-UHFFFAOYSA-N	285531	N-Cyclopropyl-3-(2-methoxypyrimidin-5-yl)imidazo[1,2-b]pyridazine-2-carboxamide (4)::US10077269, Example 4::US10669279, Example 4	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 187							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285531	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285531&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118863072	378169170							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913491	COc1ncc(cn1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C15H14N6O2/c1-23-15-16-7-9(8-17-15)13-12(14(22)19-10-4-5-10)20-11-3-2-6-18-21(11)13/h2-3,6-8,10H,4-5H2,1H3,(H,19,22)	SDZFOFNADNADKA-UHFFFAOYSA-N	285531	N-Cyclopropyl-3-(2-methoxypyrimidin-5-yl)imidazo[1,2-b]pyridazine-2-carboxamide (4)::US10077269, Example 4::US10669279, Example 4	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 380							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285531	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285531&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118863072	378169170							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913492	COc1ncc(cn1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C15H14N6O2/c1-23-15-16-7-9(8-17-15)13-12(14(22)19-10-4-5-10)20-11-3-2-6-18-21(11)13/h2-3,6-8,10H,4-5H2,1H3,(H,19,22)	SDZFOFNADNADKA-UHFFFAOYSA-N	285531	N-Cyclopropyl-3-(2-methoxypyrimidin-5-yl)imidazo[1,2-b]pyridazine-2-carboxamide (4)::US10077269, Example 4::US10669279, Example 4	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 561							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285531	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285531&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118863072	378169170							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913493	COc1ncc(cn1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C15H14N6O2/c1-23-15-16-7-9(8-17-15)13-12(14(22)19-10-4-5-10)20-11-3-2-6-18-21(11)13/h2-3,6-8,10H,4-5H2,1H3,(H,19,22)	SDZFOFNADNADKA-UHFFFAOYSA-N	285531	N-Cyclopropyl-3-(2-methoxypyrimidin-5-yl)imidazo[1,2-b]pyridazine-2-carboxamide (4)::US10077269, Example 4::US10669279, Example 4	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		>27100							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285531	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285531&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118863072	378169170							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913494	O=C(NC1CC1)c1nc2cccnn2c1-c1ccc(nc1)C#N	InChI=1S/C16H12N6O/c17-8-12-4-3-10(9-18-12)15-14(16(23)20-11-5-6-11)21-13-2-1-7-19-22(13)15/h1-4,7,9,11H,5-6H2,(H,20,23)	YDADFGXXCHDXFC-UHFFFAOYSA-N	285532	3-(6-Cyanopyridin-3-yl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide (5)::US10077269, Example 5::US10669279, Example 5::US9598421, Example 5	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 40.2							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285532	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285532&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118863059	378169171							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913495	O=C(NC1CC1)c1nc2cccnn2c1-c1ccc(nc1)C#N	InChI=1S/C16H12N6O/c17-8-12-4-3-10(9-18-12)15-14(16(23)20-11-5-6-11)21-13-2-1-7-19-22(13)15/h1-4,7,9,11H,5-6H2,(H,20,23)	YDADFGXXCHDXFC-UHFFFAOYSA-N	285532	3-(6-Cyanopyridin-3-yl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide (5)::US10077269, Example 5::US10669279, Example 5::US9598421, Example 5	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 89.5							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285532	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285532&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118863059	378169171							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913496	O=C(NC1CC1)c1nc2cccnn2c1-c1ccc(nc1)C#N	InChI=1S/C16H12N6O/c17-8-12-4-3-10(9-18-12)15-14(16(23)20-11-5-6-11)21-13-2-1-7-19-22(13)15/h1-4,7,9,11H,5-6H2,(H,20,23)	YDADFGXXCHDXFC-UHFFFAOYSA-N	285532	3-(6-Cyanopyridin-3-yl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide (5)::US10077269, Example 5::US10669279, Example 5::US9598421, Example 5	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 208							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285532	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285532&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118863059	378169171							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913497	O=C(NC1CC1)c1nc2cccnn2c1-c1ccc(nc1)C#N	InChI=1S/C16H12N6O/c17-8-12-4-3-10(9-18-12)15-14(16(23)20-11-5-6-11)21-13-2-1-7-19-22(13)15/h1-4,7,9,11H,5-6H2,(H,20,23)	YDADFGXXCHDXFC-UHFFFAOYSA-N	285532	3-(6-Cyanopyridin-3-yl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide (5)::US10077269, Example 5::US10669279, Example 5::US9598421, Example 5	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		>26600							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285532	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285532&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118863059	378169171							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913498	O=C(NC1CC1)c1nc2cccnn2c1-c1ccc2ncnn2c1	InChI=1S/C16H13N7O/c24-16(20-11-4-5-11)14-15(23-13(21-14)2-1-7-18-23)10-3-6-12-17-9-19-22(12)8-10/h1-3,6-9,11H,4-5H2,(H,20,24)	KZFDLYSKEWBCTB-UHFFFAOYSA-N	285533	N-Cyclopropyl-3-([1,2,4]triazolo[1,5-a]pyridin-6-yl)imidazo[1,2-b]pyridazine-2-carboxamide (6)::US10077269, Example 6::US10669279, Example 6::US9598421, Example 6	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 64.4							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285533	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285533&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118863057	378169172							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913499	O=C(NC1CC1)c1nc2cccnn2c1-c1ccc2ncnn2c1	InChI=1S/C16H13N7O/c24-16(20-11-4-5-11)14-15(23-13(21-14)2-1-7-18-23)10-3-6-12-17-9-19-22(12)8-10/h1-3,6-9,11H,4-5H2,(H,20,24)	KZFDLYSKEWBCTB-UHFFFAOYSA-N	285533	N-Cyclopropyl-3-([1,2,4]triazolo[1,5-a]pyridin-6-yl)imidazo[1,2-b]pyridazine-2-carboxamide (6)::US10077269, Example 6::US10669279, Example 6::US9598421, Example 6	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 49.3							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285533	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285533&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118863057	378169172							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913500	O=C(NC1CC1)c1nc2cccnn2c1-c1ccc2ncnn2c1	InChI=1S/C16H13N7O/c24-16(20-11-4-5-11)14-15(23-13(21-14)2-1-7-18-23)10-3-6-12-17-9-19-22(12)8-10/h1-3,6-9,11H,4-5H2,(H,20,24)	KZFDLYSKEWBCTB-UHFFFAOYSA-N	285533	N-Cyclopropyl-3-([1,2,4]triazolo[1,5-a]pyridin-6-yl)imidazo[1,2-b]pyridazine-2-carboxamide (6)::US10077269, Example 6::US10669279, Example 6::US9598421, Example 6	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 326							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285533	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285533&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118863057	378169172							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913501	O=C(NC1CC1)c1nc2cccnn2c1-c1ccc2ncnn2c1	InChI=1S/C16H13N7O/c24-16(20-11-4-5-11)14-15(23-13(21-14)2-1-7-18-23)10-3-6-12-17-9-19-22(12)8-10/h1-3,6-9,11H,4-5H2,(H,20,24)	KZFDLYSKEWBCTB-UHFFFAOYSA-N	285533	N-Cyclopropyl-3-([1,2,4]triazolo[1,5-a]pyridin-6-yl)imidazo[1,2-b]pyridazine-2-carboxamide (6)::US10077269, Example 6::US10669279, Example 6::US9598421, Example 6	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 4890							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285533	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285533&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118863057	378169172							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913502	Cn1cc(NC(=O)c2nc3cccnn3c2-c2ccc(Cl)c(F)c2)cn1	InChI=1S/C17H12ClFN6O/c1-24-9-11(8-21-24)22-17(26)15-16(10-4-5-12(18)13(19)7-10)25-14(23-15)3-2-6-20-25/h2-9H,1H3,(H,22,26)	LSCITVBMOOTYOS-UHFFFAOYSA-N	285534	3-(4-Chloro-3-fluorophenyl)-N-(1-methyl-1H-pyrazol-4-yl)imidazo[1,2-b]pyridazine-2-carboxamide (7)::US10077269, Example 7::US10669279, Example 7::US9598421, Example 7	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 2.77							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285534	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285534&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118863065	378169173							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913503	Cn1cc(NC(=O)c2nc3cccnn3c2-c2ccc(Cl)c(F)c2)cn1	InChI=1S/C17H12ClFN6O/c1-24-9-11(8-21-24)22-17(26)15-16(10-4-5-12(18)13(19)7-10)25-14(23-15)3-2-6-20-25/h2-9H,1H3,(H,22,26)	LSCITVBMOOTYOS-UHFFFAOYSA-N	285534	3-(4-Chloro-3-fluorophenyl)-N-(1-methyl-1H-pyrazol-4-yl)imidazo[1,2-b]pyridazine-2-carboxamide (7)::US10077269, Example 7::US10669279, Example 7::US9598421, Example 7	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		<1.89							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285534	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285534&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118863065	378169173							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913504	Cn1cc(NC(=O)c2nc3cccnn3c2-c2ccc(Cl)c(F)c2)cn1	InChI=1S/C17H12ClFN6O/c1-24-9-11(8-21-24)22-17(26)15-16(10-4-5-12(18)13(19)7-10)25-14(23-15)3-2-6-20-25/h2-9H,1H3,(H,22,26)	LSCITVBMOOTYOS-UHFFFAOYSA-N	285534	3-(4-Chloro-3-fluorophenyl)-N-(1-methyl-1H-pyrazol-4-yl)imidazo[1,2-b]pyridazine-2-carboxamide (7)::US10077269, Example 7::US10669279, Example 7::US9598421, Example 7	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 2.35							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285534	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285534&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118863065	378169173							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913505	Cn1cc(NC(=O)c2nc3cccnn3c2-c2ccc(Cl)c(F)c2)cn1	InChI=1S/C17H12ClFN6O/c1-24-9-11(8-21-24)22-17(26)15-16(10-4-5-12(18)13(19)7-10)25-14(23-15)3-2-6-20-25/h2-9H,1H3,(H,22,26)	LSCITVBMOOTYOS-UHFFFAOYSA-N	285534	3-(4-Chloro-3-fluorophenyl)-N-(1-methyl-1H-pyrazol-4-yl)imidazo[1,2-b]pyridazine-2-carboxamide (7)::US10077269, Example 7::US10669279, Example 7::US9598421, Example 7	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 34.5							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285534	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285534&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118863065	378169173							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913506	O=C(N1CCC1)c1nc2cccnn2c1-c1ccc2ccnn2c1	InChI=1S/C17H14N6O/c24-17(21-9-2-10-21)15-16(23-14(20-15)3-1-7-19-23)12-4-5-13-6-8-18-22(13)11-12/h1,3-8,11H,2,9-10H2	AAWHVDHSXWEWJR-UHFFFAOYSA-N	285535	Azetidin-1-yl[3-(pyrazolo[1,5-a]pyridin-6-yl)imidazo[1,2-b]pyridazin-2-yl]methanone (8)::US10077269, Example 8::US10669279, Example 8	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 20.0							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285535	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285535&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118863058	378169174							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913507	O=C(N1CCC1)c1nc2cccnn2c1-c1ccc2ccnn2c1	InChI=1S/C17H14N6O/c24-17(21-9-2-10-21)15-16(23-14(20-15)3-1-7-19-23)12-4-5-13-6-8-18-22(13)11-12/h1,3-8,11H,2,9-10H2	AAWHVDHSXWEWJR-UHFFFAOYSA-N	285535	Azetidin-1-yl[3-(pyrazolo[1,5-a]pyridin-6-yl)imidazo[1,2-b]pyridazin-2-yl]methanone (8)::US10077269, Example 8::US10669279, Example 8	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 41.3							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285535	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285535&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118863058	378169174							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913508	O=C(N1CCC1)c1nc2cccnn2c1-c1ccc2ccnn2c1	InChI=1S/C17H14N6O/c24-17(21-9-2-10-21)15-16(23-14(20-15)3-1-7-19-23)12-4-5-13-6-8-18-22(13)11-12/h1,3-8,11H,2,9-10H2	AAWHVDHSXWEWJR-UHFFFAOYSA-N	285535	Azetidin-1-yl[3-(pyrazolo[1,5-a]pyridin-6-yl)imidazo[1,2-b]pyridazin-2-yl]methanone (8)::US10077269, Example 8::US10669279, Example 8	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 64.9							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285535	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285535&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118863058	378169174							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913509	O=C(N1CCC1)c1nc2cccnn2c1-c1ccc2ccnn2c1	InChI=1S/C17H14N6O/c24-17(21-9-2-10-21)15-16(23-14(20-15)3-1-7-19-23)12-4-5-13-6-8-18-22(13)11-12/h1,3-8,11H,2,9-10H2	AAWHVDHSXWEWJR-UHFFFAOYSA-N	285535	Azetidin-1-yl[3-(pyrazolo[1,5-a]pyridin-6-yl)imidazo[1,2-b]pyridazin-2-yl]methanone (8)::US10077269, Example 8::US10669279, Example 8	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 5440							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285535	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285535&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118863058	378169174							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913510	Fc1cc(-c2c(nc3cccnn23)C(=O)NC2CC2)c(F)cc1Cl	InChI=1S/C16H11ClF2N4O/c17-10-7-11(18)9(6-12(10)19)15-14(16(24)21-8-3-4-8)22-13-2-1-5-20-23(13)15/h1-2,5-8H,3-4H2,(H,21,24)	IJGCWHSMOTWWLO-UHFFFAOYSA-N	285536	3-(4-Chloro-2,5-difluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide (9)::US10077269, Example 9::US10669279, Example 9::US9598421, Example 9	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 3.83							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285536	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285536&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118863077	378169175							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913511	Fc1cc(-c2c(nc3cccnn23)C(=O)NC2CC2)c(F)cc1Cl	InChI=1S/C16H11ClF2N4O/c17-10-7-11(18)9(6-12(10)19)15-14(16(24)21-8-3-4-8)22-13-2-1-5-20-23(13)15/h1-2,5-8H,3-4H2,(H,21,24)	IJGCWHSMOTWWLO-UHFFFAOYSA-N	285536	3-(4-Chloro-2,5-difluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide (9)::US10077269, Example 9::US10669279, Example 9::US9598421, Example 9	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 10.5							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285536	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285536&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118863077	378169175							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913512	Fc1cc(-c2c(nc3cccnn23)C(=O)NC2CC2)c(F)cc1Cl	InChI=1S/C16H11ClF2N4O/c17-10-7-11(18)9(6-12(10)19)15-14(16(24)21-8-3-4-8)22-13-2-1-5-20-23(13)15/h1-2,5-8H,3-4H2,(H,21,24)	IJGCWHSMOTWWLO-UHFFFAOYSA-N	285536	3-(4-Chloro-2,5-difluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide (9)::US10077269, Example 9::US10669279, Example 9::US9598421, Example 9	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 40.9							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285536	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285536&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118863077	378169175							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913513	Fc1cc(-c2c(nc3cccnn23)C(=O)NC2CC2)c(F)cc1Cl	InChI=1S/C16H11ClF2N4O/c17-10-7-11(18)9(6-12(10)19)15-14(16(24)21-8-3-4-8)22-13-2-1-5-20-23(13)15/h1-2,5-8H,3-4H2,(H,21,24)	IJGCWHSMOTWWLO-UHFFFAOYSA-N	285536	3-(4-Chloro-2,5-difluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide (9)::US10077269, Example 9::US10669279, Example 9::US9598421, Example 9	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 1490							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285536	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285536&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118863077	378169175							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913514	Fc1cc(ccc1Cl)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H12ClFN4O/c17-11-6-3-9(8-12(11)18)15-14(16(23)20-10-4-5-10)21-13-2-1-7-19-22(13)15/h1-3,6-8,10H,4-5H2,(H,20,23)	VPDYRGHPOFWFHI-UHFFFAOYSA-N	285537	3-(4-chloro-3-fluoro-phenyl)-N-cyclopropyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 10::US10669279, Example 10::US9598421, Example 10	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 1.51							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285537	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285537&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118875363	378169176							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913515	Fc1cc(ccc1Cl)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H12ClFN4O/c17-11-6-3-9(8-12(11)18)15-14(16(23)20-10-4-5-10)21-13-2-1-7-19-22(13)15/h1-3,6-8,10H,4-5H2,(H,20,23)	VPDYRGHPOFWFHI-UHFFFAOYSA-N	285537	3-(4-chloro-3-fluoro-phenyl)-N-cyclopropyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 10::US10669279, Example 10::US9598421, Example 10	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 3.80							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285537	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285537&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875363	378169176							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913516	Fc1cc(ccc1Cl)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H12ClFN4O/c17-11-6-3-9(8-12(11)18)15-14(16(23)20-10-4-5-10)21-13-2-1-7-19-22(13)15/h1-3,6-8,10H,4-5H2,(H,20,23)	VPDYRGHPOFWFHI-UHFFFAOYSA-N	285537	3-(4-chloro-3-fluoro-phenyl)-N-cyclopropyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 10::US10669279, Example 10::US9598421, Example 10	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 6.84							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285537	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285537&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118875363	378169176							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913517	Fc1cc(ccc1Cl)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H12ClFN4O/c17-11-6-3-9(8-12(11)18)15-14(16(23)20-10-4-5-10)21-13-2-1-7-19-22(13)15/h1-3,6-8,10H,4-5H2,(H,20,23)	VPDYRGHPOFWFHI-UHFFFAOYSA-N	285537	3-(4-chloro-3-fluoro-phenyl)-N-cyclopropyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 10::US10669279, Example 10::US9598421, Example 10	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 590							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285537	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285537&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875363	378169176							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913518	Clc1ccc(cc1Cl)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H12Cl2N4O/c17-11-6-3-9(8-12(11)18)15-14(16(23)20-10-4-5-10)21-13-2-1-7-19-22(13)15/h1-3,6-8,10H,4-5H2,(H,20,23)	HJVCDCPLKNQXFO-UHFFFAOYSA-N	285538	N-cyclopropyl-3-(3,4-di-chlorophenyl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 11::US10669279, Example 11::US9598421, Example 11	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 1.60							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285538	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285538&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700151	378169177							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913519	Clc1ccc(cc1Cl)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H12Cl2N4O/c17-11-6-3-9(8-12(11)18)15-14(16(23)20-10-4-5-10)21-13-2-1-7-19-22(13)15/h1-3,6-8,10H,4-5H2,(H,20,23)	HJVCDCPLKNQXFO-UHFFFAOYSA-N	285538	N-cyclopropyl-3-(3,4-di-chlorophenyl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 11::US10669279, Example 11::US9598421, Example 11	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 334							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285538	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285538&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700151	378169177							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913520	Cc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C17H15ClN4O/c1-10-9-11(18)4-7-13(10)16-15(17(23)20-12-5-6-12)21-14-3-2-8-19-22(14)16/h2-4,7-9,12H,5-6H2,1H3,(H,20,23)	SRRULVNTICTTGE-UHFFFAOYSA-N	285539	3-(4-chloro-2-methyl-phenyl)-N-cyclopropyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 12::US10669279, Example 12::US9598421, Example 12	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 14.4							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285539	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285539&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118875408	378169178							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913521	Cc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C17H15ClN4O/c1-10-9-11(18)4-7-13(10)16-15(17(23)20-12-5-6-12)21-14-3-2-8-19-22(14)16/h2-4,7-9,12H,5-6H2,1H3,(H,20,23)	SRRULVNTICTTGE-UHFFFAOYSA-N	285539	3-(4-chloro-2-methyl-phenyl)-N-cyclopropyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 12::US10669279, Example 12::US9598421, Example 12	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 35.8							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285539	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285539&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875408	378169178							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913522	Cc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C17H15ClN4O/c1-10-9-11(18)4-7-13(10)16-15(17(23)20-12-5-6-12)21-14-3-2-8-19-22(14)16/h2-4,7-9,12H,5-6H2,1H3,(H,20,23)	SRRULVNTICTTGE-UHFFFAOYSA-N	285539	3-(4-chloro-2-methyl-phenyl)-N-cyclopropyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 12::US10669279, Example 12::US9598421, Example 12	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 89.6							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285539	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285539&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118875408	378169178							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913523	Cc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C17H15ClN4O/c1-10-9-11(18)4-7-13(10)16-15(17(23)20-12-5-6-12)21-14-3-2-8-19-22(14)16/h2-4,7-9,12H,5-6H2,1H3,(H,20,23)	SRRULVNTICTTGE-UHFFFAOYSA-N	285539	3-(4-chloro-2-methyl-phenyl)-N-cyclopropyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 12::US10669279, Example 12::US9598421, Example 12	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 5220							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285539	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285539&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875408	378169178							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913524	Fc1cc(ccc1Cl)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H12ClFN4O/c17-11-5-4-10(9-12(11)18)15-14(16(23)21-7-2-8-21)20-13-3-1-6-19-22(13)15/h1,3-6,9H,2,7-8H2	IVSBLXFZMFGIAK-UHFFFAOYSA-N	285540	US10077269, Example 13::US10669279, Example 13::US9598421, Example 13::azetidin-1-yl[3-(4-chloro-3-fluorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 5.13							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285540	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285540&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			126700157	378169179							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913525	Fc1cc(ccc1Cl)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H12ClFN4O/c17-11-5-4-10(9-12(11)18)15-14(16(23)21-7-2-8-21)20-13-3-1-6-19-22(13)15/h1,3-6,9H,2,7-8H2	IVSBLXFZMFGIAK-UHFFFAOYSA-N	285540	US10077269, Example 13::US10669279, Example 13::US9598421, Example 13::azetidin-1-yl[3-(4-chloro-3-fluorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 4.63							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285540	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285540&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700157	378169179							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913526	Fc1cc(ccc1Cl)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H12ClFN4O/c17-11-5-4-10(9-12(11)18)15-14(16(23)21-7-2-8-21)20-13-3-1-6-19-22(13)15/h1,3-6,9H,2,7-8H2	IVSBLXFZMFGIAK-UHFFFAOYSA-N	285540	US10077269, Example 13::US10669279, Example 13::US9598421, Example 13::azetidin-1-yl[3-(4-chloro-3-fluorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 17.3							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285540	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285540&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			126700157	378169179							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913527	Fc1cc(ccc1Cl)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H12ClFN4O/c17-11-5-4-10(9-12(11)18)15-14(16(23)21-7-2-8-21)20-13-3-1-6-19-22(13)15/h1,3-6,9H,2,7-8H2	IVSBLXFZMFGIAK-UHFFFAOYSA-N	285540	US10077269, Example 13::US10669279, Example 13::US9598421, Example 13::azetidin-1-yl[3-(4-chloro-3-fluorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 669							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285540	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285540&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700157	378169179							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913528	Clc1cncc(c1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C15H12ClN5O/c16-10-6-9(7-17-8-10)14-13(15(22)19-11-3-4-11)20-12-2-1-5-18-21(12)14/h1-2,5-8,11H,3-4H2,(H,19,22)	BAWGMUZVOXOKPF-UHFFFAOYSA-N	285541	3-(5-chloropyridin-3-yl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 14::US10669279, Example 14::US9598421, Example 14	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 73.7							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285541	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285541&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			126700152	378169180							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913529	Clc1cncc(c1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C15H12ClN5O/c16-10-6-9(7-17-8-10)14-13(15(22)19-11-3-4-11)20-12-2-1-5-18-21(12)14/h1-2,5-8,11H,3-4H2,(H,19,22)	BAWGMUZVOXOKPF-UHFFFAOYSA-N	285541	3-(5-chloropyridin-3-yl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 14::US10669279, Example 14::US9598421, Example 14	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 79.1							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285541	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285541&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700152	378169180							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913530	Clc1cncc(c1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C15H12ClN5O/c16-10-6-9(7-17-8-10)14-13(15(22)19-11-3-4-11)20-12-2-1-5-18-21(12)14/h1-2,5-8,11H,3-4H2,(H,19,22)	BAWGMUZVOXOKPF-UHFFFAOYSA-N	285541	3-(5-chloropyridin-3-yl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 14::US10669279, Example 14::US9598421, Example 14	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 108							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285541	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285541&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			126700152	378169180							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913531	Clc1cncc(c1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C15H12ClN5O/c16-10-6-9(7-17-8-10)14-13(15(22)19-11-3-4-11)20-12-2-1-5-18-21(12)14/h1-2,5-8,11H,3-4H2,(H,19,22)	BAWGMUZVOXOKPF-UHFFFAOYSA-N	285541	3-(5-chloropyridin-3-yl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 14::US10669279, Example 14::US9598421, Example 14	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		>8010							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285541	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285541&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700152	378169180							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913532	Clc1cncc(c1)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C15H12ClN5O/c16-11-7-10(8-17-9-11)14-13(15(22)20-5-2-6-20)19-12-3-1-4-18-21(12)14/h1,3-4,7-9H,2,5-6H2	QELHEVBSVCAUHV-UHFFFAOYSA-N	285542	US10077269, Example 15::US10669279, Example 15::US9598421, Example 15::azetidin-1-yl[3-(5-chloro-pyridin-3-yl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 264							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285542	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285542&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			125474237	378169181							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913533	Clc1cncc(c1)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C15H12ClN5O/c16-11-7-10(8-17-9-11)14-13(15(22)20-5-2-6-20)19-12-3-1-4-18-21(12)14/h1,3-4,7-9H,2,5-6H2	QELHEVBSVCAUHV-UHFFFAOYSA-N	285542	US10077269, Example 15::US10669279, Example 15::US9598421, Example 15::azetidin-1-yl[3-(5-chloro-pyridin-3-yl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 252							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285542	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285542&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			125474237	378169181							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913534	Clc1cncc(c1)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C15H12ClN5O/c16-11-7-10(8-17-9-11)14-13(15(22)20-5-2-6-20)19-12-3-1-4-18-21(12)14/h1,3-4,7-9H,2,5-6H2	QELHEVBSVCAUHV-UHFFFAOYSA-N	285542	US10077269, Example 15::US10669279, Example 15::US9598421, Example 15::azetidin-1-yl[3-(5-chloro-pyridin-3-yl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 421							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285542	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285542&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			125474237	378169181							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913535	Clc1cncc(c1)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C15H12ClN5O/c16-11-7-10(8-17-9-11)14-13(15(22)20-5-2-6-20)19-12-3-1-4-18-21(12)14/h1,3-4,7-9H,2,5-6H2	QELHEVBSVCAUHV-UHFFFAOYSA-N	285542	US10077269, Example 15::US10669279, Example 15::US9598421, Example 15::azetidin-1-yl[3-(5-chloro-pyridin-3-yl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		>23700							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285542	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285542&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			125474237	378169181							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913536	O=C(N1CCC1)c1nc2cccnn2c1-c1ccc2ncnn2c1	InChI=1S/C16H13N7O/c24-16(21-7-2-8-21)14-15(23-13(20-14)3-1-6-18-23)11-4-5-12-17-10-19-22(12)9-11/h1,3-6,9-10H,2,7-8H2	WFFUVTXNYNORQT-UHFFFAOYSA-N	285543	US10077269, Example 16::US10669279, Example 16::US9598421, Example 16::azetidin-1-yl[3-([1,2,4]tri-azolo[1,5-a]pyridin-6-yl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 552							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285543	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285543&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875381	378169182							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913537	O=C(N1CCC1)c1nc2cccnn2c1-c1ccc2ncnn2c1	InChI=1S/C16H13N7O/c24-16(21-7-2-8-21)14-15(23-13(20-14)3-1-6-18-23)11-4-5-12-17-10-19-22(12)9-11/h1,3-6,9-10H,2,7-8H2	WFFUVTXNYNORQT-UHFFFAOYSA-N	285543	US10077269, Example 16::US10669279, Example 16::US9598421, Example 16::azetidin-1-yl[3-([1,2,4]tri-azolo[1,5-a]pyridin-6-yl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		>27500							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285543	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285543&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875381	378169182							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913538	Cc1cc(-c2c(nc3cccnn23)C(=O)NC2CC2)c(F)cc1C#N	InChI=1S/C18H14FN5O/c1-10-7-13(14(19)8-11(10)9-20)17-16(18(25)22-12-4-5-12)23-15-3-2-6-21-24(15)17/h2-3,6-8,12H,4-5H2,1H3,(H,22,25)	SAWDLJNAAJBRMX-UHFFFAOYSA-N	285544	3-(4-cyano-2-fluoro-5-methylphenyl)-N-cyclopropyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 17::US10669279, Example 17::US9598421, Example 17	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 89.9							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285544	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285544&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118875411	378169183							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913539	Cc1cc(-c2c(nc3cccnn23)C(=O)NC2CC2)c(F)cc1C#N	InChI=1S/C18H14FN5O/c1-10-7-13(14(19)8-11(10)9-20)17-16(18(25)22-12-4-5-12)23-15-3-2-6-21-24(15)17/h2-3,6-8,12H,4-5H2,1H3,(H,22,25)	SAWDLJNAAJBRMX-UHFFFAOYSA-N	285544	3-(4-cyano-2-fluoro-5-methylphenyl)-N-cyclopropyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 17::US10669279, Example 17::US9598421, Example 17	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 175							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285544	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285544&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875411	378169183							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913540	Cc1cc(-c2c(nc3cccnn23)C(=O)NC2CC2)c(F)cc1C#N	InChI=1S/C18H14FN5O/c1-10-7-13(14(19)8-11(10)9-20)17-16(18(25)22-12-4-5-12)23-15-3-2-6-21-24(15)17/h2-3,6-8,12H,4-5H2,1H3,(H,22,25)	SAWDLJNAAJBRMX-UHFFFAOYSA-N	285544	3-(4-cyano-2-fluoro-5-methylphenyl)-N-cyclopropyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 17::US10669279, Example 17::US9598421, Example 17	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 216							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285544	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285544&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118875411	378169183							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913541	Cc1cc(-c2c(nc3cccnn23)C(=O)NC2CC2)c(F)cc1C#N	InChI=1S/C18H14FN5O/c1-10-7-13(14(19)8-11(10)9-20)17-16(18(25)22-12-4-5-12)23-15-3-2-6-21-24(15)17/h2-3,6-8,12H,4-5H2,1H3,(H,22,25)	SAWDLJNAAJBRMX-UHFFFAOYSA-N	285544	3-(4-cyano-2-fluoro-5-methylphenyl)-N-cyclopropyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 17::US10669279, Example 17::US9598421, Example 17	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		>18200							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285544	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285544&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875411	378169183							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913542	Cc1cc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)cc1C#N	InChI=1S/C18H14FN5O/c1-11-8-13(14(19)9-12(11)10-20)17-16(18(25)23-6-3-7-23)22-15-4-2-5-21-24(15)17/h2,4-5,8-9H,3,6-7H2,1H3	GGBPMJVCUHMAJB-UHFFFAOYSA-N	285545	4-[2-(azetidin-1-ylcarbonyl)imidazo[1,2-b]pyridazin-3-yl]-5-fluoro-2-methylbenzonitrile::US10077269, Example 18::US10669279, Example 18::US9598421, Example 18	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 55.0							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285545	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285545&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			126700154	378169184							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913543	Cc1cc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)cc1C#N	InChI=1S/C18H14FN5O/c1-11-8-13(14(19)9-12(11)10-20)17-16(18(25)23-6-3-7-23)22-15-4-2-5-21-24(15)17/h2,4-5,8-9H,3,6-7H2,1H3	GGBPMJVCUHMAJB-UHFFFAOYSA-N	285545	4-[2-(azetidin-1-ylcarbonyl)imidazo[1,2-b]pyridazin-3-yl]-5-fluoro-2-methylbenzonitrile::US10077269, Example 18::US10669279, Example 18::US9598421, Example 18	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 150							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285545	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285545&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700154	378169184							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913544	Cc1cc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)cc1C#N	InChI=1S/C18H14FN5O/c1-11-8-13(14(19)9-12(11)10-20)17-16(18(25)23-6-3-7-23)22-15-4-2-5-21-24(15)17/h2,4-5,8-9H,3,6-7H2,1H3	GGBPMJVCUHMAJB-UHFFFAOYSA-N	285545	4-[2-(azetidin-1-ylcarbonyl)imidazo[1,2-b]pyridazin-3-yl]-5-fluoro-2-methylbenzonitrile::US10077269, Example 18::US10669279, Example 18::US9598421, Example 18	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 147							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285545	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285545&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			126700154	378169184							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913545	Cc1cc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)cc1C#N	InChI=1S/C18H14FN5O/c1-11-8-13(14(19)9-12(11)10-20)17-16(18(25)23-6-3-7-23)22-15-4-2-5-21-24(15)17/h2,4-5,8-9H,3,6-7H2,1H3	GGBPMJVCUHMAJB-UHFFFAOYSA-N	285545	4-[2-(azetidin-1-ylcarbonyl)imidazo[1,2-b]pyridazin-3-yl]-5-fluoro-2-methylbenzonitrile::US10077269, Example 18::US10669279, Example 18::US9598421, Example 18	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 8200							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285545	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285545&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700154	378169184							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913546	Cc1cc(C#N)c(F)cc1-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C18H14FN5O/c1-10-7-11(9-20)14(19)8-13(10)17-16(18(25)22-12-4-5-12)23-15-3-2-6-21-24(15)17/h2-3,6-8,12H,4-5H2,1H3,(H,22,25)	PMXQBXHVHKGVCD-UHFFFAOYSA-N	285546	3-(4-cyano-5-fluoro-2-methylphenyl)-N-cyclo-propylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 19::US10669279, Example 19::US9598421, Example 19	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 16.9							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285546	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285546&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118875364	378169185							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913547	Cc1cc(C#N)c(F)cc1-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C18H14FN5O/c1-10-7-11(9-20)14(19)8-13(10)17-16(18(25)22-12-4-5-12)23-15-3-2-6-21-24(15)17/h2-3,6-8,12H,4-5H2,1H3,(H,22,25)	PMXQBXHVHKGVCD-UHFFFAOYSA-N	285546	3-(4-cyano-5-fluoro-2-methylphenyl)-N-cyclo-propylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 19::US10669279, Example 19::US9598421, Example 19	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 13.6							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285546	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285546&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875364	378169185							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913548	Cc1cc(C#N)c(F)cc1-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C18H14FN5O/c1-10-7-11(9-20)14(19)8-13(10)17-16(18(25)22-12-4-5-12)23-15-3-2-6-21-24(15)17/h2-3,6-8,12H,4-5H2,1H3,(H,22,25)	PMXQBXHVHKGVCD-UHFFFAOYSA-N	285546	3-(4-cyano-5-fluoro-2-methylphenyl)-N-cyclo-propylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 19::US10669279, Example 19::US9598421, Example 19	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 98.4							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285546	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285546&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118875364	378169185							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913549	Cc1cc(C#N)c(F)cc1-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C18H14FN5O/c1-10-7-11(9-20)14(19)8-13(10)17-16(18(25)22-12-4-5-12)23-15-3-2-6-21-24(15)17/h2-3,6-8,12H,4-5H2,1H3,(H,22,25)	PMXQBXHVHKGVCD-UHFFFAOYSA-N	285546	3-(4-cyano-5-fluoro-2-methylphenyl)-N-cyclo-propylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 19::US10669279, Example 19::US9598421, Example 19	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 645							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285546	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285546&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875364	378169185							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913550	Cc1cc(C#N)c(F)cc1-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C18H14FN5O/c1-11-8-12(10-20)14(19)9-13(11)17-16(18(25)23-6-3-7-23)22-15-4-2-5-21-24(15)17/h2,4-5,8-9H,3,6-7H2,1H3	NJCCFDZQRIVPQK-UHFFFAOYSA-N	285547	4-[2-(azetidin-1-ylcarbonyl)imidazo[1,2-b]pyridazin-3-yl]-2-fluoro-5-methylbenzonitrile::US10077269, Example 20::US10669279, Example 20::US9598421, Example 20	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 6.70							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285547	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285547&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			126683777	378169186							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913551	Cc1cc(C#N)c(F)cc1-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C18H14FN5O/c1-11-8-12(10-20)14(19)9-13(11)17-16(18(25)23-6-3-7-23)22-15-4-2-5-21-24(15)17/h2,4-5,8-9H,3,6-7H2,1H3	NJCCFDZQRIVPQK-UHFFFAOYSA-N	285547	4-[2-(azetidin-1-ylcarbonyl)imidazo[1,2-b]pyridazin-3-yl]-2-fluoro-5-methylbenzonitrile::US10077269, Example 20::US10669279, Example 20::US9598421, Example 20	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 5.74							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285547	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285547&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126683777	378169186							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913552	Cc1cc(C#N)c(F)cc1-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C18H14FN5O/c1-11-8-12(10-20)14(19)9-13(11)17-16(18(25)23-6-3-7-23)22-15-4-2-5-21-24(15)17/h2,4-5,8-9H,3,6-7H2,1H3	NJCCFDZQRIVPQK-UHFFFAOYSA-N	285547	4-[2-(azetidin-1-ylcarbonyl)imidazo[1,2-b]pyridazin-3-yl]-2-fluoro-5-methylbenzonitrile::US10077269, Example 20::US10669279, Example 20::US9598421, Example 20	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 74.8							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285547	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285547&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			126683777	378169186							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913553	Cc1cc(C#N)c(F)cc1-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C18H14FN5O/c1-11-8-12(10-20)14(19)9-13(11)17-16(18(25)23-6-3-7-23)22-15-4-2-5-21-24(15)17/h2,4-5,8-9H,3,6-7H2,1H3	NJCCFDZQRIVPQK-UHFFFAOYSA-N	285547	4-[2-(azetidin-1-ylcarbonyl)imidazo[1,2-b]pyridazin-3-yl]-2-fluoro-5-methylbenzonitrile::US10077269, Example 20::US10669279, Example 20::US9598421, Example 20	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 490							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285547	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285547&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126683777	378169186							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913554	CN(C1CC1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1	InChI=1S/C17H14ClFN4O/c1-22(11-5-6-11)17(24)15-16(10-4-7-12(18)13(19)9-10)23-14(21-15)3-2-8-20-23/h2-4,7-9,11H,5-6H2,1H3	VTRNMYGATDHWOK-UHFFFAOYSA-N	285548	3-(4-chloro-3-fluorophenyl)-N-cyclopropyl-N-methyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 21::US10669279, Example 21::US9598421, Example 21	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 53.7							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285548	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285548&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			126700156	378169187							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913555	CN(C1CC1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1	InChI=1S/C17H14ClFN4O/c1-22(11-5-6-11)17(24)15-16(10-4-7-12(18)13(19)9-10)23-14(21-15)3-2-8-20-23/h2-4,7-9,11H,5-6H2,1H3	VTRNMYGATDHWOK-UHFFFAOYSA-N	285548	3-(4-chloro-3-fluorophenyl)-N-cyclopropyl-N-methyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 21::US10669279, Example 21::US9598421, Example 21	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 91.3							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285548	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285548&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700156	378169187							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913556	CN(C1CC1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1	InChI=1S/C17H14ClFN4O/c1-22(11-5-6-11)17(24)15-16(10-4-7-12(18)13(19)9-10)23-14(21-15)3-2-8-20-23/h2-4,7-9,11H,5-6H2,1H3	VTRNMYGATDHWOK-UHFFFAOYSA-N	285548	3-(4-chloro-3-fluorophenyl)-N-cyclopropyl-N-methyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 21::US10669279, Example 21::US9598421, Example 21	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 170							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285548	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285548&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			126700156	378169187							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913557	CN(C1CC1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1	InChI=1S/C17H14ClFN4O/c1-22(11-5-6-11)17(24)15-16(10-4-7-12(18)13(19)9-10)23-14(21-15)3-2-8-20-23/h2-4,7-9,11H,5-6H2,1H3	VTRNMYGATDHWOK-UHFFFAOYSA-N	285548	3-(4-chloro-3-fluorophenyl)-N-cyclopropyl-N-methyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 21::US10669279, Example 21::US9598421, Example 21	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		>12300							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285548	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285548&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700156	378169187							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913558	O=C(NC1CC1)c1nc2cccnn2c1-c1ccc2ccnn2c1	InChI=1S/C17H14N6O/c24-17(20-12-4-5-12)15-16(23-14(21-15)2-1-8-19-23)11-3-6-13-7-9-18-22(13)10-11/h1-3,6-10,12H,4-5H2,(H,20,24)	XWBNVRGWNULCLK-UHFFFAOYSA-N	285549	N-cyclopropyl-3-(pyrazolo[1,5-a]pyridin-6-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 22::US10669279, Example 22::US9598421, Example 22	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 27.6							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285549	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285549&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118875403	378169188							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913559	O=C(NC1CC1)c1nc2cccnn2c1-c1ccc2ccnn2c1	InChI=1S/C17H14N6O/c24-17(20-12-4-5-12)15-16(23-14(21-15)2-1-8-19-23)11-3-6-13-7-9-18-22(13)10-11/h1-3,6-10,12H,4-5H2,(H,20,24)	XWBNVRGWNULCLK-UHFFFAOYSA-N	285549	N-cyclopropyl-3-(pyrazolo[1,5-a]pyridin-6-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 22::US10669279, Example 22::US9598421, Example 22	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 58.9							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285549	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285549&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875403	378169188							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913560	O=C(NC1CC1)c1nc2cccnn2c1-c1ccc2ccnn2c1	InChI=1S/C17H14N6O/c24-17(20-12-4-5-12)15-16(23-14(21-15)2-1-8-19-23)11-3-6-13-7-9-18-22(13)10-11/h1-3,6-10,12H,4-5H2,(H,20,24)	XWBNVRGWNULCLK-UHFFFAOYSA-N	285549	N-cyclopropyl-3-(pyrazolo[1,5-a]pyridin-6-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 22::US10669279, Example 22::US9598421, Example 22	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 71.2							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285549	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285549&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118875403	378169188							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913561	O=C(NC1CC1)c1nc2cccnn2c1-c1ccc2ccnn2c1	InChI=1S/C17H14N6O/c24-17(20-12-4-5-12)15-16(23-14(21-15)2-1-8-19-23)11-3-6-13-7-9-18-22(13)10-11/h1-3,6-10,12H,4-5H2,(H,20,24)	XWBNVRGWNULCLK-UHFFFAOYSA-N	285549	N-cyclopropyl-3-(pyrazolo[1,5-a]pyridin-6-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 22::US10669279, Example 22::US9598421, Example 22	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 1890							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285549	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285549&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875403	378169188							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913562	Fc1cc(ccc1C#N)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H12FN5O/c18-13-9-11(4-5-12(13)10-19)16-15(17(24)22-7-2-8-22)21-14-3-1-6-20-23(14)16/h1,3-6,9H,2,7-8H2	COQGBMKNVJUVAB-UHFFFAOYSA-N	285550	4-[2-(azetidin-1-ylcarbonyl)imidazo[1,2-b]pyridazin-3-yl]-2-fluorobenzonitrile::US10077269, Example 23::US10669279, Example 23::US9598421, Example 23	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 15.1							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285550	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285550&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			126700158	378169189							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913563	Fc1cc(ccc1C#N)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H12FN5O/c18-13-9-11(4-5-12(13)10-19)16-15(17(24)22-7-2-8-22)21-14-3-1-6-20-23(14)16/h1,3-6,9H,2,7-8H2	COQGBMKNVJUVAB-UHFFFAOYSA-N	285550	4-[2-(azetidin-1-ylcarbonyl)imidazo[1,2-b]pyridazin-3-yl]-2-fluorobenzonitrile::US10077269, Example 23::US10669279, Example 23::US9598421, Example 23	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 30.5							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285550	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285550&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700158	378169189							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913564	Fc1cc(ccc1C#N)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H12FN5O/c18-13-9-11(4-5-12(13)10-19)16-15(17(24)22-7-2-8-22)21-14-3-1-6-20-23(14)16/h1,3-6,9H,2,7-8H2	COQGBMKNVJUVAB-UHFFFAOYSA-N	285550	4-[2-(azetidin-1-ylcarbonyl)imidazo[1,2-b]pyridazin-3-yl]-2-fluorobenzonitrile::US10077269, Example 23::US10669279, Example 23::US9598421, Example 23	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 45.8							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285550	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285550&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			126700158	378169189							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913565	Fc1cc(ccc1C#N)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H12FN5O/c18-13-9-11(4-5-12(13)10-19)16-15(17(24)22-7-2-8-22)21-14-3-1-6-20-23(14)16/h1,3-6,9H,2,7-8H2	COQGBMKNVJUVAB-UHFFFAOYSA-N	285550	4-[2-(azetidin-1-ylcarbonyl)imidazo[1,2-b]pyridazin-3-yl]-2-fluorobenzonitrile::US10077269, Example 23::US10669279, Example 23::US9598421, Example 23	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 4130							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285550	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285550&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700158	378169189							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913566	Fc1cc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)cc1C#N	InChI=1S/C17H11F2N5O/c18-12-8-11(13(19)7-10(12)9-20)16-15(17(25)23-5-2-6-23)22-14-3-1-4-21-24(14)16/h1,3-4,7-8H,2,5-6H2	GLYPDLWNQYDRTQ-UHFFFAOYSA-N	285551	4-[2-(azetidin-1-ylcarbonyl)imidazo[1,2-b]pyridazin-3-yl]-2,5-difluorobenzonitrile::US10077269, Example 24::US10669279, Example 24::US9598421, Example 24	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 5.04							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285551	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285551&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			126700159	378169190							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913567	Fc1cc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)cc1C#N	InChI=1S/C17H11F2N5O/c18-12-8-11(13(19)7-10(12)9-20)16-15(17(25)23-5-2-6-23)22-14-3-1-4-21-24(14)16/h1,3-4,7-8H,2,5-6H2	GLYPDLWNQYDRTQ-UHFFFAOYSA-N	285551	4-[2-(azetidin-1-ylcarbonyl)imidazo[1,2-b]pyridazin-3-yl]-2,5-difluorobenzonitrile::US10077269, Example 24::US10669279, Example 24::US9598421, Example 24	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 19.1							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285551	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285551&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700159	378169190							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913568	Fc1cc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)cc1C#N	InChI=1S/C17H11F2N5O/c18-12-8-11(13(19)7-10(12)9-20)16-15(17(25)23-5-2-6-23)22-14-3-1-4-21-24(14)16/h1,3-4,7-8H,2,5-6H2	GLYPDLWNQYDRTQ-UHFFFAOYSA-N	285551	4-[2-(azetidin-1-ylcarbonyl)imidazo[1,2-b]pyridazin-3-yl]-2,5-difluorobenzonitrile::US10077269, Example 24::US10669279, Example 24::US9598421, Example 24	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 59.7							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285551	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285551&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			126700159	378169190							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913569	Fc1cc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)cc1C#N	InChI=1S/C17H11F2N5O/c18-12-8-11(13(19)7-10(12)9-20)16-15(17(25)23-5-2-6-23)22-14-3-1-4-21-24(14)16/h1,3-4,7-8H,2,5-6H2	GLYPDLWNQYDRTQ-UHFFFAOYSA-N	285551	4-[2-(azetidin-1-ylcarbonyl)imidazo[1,2-b]pyridazin-3-yl]-2,5-difluorobenzonitrile::US10077269, Example 24::US10669279, Example 24::US9598421, Example 24	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		>2150							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285551	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285551&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700159	378169190							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913570	CNC(=O)c1nc2cccnn2c1-c1cc(F)c(Cl)cc1C	InChI=1S/C15H12ClFN4O/c1-8-6-10(16)11(17)7-9(8)14-13(15(22)18-2)20-12-4-3-5-19-21(12)14/h3-7H,1-2H3,(H,18,22)	APQCTKWSIMEXKR-UHFFFAOYSA-N	285552	3-(4-chloro-5-fluoro-2-methylphenyl)-N-methyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 25::US10669279, Example 25::US9598421, Example 25	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 38.6							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285552	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285552&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118875410	378169191							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913571	CNC(=O)c1nc2cccnn2c1-c1cc(F)c(Cl)cc1C	InChI=1S/C15H12ClFN4O/c1-8-6-10(16)11(17)7-9(8)14-13(15(22)18-2)20-12-4-3-5-19-21(12)14/h3-7H,1-2H3,(H,18,22)	APQCTKWSIMEXKR-UHFFFAOYSA-N	285552	3-(4-chloro-5-fluoro-2-methylphenyl)-N-methyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 25::US10669279, Example 25::US9598421, Example 25	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 140							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285552	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285552&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875410	378169191							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913572	CNC(=O)c1nc2cccnn2c1-c1cc(F)c(Cl)cc1C	InChI=1S/C15H12ClFN4O/c1-8-6-10(16)11(17)7-9(8)14-13(15(22)18-2)20-12-4-3-5-19-21(12)14/h3-7H,1-2H3,(H,18,22)	APQCTKWSIMEXKR-UHFFFAOYSA-N	285552	3-(4-chloro-5-fluoro-2-methylphenyl)-N-methyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 25::US10669279, Example 25::US9598421, Example 25	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 150							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285552	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285552&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118875410	378169191							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913573	CNC(=O)c1nc2cccnn2c1-c1cc(F)c(Cl)cc1C	InChI=1S/C15H12ClFN4O/c1-8-6-10(16)11(17)7-9(8)14-13(15(22)18-2)20-12-4-3-5-19-21(12)14/h3-7H,1-2H3,(H,18,22)	APQCTKWSIMEXKR-UHFFFAOYSA-N	285552	3-(4-chloro-5-fluoro-2-methylphenyl)-N-methyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 25::US10669279, Example 25::US9598421, Example 25	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 4970							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285552	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285552&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875410	378169191							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913574	CCCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C16H15ClN4O/c1-2-9-18-16(22)14-15(11-5-7-12(17)8-6-11)21-13(20-14)4-3-10-19-21/h3-8,10H,2,9H2,1H3,(H,18,22)	VDPHNQHKTFMQPH-UHFFFAOYSA-N	285553	3-(4-chlorophenyl)-N-propyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 26::US10669279, Example 26::US9598421, Example 26	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 85.5							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285553	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285553&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118875372	378169192							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913575	CCCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C16H15ClN4O/c1-2-9-18-16(22)14-15(11-5-7-12(17)8-6-11)21-13(20-14)4-3-10-19-21/h3-8,10H,2,9H2,1H3,(H,18,22)	VDPHNQHKTFMQPH-UHFFFAOYSA-N	285553	3-(4-chlorophenyl)-N-propyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 26::US10669279, Example 26::US9598421, Example 26	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 114							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285553	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285553&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875372	378169192							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913576	CCCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C16H15ClN4O/c1-2-9-18-16(22)14-15(11-5-7-12(17)8-6-11)21-13(20-14)4-3-10-19-21/h3-8,10H,2,9H2,1H3,(H,18,22)	VDPHNQHKTFMQPH-UHFFFAOYSA-N	285553	3-(4-chlorophenyl)-N-propyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 26::US10669279, Example 26::US9598421, Example 26	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 111							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285553	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285553&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118875372	378169192							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913577	CCCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C16H15ClN4O/c1-2-9-18-16(22)14-15(11-5-7-12(17)8-6-11)21-13(20-14)4-3-10-19-21/h3-8,10H,2,9H2,1H3,(H,18,22)	VDPHNQHKTFMQPH-UHFFFAOYSA-N	285553	3-(4-chlorophenyl)-N-propyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 26::US10669279, Example 26::US9598421, Example 26	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 3800							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285553	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285553&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875372	378169192							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913578	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)N1CCCC1	InChI=1S/C17H15ClN4O/c18-13-7-5-12(6-8-13)16-15(17(23)21-10-1-2-11-21)20-14-4-3-9-19-22(14)16/h3-9H,1-2,10-11H2	VGOMARAKBZMHJT-UHFFFAOYSA-N	285554	US10077269, Example 27::US10669279, Example 27::US9598421, Example 27::[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl](pyrrolidin-1-yl)methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 742							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285554	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285554&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118875398	378169193							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913579	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)N1CCCC1	InChI=1S/C17H15ClN4O/c18-13-7-5-12(6-8-13)16-15(17(23)21-10-1-2-11-21)20-14-4-3-9-19-22(14)16/h3-9H,1-2,10-11H2	VGOMARAKBZMHJT-UHFFFAOYSA-N	285554	US10077269, Example 27::US10669279, Example 27::US9598421, Example 27::[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl](pyrrolidin-1-yl)methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 609							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285554	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285554&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875398	378169193							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913580	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)N1CCCC1	InChI=1S/C17H15ClN4O/c18-13-7-5-12(6-8-13)16-15(17(23)21-10-1-2-11-21)20-14-4-3-9-19-22(14)16/h3-9H,1-2,10-11H2	VGOMARAKBZMHJT-UHFFFAOYSA-N	285554	US10077269, Example 27::US10669279, Example 27::US9598421, Example 27::[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl](pyrrolidin-1-yl)methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 768							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285554	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285554&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118875398	378169193							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913581	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)N1CCCC1	InChI=1S/C17H15ClN4O/c18-13-7-5-12(6-8-13)16-15(17(23)21-10-1-2-11-21)20-14-4-3-9-19-22(14)16/h3-9H,1-2,10-11H2	VGOMARAKBZMHJT-UHFFFAOYSA-N	285554	US10077269, Example 27::US10669279, Example 27::US9598421, Example 27::[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl](pyrrolidin-1-yl)methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 5620							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285554	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285554&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875398	378169193							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913582	CCCNC(=O)c1nc2cccnn2c1-c1cc(Cl)cc(Cl)c1	InChI=1S/C16H14Cl2N4O/c1-2-5-19-16(23)14-15(10-7-11(17)9-12(18)8-10)22-13(21-14)4-3-6-20-22/h3-4,6-9H,2,5H2,1H3,(H,19,23)	GXYHCJBIWBLNEK-UHFFFAOYSA-N	285555	3-(3,5-dichlorophenyl)-N-propylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 28::US10669279, Example 28::US9598421, Example 28	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 15.6							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285555	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285555&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118875386	378169194							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913583	CCCNC(=O)c1nc2cccnn2c1-c1cc(Cl)cc(Cl)c1	InChI=1S/C16H14Cl2N4O/c1-2-5-19-16(23)14-15(10-7-11(17)9-12(18)8-10)22-13(21-14)4-3-6-20-22/h3-4,6-9H,2,5H2,1H3,(H,19,23)	GXYHCJBIWBLNEK-UHFFFAOYSA-N	285555	3-(3,5-dichlorophenyl)-N-propylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 28::US10669279, Example 28::US9598421, Example 28	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 31.7							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285555	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285555&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875386	378169194							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913584	CCCNC(=O)c1nc2cccnn2c1-c1cc(Cl)cc(Cl)c1	InChI=1S/C16H14Cl2N4O/c1-2-5-19-16(23)14-15(10-7-11(17)9-12(18)8-10)22-13(21-14)4-3-6-20-22/h3-4,6-9H,2,5H2,1H3,(H,19,23)	GXYHCJBIWBLNEK-UHFFFAOYSA-N	285555	3-(3,5-dichlorophenyl)-N-propylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 28::US10669279, Example 28::US9598421, Example 28	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 49.0							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285555	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285555&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118875386	378169194							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913585	CCCNC(=O)c1nc2cccnn2c1-c1cc(Cl)cc(Cl)c1	InChI=1S/C16H14Cl2N4O/c1-2-5-19-16(23)14-15(10-7-11(17)9-12(18)8-10)22-13(21-14)4-3-6-20-22/h3-4,6-9H,2,5H2,1H3,(H,19,23)	GXYHCJBIWBLNEK-UHFFFAOYSA-N	285555	3-(3,5-dichlorophenyl)-N-propylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 28::US10669279, Example 28::US9598421, Example 28	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 393							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285555	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285555&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875386	378169194							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913586	CCCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1	InChI=1S/C16H14ClFN4O/c1-2-7-19-16(23)14-15(10-5-6-11(17)12(18)9-10)22-13(21-14)4-3-8-20-22/h3-6,8-9H,2,7H2,1H3,(H,19,23)	ZOPYTZDTLDQKKZ-UHFFFAOYSA-N	285556	3-(4-chloro-3-fluorophenyl)-N-propylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 29::US10669279, Example 29::US9598421, Example 29	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 3.48							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285556	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285556&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118875384	378169195							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913587	CCCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1	InChI=1S/C16H14ClFN4O/c1-2-7-19-16(23)14-15(10-5-6-11(17)12(18)9-10)22-13(21-14)4-3-8-20-22/h3-6,8-9H,2,7H2,1H3,(H,19,23)	ZOPYTZDTLDQKKZ-UHFFFAOYSA-N	285556	3-(4-chloro-3-fluorophenyl)-N-propylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 29::US10669279, Example 29::US9598421, Example 29	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 5.05							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285556	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285556&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875384	378169195							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913588	CCCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1	InChI=1S/C16H14ClFN4O/c1-2-7-19-16(23)14-15(10-5-6-11(17)12(18)9-10)22-13(21-14)4-3-8-20-22/h3-6,8-9H,2,7H2,1H3,(H,19,23)	ZOPYTZDTLDQKKZ-UHFFFAOYSA-N	285556	3-(4-chloro-3-fluorophenyl)-N-propylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 29::US10669279, Example 29::US9598421, Example 29	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 13.8							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285556	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285556&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118875384	378169195							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913589	CCCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1	InChI=1S/C16H14ClFN4O/c1-2-7-19-16(23)14-15(10-5-6-11(17)12(18)9-10)22-13(21-14)4-3-8-20-22/h3-6,8-9H,2,7H2,1H3,(H,19,23)	ZOPYTZDTLDQKKZ-UHFFFAOYSA-N	285556	3-(4-chloro-3-fluorophenyl)-N-propylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 29::US10669279, Example 29::US9598421, Example 29	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 409							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285556	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285556&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875384	378169195							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913590	CC1CC1NC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C17H15ClN4O/c1-10-9-13(10)20-17(23)15-16(11-4-6-12(18)7-5-11)22-14(21-15)3-2-8-19-22/h2-8,10,13H,9H2,1H3,(H,20,23)	VSOPHYORBVNBMU-UHFFFAOYSA-N	285557	3-(4-chlorophenyl)-N-(2-methylcyclopropyl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 30::US10669279, Example 30::US9598421, Example 30	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 11.6							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285557	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285557&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			126700166	378169196							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913591	CC1CC1NC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C17H15ClN4O/c1-10-9-13(10)20-17(23)15-16(11-4-6-12(18)7-5-11)22-14(21-15)3-2-8-19-22/h2-8,10,13H,9H2,1H3,(H,20,23)	VSOPHYORBVNBMU-UHFFFAOYSA-N	285557	3-(4-chlorophenyl)-N-(2-methylcyclopropyl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 30::US10669279, Example 30::US9598421, Example 30	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 55.0							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285557	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285557&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700166	378169196							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913592	CC1CC1NC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C17H15ClN4O/c1-10-9-13(10)20-17(23)15-16(11-4-6-12(18)7-5-11)22-14(21-15)3-2-8-19-22/h2-8,10,13H,9H2,1H3,(H,20,23)	VSOPHYORBVNBMU-UHFFFAOYSA-N	285557	3-(4-chlorophenyl)-N-(2-methylcyclopropyl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 30::US10669279, Example 30::US9598421, Example 30	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 24.5							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285557	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285557&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			126700166	378169196							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913593	CC1CC1NC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C17H15ClN4O/c1-10-9-13(10)20-17(23)15-16(11-4-6-12(18)7-5-11)22-14(21-15)3-2-8-19-22/h2-8,10,13H,9H2,1H3,(H,20,23)	VSOPHYORBVNBMU-UHFFFAOYSA-N	285557	3-(4-chlorophenyl)-N-(2-methylcyclopropyl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 30::US10669279, Example 30::US9598421, Example 30	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 4000							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285557	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285557&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700166	378169196							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913594	COC1CN(C1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C17H15ClN4O2/c1-24-13-9-21(10-13)17(23)15-16(11-4-6-12(18)7-5-11)22-14(20-15)3-2-8-19-22/h2-8,13H,9-10H2,1H3	WJDDXTCEGQNYBD-UHFFFAOYSA-N	285558	US10077269, Example 31::US10669279, Example 31::US9598421, Example 31::[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl](3-methoxy-azetidin-1-yl)methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 2820							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285558	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285558&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			126700165	378169197							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913595	COC1CN(C1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C17H15ClN4O2/c1-24-13-9-21(10-13)17(23)15-16(11-4-6-12(18)7-5-11)22-14(20-15)3-2-8-19-22/h2-8,13H,9-10H2,1H3	WJDDXTCEGQNYBD-UHFFFAOYSA-N	285558	US10077269, Example 31::US10669279, Example 31::US9598421, Example 31::[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl](3-methoxy-azetidin-1-yl)methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 2670							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285558	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285558&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700165	378169197							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913596	COC1CN(C1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C17H15ClN4O2/c1-24-13-9-21(10-13)17(23)15-16(11-4-6-12(18)7-5-11)22-14(20-15)3-2-8-19-22/h2-8,13H,9-10H2,1H3	WJDDXTCEGQNYBD-UHFFFAOYSA-N	285558	US10077269, Example 31::US10669279, Example 31::US9598421, Example 31::[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl](3-methoxy-azetidin-1-yl)methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 5810							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285558	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285558&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			126700165	378169197							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913597	COC1CN(C1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C17H15ClN4O2/c1-24-13-9-21(10-13)17(23)15-16(11-4-6-12(18)7-5-11)22-14(20-15)3-2-8-19-22/h2-8,13H,9-10H2,1H3	WJDDXTCEGQNYBD-UHFFFAOYSA-N	285558	US10077269, Example 31::US10669279, Example 31::US9598421, Example 31::[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl](3-methoxy-azetidin-1-yl)methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		>26200							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285558	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285558&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700165	378169197							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913598	CN(C1CC1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C17H15ClN4O/c1-21(13-8-9-13)17(23)15-16(11-4-6-12(18)7-5-11)22-14(20-15)3-2-10-19-22/h2-7,10,13H,8-9H2,1H3	YRYSHRMLXGRWSA-UHFFFAOYSA-N	285559	3-(4-chlorophenyl)-N-cyclo-propyl-N-methyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 32::US10669279, Example 32::US9598421, Example 32	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 1030							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285559	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285559&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118875382	378169198							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913599	CN(C1CC1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C17H15ClN4O/c1-21(13-8-9-13)17(23)15-16(11-4-6-12(18)7-5-11)22-14(20-15)3-2-10-19-22/h2-7,10,13H,8-9H2,1H3	YRYSHRMLXGRWSA-UHFFFAOYSA-N	285559	3-(4-chlorophenyl)-N-cyclo-propyl-N-methyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 32::US10669279, Example 32::US9598421, Example 32	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 419							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285559	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285559&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875382	378169198							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913600	CN(C1CC1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C17H15ClN4O/c1-21(13-8-9-13)17(23)15-16(11-4-6-12(18)7-5-11)22-14(20-15)3-2-10-19-22/h2-7,10,13H,8-9H2,1H3	YRYSHRMLXGRWSA-UHFFFAOYSA-N	285559	3-(4-chlorophenyl)-N-cyclo-propyl-N-methyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 32::US10669279, Example 32::US9598421, Example 32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 469							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285559	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285559&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118875382	378169198							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913601	CN(C1CC1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C17H15ClN4O/c1-21(13-8-9-13)17(23)15-16(11-4-6-12(18)7-5-11)22-14(20-15)3-2-10-19-22/h2-7,10,13H,8-9H2,1H3	YRYSHRMLXGRWSA-UHFFFAOYSA-N	285559	3-(4-chlorophenyl)-N-cyclo-propyl-N-methyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 32::US10669279, Example 32::US9598421, Example 32	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		>30000							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285559	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285559&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875382	378169198							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913602	CC1(CC1)NC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C17H15ClN4O/c1-17(8-9-17)21-16(23)14-15(11-4-6-12(18)7-5-11)22-13(20-14)3-2-10-19-22/h2-7,10H,8-9H2,1H3,(H,21,23)	DJBROLKNQFDUKD-UHFFFAOYSA-N	285560	3-(4-chlorophenyl)-N-(1-methylcyclopropyl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 33::US10669279, Example 33::US9598421, Example 33	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 58.6							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285560	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285560&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			126700164	378169199							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913603	CC1(CC1)NC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C17H15ClN4O/c1-17(8-9-17)21-16(23)14-15(11-4-6-12(18)7-5-11)22-13(20-14)3-2-10-19-22/h2-7,10H,8-9H2,1H3,(H,21,23)	DJBROLKNQFDUKD-UHFFFAOYSA-N	285560	3-(4-chlorophenyl)-N-(1-methylcyclopropyl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 33::US10669279, Example 33::US9598421, Example 33	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 53.6							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285560	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285560&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700164	378169199							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913604	CC1(CC1)NC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C17H15ClN4O/c1-17(8-9-17)21-16(23)14-15(11-4-6-12(18)7-5-11)22-13(20-14)3-2-10-19-22/h2-7,10H,8-9H2,1H3,(H,21,23)	DJBROLKNQFDUKD-UHFFFAOYSA-N	285560	3-(4-chlorophenyl)-N-(1-methylcyclopropyl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 33::US10669279, Example 33::US9598421, Example 33	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 127							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285560	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285560&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			126700164	378169199							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913605	CC1(CC1)NC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C17H15ClN4O/c1-17(8-9-17)21-16(23)14-15(11-4-6-12(18)7-5-11)22-13(20-14)3-2-10-19-22/h2-7,10H,8-9H2,1H3,(H,21,23)	DJBROLKNQFDUKD-UHFFFAOYSA-N	285560	3-(4-chlorophenyl)-N-(1-methylcyclopropyl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 33::US10669279, Example 33::US9598421, Example 33	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 2330							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285560	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285560&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700164	378169199							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913606	CCCNC(=O)c1nc2cccnn2c1-c1cc(F)cc(Cl)c1	InChI=1S/C16H14ClFN4O/c1-2-5-19-16(23)14-15(10-7-11(17)9-12(18)8-10)22-13(21-14)4-3-6-20-22/h3-4,6-9H,2,5H2,1H3,(H,19,23)	SRLHMGKYTUHFKW-UHFFFAOYSA-N	285561	3-(3-chloro-5-fluorophenyl)-N-propylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 34::US10669279, Example 34::US9598421, Example 34	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 29.5							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285561	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285561&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118875377	378169200							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913607	CCCNC(=O)c1nc2cccnn2c1-c1cc(F)cc(Cl)c1	InChI=1S/C16H14ClFN4O/c1-2-5-19-16(23)14-15(10-7-11(17)9-12(18)8-10)22-13(21-14)4-3-6-20-22/h3-4,6-9H,2,5H2,1H3,(H,19,23)	SRLHMGKYTUHFKW-UHFFFAOYSA-N	285561	3-(3-chloro-5-fluorophenyl)-N-propylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 34::US10669279, Example 34::US9598421, Example 34	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 83.2							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285561	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285561&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875377	378169200							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913608	CCCNC(=O)c1nc2cccnn2c1-c1cc(F)cc(Cl)c1	InChI=1S/C16H14ClFN4O/c1-2-5-19-16(23)14-15(10-7-11(17)9-12(18)8-10)22-13(21-14)4-3-6-20-22/h3-4,6-9H,2,5H2,1H3,(H,19,23)	SRLHMGKYTUHFKW-UHFFFAOYSA-N	285561	3-(3-chloro-5-fluorophenyl)-N-propylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 34::US10669279, Example 34::US9598421, Example 34	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 47.0							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285561	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285561&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118875377	378169200							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913609	CCCNC(=O)c1nc2cccnn2c1-c1cc(F)cc(Cl)c1	InChI=1S/C16H14ClFN4O/c1-2-5-19-16(23)14-15(10-7-11(17)9-12(18)8-10)22-13(21-14)4-3-6-20-22/h3-4,6-9H,2,5H2,1H3,(H,19,23)	SRLHMGKYTUHFKW-UHFFFAOYSA-N	285561	3-(3-chloro-5-fluorophenyl)-N-propylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 34::US10669279, Example 34::US9598421, Example 34	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 2110							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285561	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285561&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875377	378169200							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913610	Fc1cc(Cl)cc(c1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H12ClFN4O/c17-10-6-9(7-11(18)8-10)15-14(16(23)20-12-3-4-12)21-13-2-1-5-19-22(13)15/h1-2,5-8,12H,3-4H2,(H,20,23)	JXDYJNOWRSRYDW-UHFFFAOYSA-N	285562	3-(3-chloro-5-fluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 35::US10669279, Example 35::US9598421, Example 35	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 35.7							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285562	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285562&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118875400	378169201							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913611	Fc1cc(Cl)cc(c1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H12ClFN4O/c17-10-6-9(7-11(18)8-10)15-14(16(23)20-12-3-4-12)21-13-2-1-5-19-22(13)15/h1-2,5-8,12H,3-4H2,(H,20,23)	JXDYJNOWRSRYDW-UHFFFAOYSA-N	285562	3-(3-chloro-5-fluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 35::US10669279, Example 35::US9598421, Example 35	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 48.0							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285562	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285562&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875400	378169201							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913612	Fc1cc(Cl)cc(c1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H12ClFN4O/c17-10-6-9(7-11(18)8-10)15-14(16(23)20-12-3-4-12)21-13-2-1-5-19-22(13)15/h1-2,5-8,12H,3-4H2,(H,20,23)	JXDYJNOWRSRYDW-UHFFFAOYSA-N	285562	3-(3-chloro-5-fluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 35::US10669279, Example 35::US9598421, Example 35	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 37.0							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285562	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285562&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118875400	378169201							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913613	Fc1cc(Cl)cc(c1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H12ClFN4O/c17-10-6-9(7-11(18)8-10)15-14(16(23)20-12-3-4-12)21-13-2-1-5-19-22(13)15/h1-2,5-8,12H,3-4H2,(H,20,23)	JXDYJNOWRSRYDW-UHFFFAOYSA-N	285562	3-(3-chloro-5-fluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 35::US10669279, Example 35::US9598421, Example 35	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 1220							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285562	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285562&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875400	378169201							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913614	Clc1cccc(c1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H13ClN4O/c17-11-4-1-3-10(9-11)15-14(16(22)19-12-6-7-12)20-13-5-2-8-18-21(13)15/h1-5,8-9,12H,6-7H2,(H,19,22)	ZQTGMZNEQOGOQC-UHFFFAOYSA-N	285563	3-(3-chlorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 36::US10669279, Example 36::US9598421, Example 36	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 23.7							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285563	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285563&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118875416	378169202							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913615	Clc1cccc(c1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H13ClN4O/c17-11-4-1-3-10(9-11)15-14(16(22)19-12-6-7-12)20-13-5-2-8-18-21(13)15/h1-5,8-9,12H,6-7H2,(H,19,22)	ZQTGMZNEQOGOQC-UHFFFAOYSA-N	285563	3-(3-chlorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 36::US10669279, Example 36::US9598421, Example 36	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 6.99							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285563	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285563&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875416	378169202							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913616	Clc1cccc(c1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H13ClN4O/c17-11-4-1-3-10(9-11)15-14(16(22)19-12-6-7-12)20-13-5-2-8-18-21(13)15/h1-5,8-9,12H,6-7H2,(H,19,22)	ZQTGMZNEQOGOQC-UHFFFAOYSA-N	285563	3-(3-chlorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 36::US10669279, Example 36::US9598421, Example 36	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 21.0							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285563	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285563&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118875416	378169202							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913617	Clc1cccc(c1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H13ClN4O/c17-11-4-1-3-10(9-11)15-14(16(22)19-12-6-7-12)20-13-5-2-8-18-21(13)15/h1-5,8-9,12H,6-7H2,(H,19,22)	ZQTGMZNEQOGOQC-UHFFFAOYSA-N	285563	3-(3-chlorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 36::US10669279, Example 36::US9598421, Example 36	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 254							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285563	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285563&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875416	378169202							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913618	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)NC12CC(C1)C2	InChI=1S/C18H15ClN4O/c19-13-5-3-12(4-6-13)16-15(21-14-2-1-7-20-23(14)16)17(24)22-18-8-11(9-18)10-18/h1-7,11H,8-10H2,(H,22,24)	COONGBDOJFYLER-UHFFFAOYSA-N	285564	N-(bicyclo[1.1.1]pent-1-yl)-3-(4-chlorophenyl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 37::US10669279, Example 37::US9598421, Example 37	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 127							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285564	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285564&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			126700169	378169203							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913619	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)NC12CC(C1)C2	InChI=1S/C18H15ClN4O/c19-13-5-3-12(4-6-13)16-15(21-14-2-1-7-20-23(14)16)17(24)22-18-8-11(9-18)10-18/h1-7,11H,8-10H2,(H,22,24)	COONGBDOJFYLER-UHFFFAOYSA-N	285564	N-(bicyclo[1.1.1]pent-1-yl)-3-(4-chlorophenyl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 37::US10669279, Example 37::US9598421, Example 37	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 75.3							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285564	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285564&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700169	378169203							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913620	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)NC12CC(C1)C2	InChI=1S/C18H15ClN4O/c19-13-5-3-12(4-6-13)16-15(21-14-2-1-7-20-23(14)16)17(24)22-18-8-11(9-18)10-18/h1-7,11H,8-10H2,(H,22,24)	COONGBDOJFYLER-UHFFFAOYSA-N	285564	N-(bicyclo[1.1.1]pent-1-yl)-3-(4-chlorophenyl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 37::US10669279, Example 37::US9598421, Example 37	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 161							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285564	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285564&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			126700169	378169203							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913621	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)NC12CC(C1)C2	InChI=1S/C18H15ClN4O/c19-13-5-3-12(4-6-13)16-15(21-14-2-1-7-20-23(14)16)17(24)22-18-8-11(9-18)10-18/h1-7,11H,8-10H2,(H,22,24)	COONGBDOJFYLER-UHFFFAOYSA-N	285564	N-(bicyclo[1.1.1]pent-1-yl)-3-(4-chlorophenyl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 37::US10669279, Example 37::US9598421, Example 37	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 2570							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285564	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285564&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700169	378169203							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913622	O=C(NC1CC1)c1nc2cccnn2c1-c1cnc2ccoc2c1	InChI=1S/C17H13N5O2/c23-17(20-11-3-4-11)15-16(22-14(21-15)2-1-6-19-22)10-8-13-12(18-9-10)5-7-24-13/h1-2,5-9,11H,3-4H2,(H,20,23)	XQQOHFBKZLHZIC-UHFFFAOYSA-N	285565	N-cyclopropyl-3-(furo[3,2-b]pyridin-6-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 38::US10669279, Example 38::US9598421, Example 38	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 268							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285565	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285565&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700168	378169204							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913623	O=C(NC1CC1)c1nc2cccnn2c1-c1cnc2ccoc2c1	InChI=1S/C17H13N5O2/c23-17(20-11-3-4-11)15-16(22-14(21-15)2-1-6-19-22)10-8-13-12(18-9-10)5-7-24-13/h1-2,5-9,11H,3-4H2,(H,20,23)	XQQOHFBKZLHZIC-UHFFFAOYSA-N	285565	N-cyclopropyl-3-(furo[3,2-b]pyridin-6-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 38::US10669279, Example 38::US9598421, Example 38	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 11200							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285565	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285565&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700168	378169204							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913624	O=C(NC1CC1)c1nc2cccnn2c1-c1ccc2ocnc2c1	InChI=1S/C17H13N5O2/c23-17(20-11-4-5-11)15-16(22-14(21-15)2-1-7-19-22)10-3-6-13-12(8-10)18-9-24-13/h1-3,6-9,11H,4-5H2,(H,20,23)	WBVHJGBFCGWOMH-UHFFFAOYSA-N	285566	3-(1,3-benzoxazol-5-yl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 39::US10669279, Example 39::US9598421, Example 39	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 14.8							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285566	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285566&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			126700170	378169205							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913625	O=C(NC1CC1)c1nc2cccnn2c1-c1ccc2ocnc2c1	InChI=1S/C17H13N5O2/c23-17(20-11-4-5-11)15-16(22-14(21-15)2-1-7-19-22)10-3-6-13-12(8-10)18-9-24-13/h1-3,6-9,11H,4-5H2,(H,20,23)	WBVHJGBFCGWOMH-UHFFFAOYSA-N	285566	3-(1,3-benzoxazol-5-yl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 39::US10669279, Example 39::US9598421, Example 39	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 26.5							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285566	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285566&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700170	378169205							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913626	O=C(NC1CC1)c1nc2cccnn2c1-c1ccc2ocnc2c1	InChI=1S/C17H13N5O2/c23-17(20-11-4-5-11)15-16(22-14(21-15)2-1-7-19-22)10-3-6-13-12(8-10)18-9-24-13/h1-3,6-9,11H,4-5H2,(H,20,23)	WBVHJGBFCGWOMH-UHFFFAOYSA-N	285566	3-(1,3-benzoxazol-5-yl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 39::US10669279, Example 39::US9598421, Example 39	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 67.8							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285566	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285566&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			126700170	378169205							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913627	O=C(NC1CC1)c1nc2cccnn2c1-c1ccc2ocnc2c1	InChI=1S/C17H13N5O2/c23-17(20-11-4-5-11)15-16(22-14(21-15)2-1-7-19-22)10-3-6-13-12(8-10)18-9-24-13/h1-3,6-9,11H,4-5H2,(H,20,23)	WBVHJGBFCGWOMH-UHFFFAOYSA-N	285566	3-(1,3-benzoxazol-5-yl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 39::US10669279, Example 39::US9598421, Example 39	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 3820							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285566	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285566&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700170	378169205							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913628	Fc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H12ClFN4O/c17-9-3-6-11(12(18)8-9)15-14(16(23)20-10-4-5-10)21-13-2-1-7-19-22(13)15/h1-3,6-8,10H,4-5H2,(H,20,23)	WMBGBRRUSMUDQB-UHFFFAOYSA-N	285567	3-(4-chloro-2-fluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 40::US10669279, Example 40::US9598421, Example 40	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 19.6							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285567	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285567&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118875401	378169206							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913629	Fc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H12ClFN4O/c17-9-3-6-11(12(18)8-9)15-14(16(23)20-10-4-5-10)21-13-2-1-7-19-22(13)15/h1-3,6-8,10H,4-5H2,(H,20,23)	WMBGBRRUSMUDQB-UHFFFAOYSA-N	285567	3-(4-chloro-2-fluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 40::US10669279, Example 40::US9598421, Example 40	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 65.3							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285567	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285567&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875401	378169206							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913630	Fc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H12ClFN4O/c17-9-3-6-11(12(18)8-9)15-14(16(23)20-10-4-5-10)21-13-2-1-7-19-22(13)15/h1-3,6-8,10H,4-5H2,(H,20,23)	WMBGBRRUSMUDQB-UHFFFAOYSA-N	285567	3-(4-chloro-2-fluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 40::US10669279, Example 40::US9598421, Example 40	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 58.1							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285567	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285567&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118875401	378169206							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913631	Fc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H12ClFN4O/c17-9-3-6-11(12(18)8-9)15-14(16(23)20-10-4-5-10)21-13-2-1-7-19-22(13)15/h1-3,6-8,10H,4-5H2,(H,20,23)	WMBGBRRUSMUDQB-UHFFFAOYSA-N	285567	3-(4-chloro-2-fluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 40::US10669279, Example 40::US9598421, Example 40	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 9020							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285567	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285567&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875401	378169206							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913632	Cc1ccc(cc1F)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C17H15FN4O/c1-10-4-5-11(9-13(10)18)16-15(17(23)20-12-6-7-12)21-14-3-2-8-19-22(14)16/h2-5,8-9,12H,6-7H2,1H3,(H,20,23)	XXAZCHDKOQBDMG-UHFFFAOYSA-N	285568	N-cyclopropyl-3-(3-fluoro-4-methylphenyl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 41::US10669279, Example 41::US9598421, Example 41	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 3.13							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285568	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285568&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			126700171	378169207							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913633	Cc1ccc(cc1F)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C17H15FN4O/c1-10-4-5-11(9-13(10)18)16-15(17(23)20-12-6-7-12)21-14-3-2-8-19-22(14)16/h2-5,8-9,12H,6-7H2,1H3,(H,20,23)	XXAZCHDKOQBDMG-UHFFFAOYSA-N	285568	N-cyclopropyl-3-(3-fluoro-4-methylphenyl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 41::US10669279, Example 41::US9598421, Example 41	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 8.05							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285568	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285568&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700171	378169207							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913634	Cc1ccc(cc1F)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C17H15FN4O/c1-10-4-5-11(9-13(10)18)16-15(17(23)20-12-6-7-12)21-14-3-2-8-19-22(14)16/h2-5,8-9,12H,6-7H2,1H3,(H,20,23)	XXAZCHDKOQBDMG-UHFFFAOYSA-N	285568	N-cyclopropyl-3-(3-fluoro-4-methylphenyl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 41::US10669279, Example 41::US9598421, Example 41	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 16.8							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285568	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285568&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			126700171	378169207							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913635	Cc1ccc(cc1F)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C17H15FN4O/c1-10-4-5-11(9-13(10)18)16-15(17(23)20-12-6-7-12)21-14-3-2-8-19-22(14)16/h2-5,8-9,12H,6-7H2,1H3,(H,20,23)	XXAZCHDKOQBDMG-UHFFFAOYSA-N	285568	N-cyclopropyl-3-(3-fluoro-4-methylphenyl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 41::US10669279, Example 41::US9598421, Example 41	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 467							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285568	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285568&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700171	378169207							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913636	FC(F)(F)c1cc(ccn1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H12F3N5O/c17-16(18,19)11-8-9(5-7-20-11)14-13(15(25)22-10-3-4-10)23-12-2-1-6-21-24(12)14/h1-2,5-8,10H,3-4H2,(H,22,25)	QJYXPHGWTACNMO-UHFFFAOYSA-N	285569	N-cyclopropyl-3-[2-(tri-fluoromethyl)pyridin-4-yl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 42::US10669279, Example 42::US9598421, Example 42	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 415							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285569	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285569&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118875412	378169208							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913637	FC(F)(F)c1cc(ccn1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H12F3N5O/c17-16(18,19)11-8-9(5-7-20-11)14-13(15(25)22-10-3-4-10)23-12-2-1-6-21-24(12)14/h1-2,5-8,10H,3-4H2,(H,22,25)	QJYXPHGWTACNMO-UHFFFAOYSA-N	285569	N-cyclopropyl-3-[2-(tri-fluoromethyl)pyridin-4-yl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 42::US10669279, Example 42::US9598421, Example 42	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 393							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285569	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285569&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875412	378169208							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913638	FC(F)(F)c1cc(ccn1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H12F3N5O/c17-16(18,19)11-8-9(5-7-20-11)14-13(15(25)22-10-3-4-10)23-12-2-1-6-21-24(12)14/h1-2,5-8,10H,3-4H2,(H,22,25)	QJYXPHGWTACNMO-UHFFFAOYSA-N	285569	N-cyclopropyl-3-[2-(tri-fluoromethyl)pyridin-4-yl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 42::US10669279, Example 42::US9598421, Example 42	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 357							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285569	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285569&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118875412	378169208							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913639	FC(F)(F)c1cc(ccn1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H12F3N5O/c17-16(18,19)11-8-9(5-7-20-11)14-13(15(25)22-10-3-4-10)23-12-2-1-6-21-24(12)14/h1-2,5-8,10H,3-4H2,(H,22,25)	QJYXPHGWTACNMO-UHFFFAOYSA-N	285569	N-cyclopropyl-3-[2-(tri-fluoromethyl)pyridin-4-yl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 42::US10669279, Example 42::US9598421, Example 42	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		>12200							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285569	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285569&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875412	378169208							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913640	FC(F)(F)c1cc(ccn1)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H12F3N5O/c17-16(18,19)11-9-10(4-6-20-11)14-13(15(25)23-7-2-8-23)22-12-3-1-5-21-24(12)14/h1,3-6,9H,2,7-8H2	GXXYJNKWPOFUGD-UHFFFAOYSA-N	285570	US10077269, Example 43::US10669279, Example 43::US9598421, Example 43::azetidin-1-yl{3-[2-(tri-fluoromethyl)pyridin-4-yl]imidazo[1,2-b]pyridazin-2-yl}methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 270							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285570	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285570&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875413	378169209							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913641	FC(F)(F)c1cc(ccn1)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H12F3N5O/c17-16(18,19)11-9-10(4-6-20-11)14-13(15(25)23-7-2-8-23)22-12-3-1-5-21-24(12)14/h1,3-6,9H,2,7-8H2	GXXYJNKWPOFUGD-UHFFFAOYSA-N	285570	US10077269, Example 43::US10669279, Example 43::US9598421, Example 43::azetidin-1-yl{3-[2-(tri-fluoromethyl)pyridin-4-yl]imidazo[1,2-b]pyridazin-2-yl}methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		>16900							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285570	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285570&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875413	378169209							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913642	Fc1cc(ccc1Cl)-c1c(nc2cccnn12)C(=O)NC1CC1(F)F	InChI=1S/C16H10ClF3N4O/c17-9-4-3-8(6-10(9)18)14-13(15(25)22-11-7-16(11,19)20)23-12-2-1-5-21-24(12)14/h1-6,11H,7H2,(H,22,25)	LLYJCFVFPOZAJN-UHFFFAOYSA-N	285571	3-(4-chloro-3-fluorophenyl)-N-(2,2-difluorocyclopro-pyl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 44::US10669279, Example 44::US9598421, Example 44	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 3.92							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285571	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285571&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875387	378169210							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913643	Fc1cc(ccc1Cl)-c1c(nc2cccnn12)C(=O)NC1CC1(F)F	InChI=1S/C16H10ClF3N4O/c17-9-4-3-8(6-10(9)18)14-13(15(25)22-11-7-16(11,19)20)23-12-2-1-5-21-24(12)14/h1-6,11H,7H2,(H,22,25)	LLYJCFVFPOZAJN-UHFFFAOYSA-N	285571	3-(4-chloro-3-fluorophenyl)-N-(2,2-difluorocyclopro-pyl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 44::US10669279, Example 44::US9598421, Example 44	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 320							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285571	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285571&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875387	378169210							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913644	F[C@H]1C[C@H]1NC(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1	InChI=1S/C16H11ClF2N4O/c17-9-4-3-8(6-10(9)18)15-14(16(24)21-12-7-11(12)19)22-13-2-1-5-20-23(13)15/h1-6,11-12H,7H2,(H,21,24)/t11-,12+/m0/s1	QSRJUMJDYNOQBS-NWDGAFQWSA-N	285572	3-(4-chloro-3-fluorophenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 45::US10669279, Example 45::US9598421, Example 45	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 2.91							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285572	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285572&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			126700172	378169211							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913645	F[C@H]1C[C@H]1NC(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1	InChI=1S/C16H11ClF2N4O/c17-9-4-3-8(6-10(9)18)15-14(16(24)21-12-7-11(12)19)22-13-2-1-5-20-23(13)15/h1-6,11-12H,7H2,(H,21,24)/t11-,12+/m0/s1	QSRJUMJDYNOQBS-NWDGAFQWSA-N	285572	3-(4-chloro-3-fluorophenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 45::US10669279, Example 45::US9598421, Example 45	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 1.97							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285572	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285572&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700172	378169211							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913646	F[C@H]1C[C@H]1NC(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1	InChI=1S/C16H11ClF2N4O/c17-9-4-3-8(6-10(9)18)15-14(16(24)21-12-7-11(12)19)22-13-2-1-5-20-23(13)15/h1-6,11-12H,7H2,(H,21,24)/t11-,12+/m0/s1	QSRJUMJDYNOQBS-NWDGAFQWSA-N	285572	3-(4-chloro-3-fluorophenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 45::US10669279, Example 45::US9598421, Example 45	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 11.7							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285572	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285572&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			126700172	378169211							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913647	F[C@H]1C[C@H]1NC(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1	InChI=1S/C16H11ClF2N4O/c17-9-4-3-8(6-10(9)18)15-14(16(24)21-12-7-11(12)19)22-13-2-1-5-20-23(13)15/h1-6,11-12H,7H2,(H,21,24)/t11-,12+/m0/s1	QSRJUMJDYNOQBS-NWDGAFQWSA-N	285572	3-(4-chloro-3-fluorophenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 45::US10669279, Example 45::US9598421, Example 45	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 159							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285572	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285572&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700172	378169211							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913648	F[C@H]1C[C@H]1NC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C16H12ClFN4O/c17-10-5-3-9(4-6-10)15-14(16(23)20-12-8-11(12)18)21-13-2-1-7-19-22(13)15/h1-7,11-12H,8H2,(H,20,23)/t11-,12+/m0/s1	LROCAZWHWFXPFN-NWDGAFQWSA-N	285573	3-(4-chlorophenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 46::US10669279, Example 46::US9598421, Example 46	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 15.2							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285573	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285573&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			126700173	378169212							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913649	F[C@H]1C[C@H]1NC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C16H12ClFN4O/c17-10-5-3-9(4-6-10)15-14(16(23)20-12-8-11(12)18)21-13-2-1-7-19-22(13)15/h1-7,11-12H,8H2,(H,20,23)/t11-,12+/m0/s1	LROCAZWHWFXPFN-NWDGAFQWSA-N	285573	3-(4-chlorophenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 46::US10669279, Example 46::US9598421, Example 46	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 12.3							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285573	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285573&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700173	378169212							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913650	F[C@H]1C[C@H]1NC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C16H12ClFN4O/c17-10-5-3-9(4-6-10)15-14(16(23)20-12-8-11(12)18)21-13-2-1-7-19-22(13)15/h1-7,11-12H,8H2,(H,20,23)/t11-,12+/m0/s1	LROCAZWHWFXPFN-NWDGAFQWSA-N	285573	3-(4-chlorophenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 46::US10669279, Example 46::US9598421, Example 46	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 39.3							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285573	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285573&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			126700173	378169212							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913651	F[C@H]1C[C@H]1NC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C16H12ClFN4O/c17-10-5-3-9(4-6-10)15-14(16(23)20-12-8-11(12)18)21-13-2-1-7-19-22(13)15/h1-7,11-12H,8H2,(H,20,23)/t11-,12+/m0/s1	LROCAZWHWFXPFN-NWDGAFQWSA-N	285573	3-(4-chlorophenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 46::US10669279, Example 46::US9598421, Example 46	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 971							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285573	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285573&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700173	378169212							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913652	Fc1cc(cc(F)c1Cl)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H11ClF2N4O/c17-13-10(18)7-9(8-11(13)19)15-14(16(24)22-5-2-6-22)21-12-3-1-4-20-23(12)15/h1,3-4,7-8H,2,5-6H2	UGUNGNPFDJUJNI-UHFFFAOYSA-N	285574	US10077269, Example 47::US10669279, Example 47::US9598421, Example 47::azetidin-1-yl[3-(4-chloro-3,5-difluorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 7.37							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285574	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285574&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			126700174	378169213							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913653	Fc1cc(cc(F)c1Cl)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H11ClF2N4O/c17-13-10(18)7-9(8-11(13)19)15-14(16(24)22-5-2-6-22)21-12-3-1-4-20-23(12)15/h1,3-4,7-8H,2,5-6H2	UGUNGNPFDJUJNI-UHFFFAOYSA-N	285574	US10077269, Example 47::US10669279, Example 47::US9598421, Example 47::azetidin-1-yl[3-(4-chloro-3,5-difluorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 3.90							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285574	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285574&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700174	378169213							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913654	Fc1cc(cc(F)c1Cl)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H11ClF2N4O/c17-13-10(18)7-9(8-11(13)19)15-14(16(24)22-5-2-6-22)21-12-3-1-4-20-23(12)15/h1,3-4,7-8H,2,5-6H2	UGUNGNPFDJUJNI-UHFFFAOYSA-N	285574	US10077269, Example 47::US10669279, Example 47::US9598421, Example 47::azetidin-1-yl[3-(4-chloro-3,5-difluorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 23.9							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285574	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285574&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			126700174	378169213							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913655	Fc1cc(cc(F)c1Cl)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H11ClF2N4O/c17-13-10(18)7-9(8-11(13)19)15-14(16(24)22-5-2-6-22)21-12-3-1-4-20-23(12)15/h1,3-4,7-8H,2,5-6H2	UGUNGNPFDJUJNI-UHFFFAOYSA-N	285574	US10077269, Example 47::US10669279, Example 47::US9598421, Example 47::azetidin-1-yl[3-(4-chloro-3,5-difluorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 334							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285574	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285574&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700174	378169213							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913656	CCCNC(=O)c1nc2cccnn2c1-c1cncc(Cl)c1	InChI=1S/C15H14ClN5O/c1-2-5-18-15(22)13-14(10-7-11(16)9-17-8-10)21-12(20-13)4-3-6-19-21/h3-4,6-9H,2,5H2,1H3,(H,18,22)	XXRCLGJTXPMSDT-UHFFFAOYSA-N	285575	3-(5-chloropyridin-3-yl)-N-propylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 48::US10669279, Example 48::US9598421, Example 48	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 768							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285575	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285575&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118875389	378169214							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913657	CCCNC(=O)c1nc2cccnn2c1-c1cncc(Cl)c1	InChI=1S/C15H14ClN5O/c1-2-5-18-15(22)13-14(10-7-11(16)9-17-8-10)21-12(20-13)4-3-6-19-21/h3-4,6-9H,2,5H2,1H3,(H,18,22)	XXRCLGJTXPMSDT-UHFFFAOYSA-N	285575	3-(5-chloropyridin-3-yl)-N-propylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 48::US10669279, Example 48::US9598421, Example 48	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 322							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285575	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285575&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875389	378169214							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913658	CCCNC(=O)c1nc2cccnn2c1-c1cncc(Cl)c1	InChI=1S/C15H14ClN5O/c1-2-5-18-15(22)13-14(10-7-11(16)9-17-8-10)21-12(20-13)4-3-6-19-21/h3-4,6-9H,2,5H2,1H3,(H,18,22)	XXRCLGJTXPMSDT-UHFFFAOYSA-N	285575	3-(5-chloropyridin-3-yl)-N-propylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 48::US10669279, Example 48::US9598421, Example 48	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 212							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285575	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285575&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118875389	378169214							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913659	CCCNC(=O)c1nc2cccnn2c1-c1cncc(Cl)c1	InChI=1S/C15H14ClN5O/c1-2-5-18-15(22)13-14(10-7-11(16)9-17-8-10)21-12(20-13)4-3-6-19-21/h3-4,6-9H,2,5H2,1H3,(H,18,22)	XXRCLGJTXPMSDT-UHFFFAOYSA-N	285575	3-(5-chloropyridin-3-yl)-N-propylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 48::US10669279, Example 48::US9598421, Example 48	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		>7670							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285575	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285575&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875389	378169214							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913660	Cc1ccc(cc1Cl)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H15ClN4O/c1-11-5-6-12(10-13(11)18)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	MBBSPQBGJJWYLF-UHFFFAOYSA-N	285576	US10077269, Example 49::US10669279, Example 49::US9598421, Example 49::azetidin-1-yl[3-(3-chloro-4-methylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 4.16							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285576	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285576&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118875405	378169215							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913661	Cc1ccc(cc1Cl)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H15ClN4O/c1-11-5-6-12(10-13(11)18)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	MBBSPQBGJJWYLF-UHFFFAOYSA-N	285576	US10077269, Example 49::US10669279, Example 49::US9598421, Example 49::azetidin-1-yl[3-(3-chloro-4-methylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 13.3							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285576	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285576&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875405	378169215							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913662	Cc1ccc(cc1Cl)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H15ClN4O/c1-11-5-6-12(10-13(11)18)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	MBBSPQBGJJWYLF-UHFFFAOYSA-N	285576	US10077269, Example 49::US10669279, Example 49::US9598421, Example 49::azetidin-1-yl[3-(3-chloro-4-methylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 19.0							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285576	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285576&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118875405	378169215							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913663	Cc1ccc(cc1Cl)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H15ClN4O/c1-11-5-6-12(10-13(11)18)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	MBBSPQBGJJWYLF-UHFFFAOYSA-N	285576	US10077269, Example 49::US10669279, Example 49::US9598421, Example 49::azetidin-1-yl[3-(3-chloro-4-methylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 535							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285576	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285576&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875405	378169215							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913664	O=C(N1CCC1)c1nc2cccnn2c1-c1ccc2OCCc2c1	InChI=1S/C18H16N4O2/c23-18(21-8-2-9-21)16-17(22-15(20-16)3-1-7-19-22)13-4-5-14-12(11-13)6-10-24-14/h1,3-5,7,11H,2,6,8-10H2	HVVGNLROCIOALI-UHFFFAOYSA-N	285577	US10077269, Example 50::US10669279, Example 50::US9598421, Example 50::azetidin-1-yl[3-(2,3-dihydro-1-benzofuran-5-yl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 28.1							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285577	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285577&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			126700175	378169216							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913665	O=C(N1CCC1)c1nc2cccnn2c1-c1ccc2OCCc2c1	InChI=1S/C18H16N4O2/c23-18(21-8-2-9-21)16-17(22-15(20-16)3-1-7-19-22)13-4-5-14-12(11-13)6-10-24-14/h1,3-5,7,11H,2,6,8-10H2	HVVGNLROCIOALI-UHFFFAOYSA-N	285577	US10077269, Example 50::US10669279, Example 50::US9598421, Example 50::azetidin-1-yl[3-(2,3-dihydro-1-benzofuran-5-yl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 116							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285577	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285577&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700175	378169216							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913666	O=C(N1CCC1)c1nc2cccnn2c1-c1ccc2OCCc2c1	InChI=1S/C18H16N4O2/c23-18(21-8-2-9-21)16-17(22-15(20-16)3-1-7-19-22)13-4-5-14-12(11-13)6-10-24-14/h1,3-5,7,11H,2,6,8-10H2	HVVGNLROCIOALI-UHFFFAOYSA-N	285577	US10077269, Example 50::US10669279, Example 50::US9598421, Example 50::azetidin-1-yl[3-(2,3-dihydro-1-benzofuran-5-yl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 235							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285577	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285577&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			126700175	378169216							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913667	O=C(N1CCC1)c1nc2cccnn2c1-c1ccc2OCCc2c1	InChI=1S/C18H16N4O2/c23-18(21-8-2-9-21)16-17(22-15(20-16)3-1-7-19-22)13-4-5-14-12(11-13)6-10-24-14/h1,3-5,7,11H,2,6,8-10H2	HVVGNLROCIOALI-UHFFFAOYSA-N	285577	US10077269, Example 50::US10669279, Example 50::US9598421, Example 50::azetidin-1-yl[3-(2,3-dihydro-1-benzofuran-5-yl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 3140							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285577	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285577&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700175	378169216							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913668	Cc1cc(ccc1Cl)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H15ClN4O/c1-11-10-12(5-6-13(11)18)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	TZEKFEDRWKCDSN-UHFFFAOYSA-N	285578	US10077269, Example 51::US10669279, Example 51::US9598421, Example 51::azetidin-1-yl[3-(4-chloro-3-methylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 42.9							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285578	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285578&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700177	378169217							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913669	Cc1cc(ccc1Cl)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H15ClN4O/c1-11-10-12(5-6-13(11)18)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	TZEKFEDRWKCDSN-UHFFFAOYSA-N	285578	US10077269, Example 51::US10669279, Example 51::US9598421, Example 51::azetidin-1-yl[3-(4-chloro-3-methylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 2810							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285578	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285578&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700177	378169217							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913670	Fc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H12ClFN4O/c17-10-4-5-11(12(18)9-10)15-14(16(23)21-7-2-8-21)20-13-3-1-6-19-22(13)15/h1,3-6,9H,2,7-8H2	FRHMLRQQIOCJKU-UHFFFAOYSA-N	285579	US10077269, Example 52::US10669279, Example 52::US9598421, Example 52::azetidin-1-yl[3-(4-chloro-2-fluorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 24.3							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285579	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285579&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			126700176	378169218							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913671	Fc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H12ClFN4O/c17-10-4-5-11(12(18)9-10)15-14(16(23)21-7-2-8-21)20-13-3-1-6-19-22(13)15/h1,3-6,9H,2,7-8H2	FRHMLRQQIOCJKU-UHFFFAOYSA-N	285579	US10077269, Example 52::US10669279, Example 52::US9598421, Example 52::azetidin-1-yl[3-(4-chloro-2-fluorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 37.3							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285579	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285579&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700176	378169218							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913672	Fc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H12ClFN4O/c17-10-4-5-11(12(18)9-10)15-14(16(23)21-7-2-8-21)20-13-3-1-6-19-22(13)15/h1,3-6,9H,2,7-8H2	FRHMLRQQIOCJKU-UHFFFAOYSA-N	285579	US10077269, Example 52::US10669279, Example 52::US9598421, Example 52::azetidin-1-yl[3-(4-chloro-2-fluorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 113							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285579	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285579&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			126700176	378169218							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913673	Fc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H12ClFN4O/c17-10-4-5-11(12(18)9-10)15-14(16(23)21-7-2-8-21)20-13-3-1-6-19-22(13)15/h1,3-6,9H,2,7-8H2	FRHMLRQQIOCJKU-UHFFFAOYSA-N	285579	US10077269, Example 52::US10669279, Example 52::US9598421, Example 52::azetidin-1-yl[3-(4-chloro-2-fluorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 5510							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285579	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285579&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700176	378169218							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913674	Cc1cc(cc(C)c1F)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C18H17FN4O/c1-11-9-13(10-12(2)15(11)19)17-16(18(24)22-7-4-8-22)21-14-5-3-6-20-23(14)17/h3,5-6,9-10H,4,7-8H2,1-2H3	CTXZJNXACMKAGH-UHFFFAOYSA-N	285580	US10077269, Example 53::US10669279, Example 53::US9598421, Example 53::azetidin-1-yl[3-(4-fluoro-3,5-dimethylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 17.8							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285580	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285580&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			126700178	378169219							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913675	Cc1cc(cc(C)c1F)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C18H17FN4O/c1-11-9-13(10-12(2)15(11)19)17-16(18(24)22-7-4-8-22)21-14-5-3-6-20-23(14)17/h3,5-6,9-10H,4,7-8H2,1-2H3	CTXZJNXACMKAGH-UHFFFAOYSA-N	285580	US10077269, Example 53::US10669279, Example 53::US9598421, Example 53::azetidin-1-yl[3-(4-fluoro-3,5-dimethylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 63.3							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285580	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285580&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700178	378169219							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913676	Cc1cc(cc(C)c1F)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C18H17FN4O/c1-11-9-13(10-12(2)15(11)19)17-16(18(24)22-7-4-8-22)21-14-5-3-6-20-23(14)17/h3,5-6,9-10H,4,7-8H2,1-2H3	CTXZJNXACMKAGH-UHFFFAOYSA-N	285580	US10077269, Example 53::US10669279, Example 53::US9598421, Example 53::azetidin-1-yl[3-(4-fluoro-3,5-dimethylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 153							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285580	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285580&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			126700178	378169219							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913677	Cc1cc(cc(C)c1F)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C18H17FN4O/c1-11-9-13(10-12(2)15(11)19)17-16(18(24)22-7-4-8-22)21-14-5-3-6-20-23(14)17/h3,5-6,9-10H,4,7-8H2,1-2H3	CTXZJNXACMKAGH-UHFFFAOYSA-N	285580	US10077269, Example 53::US10669279, Example 53::US9598421, Example 53::azetidin-1-yl[3-(4-fluoro-3,5-dimethylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 3110							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285580	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285580&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700178	378169219							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913678	Cc1ccc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)c1	InChI=1S/C17H15FN4O/c1-11-5-6-12(13(18)10-11)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	BDIWEEUPORVMSZ-UHFFFAOYSA-N	285581	US10077269, Example 54::US10669279, Example 54::US9598421, Example 54::azetidin-1-yl[3-(2-fluoro-4-methylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 103							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285581	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285581&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			126700179	378169220							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913679	Cc1ccc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)c1	InChI=1S/C17H15FN4O/c1-11-5-6-12(13(18)10-11)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	BDIWEEUPORVMSZ-UHFFFAOYSA-N	285581	US10077269, Example 54::US10669279, Example 54::US9598421, Example 54::azetidin-1-yl[3-(2-fluoro-4-methylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 107							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285581	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285581&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700179	378169220							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913680	Cc1ccc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)c1	InChI=1S/C17H15FN4O/c1-11-5-6-12(13(18)10-11)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	BDIWEEUPORVMSZ-UHFFFAOYSA-N	285581	US10077269, Example 54::US10669279, Example 54::US9598421, Example 54::azetidin-1-yl[3-(2-fluoro-4-methylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 136							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285581	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285581&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			126700179	378169220							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913681	Cc1ccc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)c1	InChI=1S/C17H15FN4O/c1-11-5-6-12(13(18)10-11)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	BDIWEEUPORVMSZ-UHFFFAOYSA-N	285581	US10077269, Example 54::US10669279, Example 54::US9598421, Example 54::azetidin-1-yl[3-(2-fluoro-4-methylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		>20000							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285581	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285581&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700179	378169220							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913682	COc1ccc(cc1F)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H15FN4O2/c1-24-13-6-5-11(10-12(13)18)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	GGBSVVWNJGUOLN-UHFFFAOYSA-N	285582	US10077269, Example 55::US10669279, Example 55::US9598421, Example 55::azetidin-1-yl[3-(3-fluoro-4-methoxyphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 176							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285582	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285582&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			126700180	378169221							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913683	COc1ccc(cc1F)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H15FN4O2/c1-24-13-6-5-11(10-12(13)18)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	GGBSVVWNJGUOLN-UHFFFAOYSA-N	285582	US10077269, Example 55::US10669279, Example 55::US9598421, Example 55::azetidin-1-yl[3-(3-fluoro-4-methoxyphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 200							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285582	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285582&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700180	378169221							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913684	COc1ccc(cc1F)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H15FN4O2/c1-24-13-6-5-11(10-12(13)18)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	GGBSVVWNJGUOLN-UHFFFAOYSA-N	285582	US10077269, Example 55::US10669279, Example 55::US9598421, Example 55::azetidin-1-yl[3-(3-fluoro-4-methoxyphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		>1550							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285582	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285582&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			126700180	378169221							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913685	COc1ccc(cc1F)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H15FN4O2/c1-24-13-6-5-11(10-12(13)18)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	GGBSVVWNJGUOLN-UHFFFAOYSA-N	285582	US10077269, Example 55::US10669279, Example 55::US9598421, Example 55::azetidin-1-yl[3-(3-fluoro-4-methoxyphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		>20900							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285582	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285582&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700180	378169221							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913686	Cc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H15ClN4O/c1-11-10-12(18)5-6-13(11)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	KDPKDOHAJHCGSZ-UHFFFAOYSA-N	285583	US10077269, Example 56::US10669279, Example 56::US9598421, Example 56::azetidin-1-yl[3-(4-chloro-2-methylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 22.7							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285583	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285583&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			126700181	378169222							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913687	Cc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H15ClN4O/c1-11-10-12(18)5-6-13(11)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	KDPKDOHAJHCGSZ-UHFFFAOYSA-N	285583	US10077269, Example 56::US10669279, Example 56::US9598421, Example 56::azetidin-1-yl[3-(4-chloro-2-methylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 43.1							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285583	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285583&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700181	378169222							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913688	Cc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H15ClN4O/c1-11-10-12(18)5-6-13(11)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	KDPKDOHAJHCGSZ-UHFFFAOYSA-N	285583	US10077269, Example 56::US10669279, Example 56::US9598421, Example 56::azetidin-1-yl[3-(4-chloro-2-methylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 84.5							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285583	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285583&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			126700181	378169222							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913689	Cc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H15ClN4O/c1-11-10-12(18)5-6-13(11)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	KDPKDOHAJHCGSZ-UHFFFAOYSA-N	285583	US10077269, Example 56::US10669279, Example 56::US9598421, Example 56::azetidin-1-yl[3-(4-chloro-2-methylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 3930							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285583	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285583&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700181	378169222							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913690	Oc1ccccc1CCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C21H17ClN4O2/c22-16-9-7-15(8-10-16)20-19(25-18-6-3-12-24-26(18)20)21(28)23-13-11-14-4-1-2-5-17(14)27/h1-10,12,27H,11,13H2,(H,23,28)	AQSPRZIQVZXKMZ-UHFFFAOYSA-N	285584	3-(4-chlorophenyl)-N-[2-(2-hydroxyphenyl)ethyl]imidazo[1,2-b]pyridazine-2-carboxamide,formate salt::US10077269, Example 57::US10669279, Example 57::US9598421, Example 57	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 236							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285584	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285584&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700182	378169223							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913691	Oc1ccccc1CCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C21H17ClN4O2/c22-16-9-7-15(8-10-16)20-19(25-18-6-3-12-24-26(18)20)21(28)23-13-11-14-4-1-2-5-17(14)27/h1-10,12,27H,11,13H2,(H,23,28)	AQSPRZIQVZXKMZ-UHFFFAOYSA-N	285584	3-(4-chlorophenyl)-N-[2-(2-hydroxyphenyl)ethyl]imidazo[1,2-b]pyridazine-2-carboxamide,formate salt::US10077269, Example 57::US10669279, Example 57::US9598421, Example 57	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		>21800							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285584	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285584&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700182	378169223							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913692	Cc1cc(NC(=O)c2nc3cccnn3c2-c2ccc(Cl)cc2)no1	InChI=1S/C17H12ClN5O2/c1-10-9-13(22-25-10)20-17(24)15-16(11-4-6-12(18)7-5-11)23-14(21-15)3-2-8-19-23/h2-9H,1H3,(H,20,22,24)	WFHCBSIMFWEHOP-UHFFFAOYSA-N	285585	3-(4-chlorophenyl)-N-(5-methyl-1,2-oxazol-3-yl)imidazo[1,2-b]pyridazine-2-carboxamide,trifluoroacetate salt::US10077269, Example 58::US10669279, Example 58::US9598421, Example 58	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 43.3							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285585	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285585&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700183	378169224							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913693	Cc1cc(NC(=O)c2nc3cccnn3c2-c2ccc(Cl)cc2)no1	InChI=1S/C17H12ClN5O2/c1-10-9-13(22-25-10)20-17(24)15-16(11-4-6-12(18)7-5-11)23-14(21-15)3-2-8-19-23/h2-9H,1H3,(H,20,22,24)	WFHCBSIMFWEHOP-UHFFFAOYSA-N	285585	3-(4-chlorophenyl)-N-(5-methyl-1,2-oxazol-3-yl)imidazo[1,2-b]pyridazine-2-carboxamide,trifluoroacetate salt::US10077269, Example 58::US10669279, Example 58::US9598421, Example 58	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 831							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285585	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285585&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700183	378169224							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913694	Cn1ncc(NC(=O)c2nc3cccnn3c2-c2ccc(Cl)cc2)n1	InChI=1S/C16H12ClN7O/c1-23-19-9-12(22-23)20-16(25)14-15(10-4-6-11(17)7-5-10)24-13(21-14)3-2-8-18-24/h2-9H,1H3,(H,20,22,25)	KUCAVVPPPHKSFZ-UHFFFAOYSA-N	285586	3-(4-chlorophenyl)-N-(2-methyl-2H-1,2,3-triazol-4-yl)imidazo[1,2-b]pyridazine-2-carboxamide,trifluoroacetate salt::US10077269, Example 59::US10669279, Example 59::US9598421, Example 59	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 58.5							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285586	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285586&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700184	378169225							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913695	Cn1ncc(NC(=O)c2nc3cccnn3c2-c2ccc(Cl)cc2)n1	InChI=1S/C16H12ClN7O/c1-23-19-9-12(22-23)20-16(25)14-15(10-4-6-11(17)7-5-10)24-13(21-14)3-2-8-18-24/h2-9H,1H3,(H,20,22,25)	KUCAVVPPPHKSFZ-UHFFFAOYSA-N	285586	3-(4-chlorophenyl)-N-(2-methyl-2H-1,2,3-triazol-4-yl)imidazo[1,2-b]pyridazine-2-carboxamide,trifluoroacetate salt::US10077269, Example 59::US10669279, Example 59::US9598421, Example 59	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 749							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285586	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285586&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700184	378169225							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913696	FC1CN(C1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C16H12ClFN4O/c17-11-5-3-10(4-6-11)15-14(16(23)21-8-12(18)9-21)20-13-2-1-7-19-22(13)15/h1-7,12H,8-9H2	LLONFBHYVKPZCK-UHFFFAOYSA-N	285587	US10077269, Example 60::US10669279, Example 60::US9598421, Example 60::[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl](3-fluoroazetidin-1-yl)methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 269							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285587	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285587&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			126700185	378169226							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913697	FC1CN(C1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C16H12ClFN4O/c17-11-5-3-10(4-6-11)15-14(16(23)21-8-12(18)9-21)20-13-2-1-7-19-22(13)15/h1-7,12H,8-9H2	LLONFBHYVKPZCK-UHFFFAOYSA-N	285587	US10077269, Example 60::US10669279, Example 60::US9598421, Example 60::[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl](3-fluoroazetidin-1-yl)methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 196							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285587	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285587&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700185	378169226							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913698	FC1CN(C1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C16H12ClFN4O/c17-11-5-3-10(4-6-11)15-14(16(23)21-8-12(18)9-21)20-13-2-1-7-19-22(13)15/h1-7,12H,8-9H2	LLONFBHYVKPZCK-UHFFFAOYSA-N	285587	US10077269, Example 60::US10669279, Example 60::US9598421, Example 60::[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl](3-fluoroazetidin-1-yl)methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 287							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285587	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285587&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			126700185	378169226							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913699	FC1CN(C1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C16H12ClFN4O/c17-11-5-3-10(4-6-11)15-14(16(23)21-8-12(18)9-21)20-13-2-1-7-19-22(13)15/h1-7,12H,8-9H2	LLONFBHYVKPZCK-UHFFFAOYSA-N	285587	US10077269, Example 60::US10669279, Example 60::US9598421, Example 60::[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl](3-fluoroazetidin-1-yl)methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		>4930							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285587	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285587&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700185	378169226							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913700	FC1(F)CN(C1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C16H11ClF2N4O/c17-11-5-3-10(4-6-11)14-13(15(24)22-8-16(18,19)9-22)21-12-2-1-7-20-23(12)14/h1-7H,8-9H2	PKGAXGNVVMHTJZ-UHFFFAOYSA-N	285588	US10077269, Example 61::US10669279, Example 61::US9598421, Example 61::[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl](3,3-di-fluoroazetidin-1-yl)methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 144							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285588	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285588&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			126700186	378169227							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913701	FC1(F)CN(C1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C16H11ClF2N4O/c17-11-5-3-10(4-6-11)14-13(15(24)22-8-16(18,19)9-22)21-12-2-1-7-20-23(12)14/h1-7H,8-9H2	PKGAXGNVVMHTJZ-UHFFFAOYSA-N	285588	US10077269, Example 61::US10669279, Example 61::US9598421, Example 61::[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl](3,3-di-fluoroazetidin-1-yl)methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 184							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285588	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285588&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700186	378169227							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913702	FC1(F)CN(C1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C16H11ClF2N4O/c17-11-5-3-10(4-6-11)14-13(15(24)22-8-16(18,19)9-22)21-12-2-1-7-20-23(12)14/h1-7H,8-9H2	PKGAXGNVVMHTJZ-UHFFFAOYSA-N	285588	US10077269, Example 61::US10669279, Example 61::US9598421, Example 61::[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl](3,3-di-fluoroazetidin-1-yl)methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 126							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285588	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285588&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			126700186	378169227							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913703	FC1(F)CN(C1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C16H11ClF2N4O/c17-11-5-3-10(4-6-11)14-13(15(24)22-8-16(18,19)9-22)21-12-2-1-7-20-23(12)14/h1-7H,8-9H2	PKGAXGNVVMHTJZ-UHFFFAOYSA-N	285588	US10077269, Example 61::US10669279, Example 61::US9598421, Example 61::[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl](3,3-di-fluoroazetidin-1-yl)methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 1930							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285588	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285588&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700186	378169227							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913704	O=C(N1CCC1)c1nc2cccnn2c1-c1ccc2nccnc2c1	InChI=1S/C18H14N6O/c25-18(23-9-2-10-23)16-17(24-15(22-16)3-1-6-21-24)12-4-5-13-14(11-12)20-8-7-19-13/h1,3-8,11H,2,9-10H2	BGLGXXOVOLTBJL-UHFFFAOYSA-N	285589	US10077269, Example 62::US10669279, Example 62::US9598421, Example 62::azetidin-1-yl[3-(quinoxalin-6-yl)imidazo[1,2-b]pyridazin-2-yl]methanone, formate salt	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 275							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285589	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285589&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700187	378169228							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913705	O=C(N1CCC1)c1nc2cccnn2c1-c1ccc2nccnc2c1	InChI=1S/C18H14N6O/c25-18(23-9-2-10-23)16-17(24-15(22-16)3-1-6-21-24)12-4-5-13-14(11-12)20-8-7-19-13/h1,3-8,11H,2,9-10H2	BGLGXXOVOLTBJL-UHFFFAOYSA-N	285589	US10077269, Example 62::US10669279, Example 62::US9598421, Example 62::azetidin-1-yl[3-(quinoxalin-6-yl)imidazo[1,2-b]pyridazin-2-yl]methanone, formate salt	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 11000							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285589	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285589&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700187	378169228							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913706	CC(=O)c1ccc(F)c(c1)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C18H15FN4O2/c1-11(24)12-5-6-14(19)13(10-12)17-16(18(25)22-8-3-9-22)21-15-4-2-7-20-23(15)17/h2,4-7,10H,3,8-9H2,1H3	QERGAMABSQIOLR-UHFFFAOYSA-N	285590	1-{3-[2-(azetidin-1-ylcarbonyl)imidazo[1,2-b]pyridazin-3-yl]-4-fluoro-phenyl}ethanone, formate salt::US10077269, Example 63::US10669279, Example 63::US9598421, Example 63	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 17.7							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285590	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285590&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875365	378169229							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913707	CC(=O)c1ccc(F)c(c1)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C18H15FN4O2/c1-11(24)12-5-6-14(19)13(10-12)17-16(18(25)22-8-3-9-22)21-15-4-2-7-20-23(15)17/h2,4-7,10H,3,8-9H2,1H3	QERGAMABSQIOLR-UHFFFAOYSA-N	285590	1-{3-[2-(azetidin-1-ylcarbonyl)imidazo[1,2-b]pyridazin-3-yl]-4-fluoro-phenyl}ethanone, formate salt::US10077269, Example 63::US10669279, Example 63::US9598421, Example 63	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 394							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285590	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285590&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875365	378169229							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913708	Cc1ccc(Cl)cc1-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H15ClN4O/c1-11-5-6-12(18)10-13(11)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	COVWSPFRFUFHGD-UHFFFAOYSA-N	285591	US10077269, Example 64::US10669279, Example 64::US9598421, Example 64::azetidin-1-yl[3-(5-chloro-2-methylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 24.2							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285591	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285591&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700189	378169230							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913709	Cc1ccc(Cl)cc1-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H15ClN4O/c1-11-5-6-12(18)10-13(11)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	COVWSPFRFUFHGD-UHFFFAOYSA-N	285591	US10077269, Example 64::US10669279, Example 64::US9598421, Example 64::azetidin-1-yl[3-(5-chloro-2-methylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 844							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285591	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285591&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700189	378169230							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913710	Clc1ccc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(Cl)c1	InChI=1S/C16H12Cl2N4O/c17-10-4-5-11(12(18)9-10)15-14(16(23)21-7-2-8-21)20-13-3-1-6-19-22(13)15/h1,3-6,9H,2,7-8H2	HDPIQIDAUQGIBP-UHFFFAOYSA-N	285592	US10077269, Example 65::US10669279, Example 65::US9598421, Example 65::azetidin-1-yl[3-(2,4-dichlorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 71.9							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285592	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285592&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700188	378169231							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913711	Clc1ccc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(Cl)c1	InChI=1S/C16H12Cl2N4O/c17-10-4-5-11(12(18)9-10)15-14(16(23)21-7-2-8-21)20-13-3-1-6-19-22(13)15/h1,3-6,9H,2,7-8H2	HDPIQIDAUQGIBP-UHFFFAOYSA-N	285592	US10077269, Example 65::US10669279, Example 65::US9598421, Example 65::azetidin-1-yl[3-(2,4-dichlorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 3720							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285592	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285592&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700188	378169231							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913712	Cc1ccc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(C)c1Cl	InChI=1S/C18H17ClN4O/c1-11-6-7-13(12(2)15(11)19)17-16(18(24)22-9-4-10-22)21-14-5-3-8-20-23(14)17/h3,5-8H,4,9-10H2,1-2H3	FQEXMVRMBJXJHA-UHFFFAOYSA-N	285593	US10077269, Example 66::US10669279, Example 66::US9598421, Example 66::azetidin-1-yl[3-(3-chloro-2,4-dimethylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone,formate salt	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 41.0							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285593	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285593&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700190	378169232							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913713	Cc1ccc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(C)c1Cl	InChI=1S/C18H17ClN4O/c1-11-6-7-13(12(2)15(11)19)17-16(18(24)22-9-4-10-22)21-14-5-3-8-20-23(14)17/h3,5-8H,4,9-10H2,1-2H3	FQEXMVRMBJXJHA-UHFFFAOYSA-N	285593	US10077269, Example 66::US10669279, Example 66::US9598421, Example 66::azetidin-1-yl[3-(3-chloro-2,4-dimethylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone,formate salt	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 3390							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285593	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285593&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700190	378169232							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913714	O=C(N1CCC1)c1nc2cccnn2c1-c1ccc2OCCOc2c1	InChI=1S/C18H16N4O3/c23-18(21-7-2-8-21)16-17(22-15(20-16)3-1-6-19-22)12-4-5-13-14(11-12)25-10-9-24-13/h1,3-6,11H,2,7-10H2	KQJWGLFCGGXBHN-UHFFFAOYSA-N	285594	US10077269, Example 67::US10669279, Example 67::US9598421, Example 67::azetidin-1-yl[3-(2,3-dihydro-1,4-benzodioxin-6-yl)imidazo[1,2-b]pyridazin-2-yl]methanone,formate salt	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 59.8							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285594	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285594&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875392	378169233							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913715	O=C(N1CCC1)c1nc2cccnn2c1-c1ccc2OCCOc2c1	InChI=1S/C18H16N4O3/c23-18(21-7-2-8-21)16-17(22-15(20-16)3-1-6-19-22)12-4-5-13-14(11-12)25-10-9-24-13/h1,3-6,11H,2,7-10H2	KQJWGLFCGGXBHN-UHFFFAOYSA-N	285594	US10077269, Example 67::US10669279, Example 67::US9598421, Example 67::azetidin-1-yl[3-(2,3-dihydro-1,4-benzodioxin-6-yl)imidazo[1,2-b]pyridazin-2-yl]methanone,formate salt	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 2260							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285594	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285594&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875392	378169233							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913716	F[C@H]1C[C@H]1NC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1F	InChI=1S/C16H11ClF2N4O/c17-8-3-4-9(10(18)6-8)15-14(16(24)21-12-7-11(12)19)22-13-2-1-5-20-23(13)15/h1-6,11-12H,7H2,(H,21,24)/t11-,12+/m0/s1	OPBIZTGCIJZSGG-NWDGAFQWSA-N	285595	3-(4-chloro-2-fluorophenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 68::US10669279, Example 68::US9598421, Example 68	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 10.6							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285595	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285595&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			126700194	378169234							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913717	F[C@H]1C[C@H]1NC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1F	InChI=1S/C16H11ClF2N4O/c17-8-3-4-9(10(18)6-8)15-14(16(24)21-12-7-11(12)19)22-13-2-1-5-20-23(13)15/h1-6,11-12H,7H2,(H,21,24)/t11-,12+/m0/s1	OPBIZTGCIJZSGG-NWDGAFQWSA-N	285595	3-(4-chloro-2-fluorophenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 68::US10669279, Example 68::US9598421, Example 68	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 35.4							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285595	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285595&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700194	378169234							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913718	F[C@H]1C[C@H]1NC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1F	InChI=1S/C16H11ClF2N4O/c17-8-3-4-9(10(18)6-8)15-14(16(24)21-12-7-11(12)19)22-13-2-1-5-20-23(13)15/h1-6,11-12H,7H2,(H,21,24)/t11-,12+/m0/s1	OPBIZTGCIJZSGG-NWDGAFQWSA-N	285595	3-(4-chloro-2-fluorophenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 68::US10669279, Example 68::US9598421, Example 68	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 25.1							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285595	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285595&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			126700194	378169234							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913719	F[C@H]1C[C@H]1NC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1F	InChI=1S/C16H11ClF2N4O/c17-8-3-4-9(10(18)6-8)15-14(16(24)21-12-7-11(12)19)22-13-2-1-5-20-23(13)15/h1-6,11-12H,7H2,(H,21,24)/t11-,12+/m0/s1	OPBIZTGCIJZSGG-NWDGAFQWSA-N	285595	3-(4-chloro-2-fluorophenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 68::US10669279, Example 68::US9598421, Example 68	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 2620							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285595	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285595&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700194	378169234							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913720	F[C@H]1C[C@H]1NC(=O)c1nc2cccnn2c1-c1cncc(Cl)c1	InChI=1S/C15H11ClFN5O/c16-9-4-8(6-18-7-9)14-13(15(23)20-11-5-10(11)17)21-12-2-1-3-19-22(12)14/h1-4,6-7,10-11H,5H2,(H,20,23)/t10-,11+/m0/s1	ZHXHNZIKCBDMKP-WDEREUQCSA-N	285596	3-(5-chloropyridin-3-yl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 69::US10669279, Example 69::US9598421, Example 69	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 116							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285596	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285596&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700193	378169235							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913721	F[C@H]1C[C@H]1NC(=O)c1nc2cccnn2c1-c1cncc(Cl)c1	InChI=1S/C15H11ClFN5O/c16-9-4-8(6-18-7-9)14-13(15(23)20-11-5-10(11)17)21-12-2-1-3-19-22(12)14/h1-4,6-7,10-11H,5H2,(H,20,23)/t10-,11+/m0/s1	ZHXHNZIKCBDMKP-WDEREUQCSA-N	285596	3-(5-chloropyridin-3-yl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 69::US10669279, Example 69::US9598421, Example 69	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 3330							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285596	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285596&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700193	378169235							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913722	Cc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)N[C@@H]1C[C@@H]1F	InChI=1S/C17H14ClFN4O/c1-9-7-10(18)4-5-11(9)16-15(17(24)21-13-8-12(13)19)22-14-3-2-6-20-23(14)16/h2-7,12-13H,8H2,1H3,(H,21,24)/t12-,13+/m0/s1	XIVVDTJZCTVMFP-QWHCGFSZSA-N	285597	3-(4-chloro-2-methylphenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 70::US10669279, Example 70::US9598421, Example 70	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 36.4							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285597	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285597&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			126700199	378169236							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913723	Cc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)N[C@@H]1C[C@@H]1F	InChI=1S/C17H14ClFN4O/c1-9-7-10(18)4-5-11(9)16-15(17(24)21-13-8-12(13)19)22-14-3-2-6-20-23(14)16/h2-7,12-13H,8H2,1H3,(H,21,24)/t12-,13+/m0/s1	XIVVDTJZCTVMFP-QWHCGFSZSA-N	285597	3-(4-chloro-2-methylphenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 70::US10669279, Example 70::US9598421, Example 70	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 31.0							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285597	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285597&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700199	378169236							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913724	Cc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)N[C@@H]1C[C@@H]1F	InChI=1S/C17H14ClFN4O/c1-9-7-10(18)4-5-11(9)16-15(17(24)21-13-8-12(13)19)22-14-3-2-6-20-23(14)16/h2-7,12-13H,8H2,1H3,(H,21,24)/t12-,13+/m0/s1	XIVVDTJZCTVMFP-QWHCGFSZSA-N	285597	3-(4-chloro-2-methylphenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 70::US10669279, Example 70::US9598421, Example 70	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 90.0							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285597	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285597&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			126700199	378169236							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913725	Cc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)N[C@@H]1C[C@@H]1F	InChI=1S/C17H14ClFN4O/c1-9-7-10(18)4-5-11(9)16-15(17(24)21-13-8-12(13)19)22-14-3-2-6-20-23(14)16/h2-7,12-13H,8H2,1H3,(H,21,24)/t12-,13+/m0/s1	XIVVDTJZCTVMFP-QWHCGFSZSA-N	285597	3-(4-chloro-2-methylphenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 70::US10669279, Example 70::US9598421, Example 70	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 5760							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285597	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285597&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700199	378169236							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913726	Cc1ccc(cc1Cl)-c1c(nc2cccnn12)C(=O)N[C@@H]1C[C@@H]1F	InChI=1S/C17H14ClFN4O/c1-9-4-5-10(7-11(9)18)16-15(17(24)21-13-8-12(13)19)22-14-3-2-6-20-23(14)16/h2-7,12-13H,8H2,1H3,(H,21,24)/t12-,13+/m0/s1	GAGSQLMTGCAMOG-QWHCGFSZSA-N	285598	3-(3-chloro-4-methylphenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 71::US10669279, Example 71::US9598421, Example 71	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		<0.669							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285598	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285598&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			126700196	378169237							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913727	Cc1ccc(cc1Cl)-c1c(nc2cccnn12)C(=O)N[C@@H]1C[C@@H]1F	InChI=1S/C17H14ClFN4O/c1-9-4-5-10(7-11(9)18)16-15(17(24)21-13-8-12(13)19)22-14-3-2-6-20-23(14)16/h2-7,12-13H,8H2,1H3,(H,21,24)/t12-,13+/m0/s1	GAGSQLMTGCAMOG-QWHCGFSZSA-N	285598	3-(3-chloro-4-methylphenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 71::US10669279, Example 71::US9598421, Example 71	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 2.82							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285598	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285598&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700196	378169237							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913728	Cc1ccc(cc1Cl)-c1c(nc2cccnn12)C(=O)N[C@@H]1C[C@@H]1F	InChI=1S/C17H14ClFN4O/c1-9-4-5-10(7-11(9)18)16-15(17(24)21-13-8-12(13)19)22-14-3-2-6-20-23(14)16/h2-7,12-13H,8H2,1H3,(H,21,24)/t12-,13+/m0/s1	GAGSQLMTGCAMOG-QWHCGFSZSA-N	285598	3-(3-chloro-4-methylphenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 71::US10669279, Example 71::US9598421, Example 71	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 2.00							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285598	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285598&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			126700196	378169237							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913729	Cc1ccc(cc1Cl)-c1c(nc2cccnn12)C(=O)N[C@@H]1C[C@@H]1F	InChI=1S/C17H14ClFN4O/c1-9-4-5-10(7-11(9)18)16-15(17(24)21-13-8-12(13)19)22-14-3-2-6-20-23(14)16/h2-7,12-13H,8H2,1H3,(H,21,24)/t12-,13+/m0/s1	GAGSQLMTGCAMOG-QWHCGFSZSA-N	285598	3-(3-chloro-4-methylphenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 71::US10669279, Example 71::US9598421, Example 71	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 113							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285598	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285598&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700196	378169237							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913730	Cc1ccc(-c2c(nc3cccnn23)C(=O)N[C@@H]2C[C@@H]2F)c(F)c1	InChI=1S/C17H14F2N4O/c1-9-4-5-10(11(18)7-9)16-15(17(24)21-13-8-12(13)19)22-14-3-2-6-20-23(14)16/h2-7,12-13H,8H2,1H3,(H,21,24)/t12-,13+/m0/s1	LTEXTCILPHUJPK-QWHCGFSZSA-N	285599	N-[(1R,2S)-2-fluorocyclopro-pyl]-3-(2-fluoro-4-methyl-phenyl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 72::US10669279, Example 72::US9598421, Example 72	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 192							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285599	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285599&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700195	378169238							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913731	Cc1ccc(-c2c(nc3cccnn23)C(=O)N[C@@H]2C[C@@H]2F)c(F)c1	InChI=1S/C17H14F2N4O/c1-9-4-5-10(11(18)7-9)16-15(17(24)21-13-8-12(13)19)22-14-3-2-6-20-23(14)16/h2-7,12-13H,8H2,1H3,(H,21,24)/t12-,13+/m0/s1	LTEXTCILPHUJPK-QWHCGFSZSA-N	285599	N-[(1R,2S)-2-fluorocyclopro-pyl]-3-(2-fluoro-4-methyl-phenyl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 72::US10669279, Example 72::US9598421, Example 72	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 6590							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285599	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285599&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700195	378169238							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913732	COc1ccc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)c1	InChI=1S/C17H15FN4O2/c1-24-11-5-6-12(13(18)10-11)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	WXZZRVFNPNQGRD-UHFFFAOYSA-N	285600	US10077269, Example 73::US10669279, Example 73::US9598421, Example 73::azetidin-1-yl[3-(2-fluoro-4-methoxyphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 165							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285600	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285600&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			126700197	378169239							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913733	COc1ccc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)c1	InChI=1S/C17H15FN4O2/c1-24-11-5-6-12(13(18)10-11)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	WXZZRVFNPNQGRD-UHFFFAOYSA-N	285600	US10077269, Example 73::US10669279, Example 73::US9598421, Example 73::azetidin-1-yl[3-(2-fluoro-4-methoxyphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 495							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285600	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285600&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700197	378169239							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913734	COc1ccc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)c1	InChI=1S/C17H15FN4O2/c1-24-11-5-6-12(13(18)10-11)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	WXZZRVFNPNQGRD-UHFFFAOYSA-N	285600	US10077269, Example 73::US10669279, Example 73::US9598421, Example 73::azetidin-1-yl[3-(2-fluoro-4-methoxyphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 1440							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285600	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285600&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			126700197	378169239							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913735	COc1ccc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)c1	InChI=1S/C17H15FN4O2/c1-24-11-5-6-12(13(18)10-11)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	WXZZRVFNPNQGRD-UHFFFAOYSA-N	285600	US10077269, Example 73::US10669279, Example 73::US9598421, Example 73::azetidin-1-yl[3-(2-fluoro-4-methoxyphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		>24700							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285600	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285600&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700197	378169239							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913736	O=C(N1CCC1)c1nc2cccnn2c1-c1cnc2ccnn2c1	InChI=1S/C16H13N7O/c24-16(21-7-2-8-21)14-15(23-13(20-14)3-1-5-19-23)11-9-17-12-4-6-18-22(12)10-11/h1,3-6,9-10H,2,7-8H2	RINAWWCARFNGLM-UHFFFAOYSA-N	285601	US10077269, Example 74::US10669279, Example 74::US9598421, Example 74::azetidin-1-yl[3-(pyrazolo[1,5-a]pyrimidin-6-yl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 225							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285601	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285601&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700198	378169240							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913737	O=C(N1CCC1)c1nc2cccnn2c1-c1cnc2ccnn2c1	InChI=1S/C16H13N7O/c24-16(21-7-2-8-21)14-15(23-13(20-14)3-1-5-19-23)11-9-17-12-4-6-18-22(12)10-11/h1,3-6,9-10H,2,7-8H2	RINAWWCARFNGLM-UHFFFAOYSA-N	285601	US10077269, Example 74::US10669279, Example 74::US9598421, Example 74::azetidin-1-yl[3-(pyrazolo[1,5-a]pyrimidin-6-yl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 10500							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285601	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285601&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700198	378169240							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913738	FC(F)Oc1cc(ccn1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H13F2N5O2/c17-16(18)25-12-8-9(5-7-19-12)14-13(15(24)21-10-3-4-10)22-11-2-1-6-20-23(11)14/h1-2,5-8,10,16H,3-4H2,(H,21,24)	DSCLXJMGAQHPPO-UHFFFAOYSA-N	285602	N-cyclopropyl-3-[2-(difluoro-methoxy)pyridin-4-yl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 75::US10669279, Example 75::US9598421, Example 75	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 10.5							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285602	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285602&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118875376	378169241							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913739	FC(F)Oc1cc(ccn1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H13F2N5O2/c17-16(18)25-12-8-9(5-7-19-12)14-13(15(24)21-10-3-4-10)22-11-2-1-6-20-23(11)14/h1-2,5-8,10,16H,3-4H2,(H,21,24)	DSCLXJMGAQHPPO-UHFFFAOYSA-N	285602	N-cyclopropyl-3-[2-(difluoro-methoxy)pyridin-4-yl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 75::US10669279, Example 75::US9598421, Example 75	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 5.99							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285602	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285602&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875376	378169241							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913740	FC(F)Oc1cc(ccn1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H13F2N5O2/c17-16(18)25-12-8-9(5-7-19-12)14-13(15(24)21-10-3-4-10)22-11-2-1-6-20-23(11)14/h1-2,5-8,10,16H,3-4H2,(H,21,24)	DSCLXJMGAQHPPO-UHFFFAOYSA-N	285602	N-cyclopropyl-3-[2-(difluoro-methoxy)pyridin-4-yl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 75::US10669279, Example 75::US9598421, Example 75	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 24.9							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285602	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285602&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118875376	378169241							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913741	FC(F)Oc1cc(ccn1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H13F2N5O2/c17-16(18)25-12-8-9(5-7-19-12)14-13(15(24)21-10-3-4-10)22-11-2-1-6-20-23(11)14/h1-2,5-8,10,16H,3-4H2,(H,21,24)	DSCLXJMGAQHPPO-UHFFFAOYSA-N	285602	N-cyclopropyl-3-[2-(difluoro-methoxy)pyridin-4-yl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 75::US10669279, Example 75::US9598421, Example 75	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 104							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285602	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285602&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875376	378169241							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913742	FC(F)Oc1cc(ccn1)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H13F2N5O2/c17-16(18)25-12-9-10(4-6-19-12)14-13(15(24)22-7-2-8-22)21-11-3-1-5-20-23(11)14/h1,3-6,9,16H,2,7-8H2	FGLJIZXIRLUUJT-UHFFFAOYSA-N	285603	US10077269, Example 76::US10669279, Example 76::US9598421, Example 76::azetidin-1-yl{3-[2-(difluoro-methoxy)pyridin-4-yl]imidazo[1,2-b]pyridazin-2-yl}methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 7.09							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285603	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285603&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118875361	378169242							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913743	FC(F)Oc1cc(ccn1)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H13F2N5O2/c17-16(18)25-12-9-10(4-6-19-12)14-13(15(24)22-7-2-8-22)21-11-3-1-5-20-23(11)14/h1,3-6,9,16H,2,7-8H2	FGLJIZXIRLUUJT-UHFFFAOYSA-N	285603	US10077269, Example 76::US10669279, Example 76::US9598421, Example 76::azetidin-1-yl{3-[2-(difluoro-methoxy)pyridin-4-yl]imidazo[1,2-b]pyridazin-2-yl}methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 5.43							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285603	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285603&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875361	378169242							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913744	FC(F)Oc1cc(ccn1)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H13F2N5O2/c17-16(18)25-12-9-10(4-6-19-12)14-13(15(24)22-7-2-8-22)21-11-3-1-5-20-23(11)14/h1,3-6,9,16H,2,7-8H2	FGLJIZXIRLUUJT-UHFFFAOYSA-N	285603	US10077269, Example 76::US10669279, Example 76::US9598421, Example 76::azetidin-1-yl{3-[2-(difluoro-methoxy)pyridin-4-yl]imidazo[1,2-b]pyridazin-2-yl}methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 22.2							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285603	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285603&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118875361	378169242							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913745	FC(F)Oc1cc(ccn1)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H13F2N5O2/c17-16(18)25-12-9-10(4-6-19-12)14-13(15(24)22-7-2-8-22)21-11-3-1-5-20-23(11)14/h1,3-6,9,16H,2,7-8H2	FGLJIZXIRLUUJT-UHFFFAOYSA-N	285603	US10077269, Example 76::US10669279, Example 76::US9598421, Example 76::azetidin-1-yl{3-[2-(difluoro-methoxy)pyridin-4-yl]imidazo[1,2-b]pyridazin-2-yl}methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 94.5							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285603	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285603&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875361	378169242							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913746	O=C(N1CCC1)c1nc2cccnn2c1-c1ccc2ncoc2c1	InChI=1S/C17H13N5O2/c23-17(21-7-2-8-21)15-16(22-14(20-15)3-1-6-19-22)11-4-5-12-13(9-11)24-10-18-12/h1,3-6,9-10H,2,7-8H2	AZGFYUPSXODBAO-UHFFFAOYSA-N	285607	US10077269, Example 77::US10669279, Example 77::US9598421, Example 77::azetidin-1-yl[3-(1,3-ben-zoxazol-6-yl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 46.1							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285607	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285607&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			126700200	378169246							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913747	O=C(N1CCC1)c1nc2cccnn2c1-c1ccc2ncoc2c1	InChI=1S/C17H13N5O2/c23-17(21-7-2-8-21)15-16(22-14(20-15)3-1-6-19-22)11-4-5-12-13(9-11)24-10-18-12/h1,3-6,9-10H,2,7-8H2	AZGFYUPSXODBAO-UHFFFAOYSA-N	285607	US10077269, Example 77::US10669279, Example 77::US9598421, Example 77::azetidin-1-yl[3-(1,3-ben-zoxazol-6-yl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 80.4							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285607	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285607&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700200	378169246							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913748	O=C(N1CCC1)c1nc2cccnn2c1-c1ccc2ncoc2c1	InChI=1S/C17H13N5O2/c23-17(21-7-2-8-21)15-16(22-14(20-15)3-1-6-19-22)11-4-5-12-13(9-11)24-10-18-12/h1,3-6,9-10H,2,7-8H2	AZGFYUPSXODBAO-UHFFFAOYSA-N	285607	US10077269, Example 77::US10669279, Example 77::US9598421, Example 77::azetidin-1-yl[3-(1,3-ben-zoxazol-6-yl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 186							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285607	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285607&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			126700200	378169246							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913749	O=C(N1CCC1)c1nc2cccnn2c1-c1ccc2ncoc2c1	InChI=1S/C17H13N5O2/c23-17(21-7-2-8-21)15-16(22-14(20-15)3-1-6-19-22)11-4-5-12-13(9-11)24-10-18-12/h1,3-6,9-10H,2,7-8H2	AZGFYUPSXODBAO-UHFFFAOYSA-N	285607	US10077269, Example 77::US10669279, Example 77::US9598421, Example 77::azetidin-1-yl[3-(1,3-ben-zoxazol-6-yl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		>16600							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285607	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285607&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700200	378169246							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913750	O=C(NC1CC1)c1nc2cccnn2c1-c1cnc2ccnn2c1	InChI=1S/C16H13N7O/c24-16(20-11-3-4-11)14-15(23-13(21-14)2-1-6-19-23)10-8-17-12-5-7-18-22(12)9-10/h1-2,5-9,11H,3-4H2,(H,20,24)	CWHUSRYDJYDLGV-UHFFFAOYSA-N	285608	N-cyclopropyl-3-(pyrazolo[1,5-a]pyrimidin-6-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 78::US10669279, Example 78::US9598421, Example 78	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 364							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285608	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285608&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875395	378169247							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913751	O=C(NC1CC1)c1nc2cccnn2c1-c1cnc2ccnn2c1	InChI=1S/C16H13N7O/c24-16(20-11-3-4-11)14-15(23-13(21-14)2-1-6-19-23)10-8-17-12-5-7-18-22(12)9-10/h1-2,5-9,11H,3-4H2,(H,20,24)	CWHUSRYDJYDLGV-UHFFFAOYSA-N	285608	N-cyclopropyl-3-(pyrazolo[1,5-a]pyrimidin-6-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 78::US10669279, Example 78::US9598421, Example 78	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 6490							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285608	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285608&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875395	378169247							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913752	Fc1cc(ccc1-c1c(nc2cccnn12)C(=O)NC1CC1)C#N	InChI=1S/C17H12FN5O/c18-13-8-10(9-19)3-6-12(13)16-15(17(24)21-11-4-5-11)22-14-2-1-7-20-23(14)16/h1-3,6-8,11H,4-5H2,(H,21,24)	NOSXOAFVJDFCQR-UHFFFAOYSA-N	285609	3-(4-cyano-2-fluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 79::US10669279, Example 79::US9598421, Example 79	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 48.8							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285609	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285609&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118875362	378169248							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913753	Fc1cc(ccc1-c1c(nc2cccnn12)C(=O)NC1CC1)C#N	InChI=1S/C17H12FN5O/c18-13-8-10(9-19)3-6-12(13)16-15(17(24)21-11-4-5-11)22-14-2-1-7-20-23(14)16/h1-3,6-8,11H,4-5H2,(H,21,24)	NOSXOAFVJDFCQR-UHFFFAOYSA-N	285609	3-(4-cyano-2-fluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 79::US10669279, Example 79::US9598421, Example 79	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 190							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285609	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285609&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875362	378169248							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913754	Fc1cc(ccc1-c1c(nc2cccnn12)C(=O)NC1CC1)C#N	InChI=1S/C17H12FN5O/c18-13-8-10(9-19)3-6-12(13)16-15(17(24)21-11-4-5-11)22-14-2-1-7-20-23(14)16/h1-3,6-8,11H,4-5H2,(H,21,24)	NOSXOAFVJDFCQR-UHFFFAOYSA-N	285609	3-(4-cyano-2-fluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 79::US10669279, Example 79::US9598421, Example 79	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 297							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285609	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285609&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118875362	378169248							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913755	Fc1cc(ccc1-c1c(nc2cccnn12)C(=O)NC1CC1)C#N	InChI=1S/C17H12FN5O/c18-13-8-10(9-19)3-6-12(13)16-15(17(24)21-11-4-5-11)22-14-2-1-7-20-23(14)16/h1-3,6-8,11H,4-5H2,(H,21,24)	NOSXOAFVJDFCQR-UHFFFAOYSA-N	285609	3-(4-cyano-2-fluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 79::US10669279, Example 79::US9598421, Example 79	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		>25400							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285609	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285609&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875362	378169248							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913756	Cc1ccc(cc1-c1c(nc2cccnn12)C(=O)NC1CC1)C#N	InChI=1S/C18H15N5O/c1-11-4-5-12(10-19)9-14(11)17-16(18(24)21-13-6-7-13)22-15-3-2-8-20-23(15)17/h2-5,8-9,13H,6-7H2,1H3,(H,21,24)	AYAPJFYFCDHLKN-UHFFFAOYSA-N	285610	3-(5-cyano-2-methylphenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 80::US10669279, Example 80::US9598421, Example 80	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 344							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285610	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285610&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875393	378169249							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913757	Cc1ccc(cc1-c1c(nc2cccnn12)C(=O)NC1CC1)C#N	InChI=1S/C18H15N5O/c1-11-4-5-12(10-19)9-14(11)17-16(18(24)21-13-6-7-13)22-15-3-2-8-20-23(15)17/h2-5,8-9,13H,6-7H2,1H3,(H,21,24)	AYAPJFYFCDHLKN-UHFFFAOYSA-N	285610	3-(5-cyano-2-methylphenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 80::US10669279, Example 80::US9598421, Example 80	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		>25400							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285610	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285610&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875393	378169249							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913758	CCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1	InChI=1S/C15H12ClFN4O/c1-2-18-15(22)13-14(9-5-6-10(16)11(17)8-9)21-12(20-13)4-3-7-19-21/h3-8H,2H2,1H3,(H,18,22)	KMAXAJFXSIHYPS-UHFFFAOYSA-N	285611	3-(4-chloro-3-fluorophenyl)-N-ethylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 81::US10669279, Example 81::US9598421, Example 81	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 7.86							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285611	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285611&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118875415	378169250							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913759	CCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1	InChI=1S/C15H12ClFN4O/c1-2-18-15(22)13-14(9-5-6-10(16)11(17)8-9)21-12(20-13)4-3-7-19-21/h3-8H,2H2,1H3,(H,18,22)	KMAXAJFXSIHYPS-UHFFFAOYSA-N	285611	3-(4-chloro-3-fluorophenyl)-N-ethylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 81::US10669279, Example 81::US9598421, Example 81	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 9.34							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285611	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285611&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875415	378169250							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913760	CCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1	InChI=1S/C15H12ClFN4O/c1-2-18-15(22)13-14(9-5-6-10(16)11(17)8-9)21-12(20-13)4-3-7-19-21/h3-8H,2H2,1H3,(H,18,22)	KMAXAJFXSIHYPS-UHFFFAOYSA-N	285611	3-(4-chloro-3-fluorophenyl)-N-ethylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 81::US10669279, Example 81::US9598421, Example 81	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 25.8							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285611	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285611&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118875415	378169250							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913761	CCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1	InChI=1S/C15H12ClFN4O/c1-2-18-15(22)13-14(9-5-6-10(16)11(17)8-9)21-12(20-13)4-3-7-19-21/h3-8H,2H2,1H3,(H,18,22)	KMAXAJFXSIHYPS-UHFFFAOYSA-N	285611	3-(4-chloro-3-fluorophenyl)-N-ethylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 81::US10669279, Example 81::US9598421, Example 81	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 853							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285611	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285611&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875415	378169250							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913762	Fc1cc(ccc1Cl)-c1c(nc2cccnn12)C(=O)Nc1cn[nH]c1	InChI=1S/C16H10ClFN6O/c17-11-4-3-9(6-12(11)18)15-14(16(25)22-10-7-19-20-8-10)23-13-2-1-5-21-24(13)15/h1-8H,(H,19,20)(H,22,25)	YEUSBANVZAFKBV-UHFFFAOYSA-N	285612	3-(4-chloro-3-fluorophenyl)-N-(1H-pyrazol-4-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 82::US10669279, Example 82::US9598421, Example 82	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 12.0							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285612	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285612&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118875379	378169251							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913763	Fc1cc(ccc1Cl)-c1c(nc2cccnn12)C(=O)Nc1cn[nH]c1	InChI=1S/C16H10ClFN6O/c17-11-4-3-9(6-12(11)18)15-14(16(25)22-10-7-19-20-8-10)23-13-2-1-5-21-24(13)15/h1-8H,(H,19,20)(H,22,25)	YEUSBANVZAFKBV-UHFFFAOYSA-N	285612	3-(4-chloro-3-fluorophenyl)-N-(1H-pyrazol-4-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 82::US10669279, Example 82::US9598421, Example 82	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 5.14							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285612	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285612&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875379	378169251							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913764	Fc1cc(ccc1Cl)-c1c(nc2cccnn12)C(=O)Nc1cn[nH]c1	InChI=1S/C16H10ClFN6O/c17-11-4-3-9(6-12(11)18)15-14(16(25)22-10-7-19-20-8-10)23-13-2-1-5-21-24(13)15/h1-8H,(H,19,20)(H,22,25)	YEUSBANVZAFKBV-UHFFFAOYSA-N	285612	3-(4-chloro-3-fluorophenyl)-N-(1H-pyrazol-4-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 82::US10669279, Example 82::US9598421, Example 82	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 43.4							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285612	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285612&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118875379	378169251							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913765	Fc1cc(ccc1Cl)-c1c(nc2cccnn12)C(=O)Nc1cn[nH]c1	InChI=1S/C16H10ClFN6O/c17-11-4-3-9(6-12(11)18)15-14(16(25)22-10-7-19-20-8-10)23-13-2-1-5-21-24(13)15/h1-8H,(H,19,20)(H,22,25)	YEUSBANVZAFKBV-UHFFFAOYSA-N	285612	3-(4-chloro-3-fluorophenyl)-N-(1H-pyrazol-4-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 82::US10669279, Example 82::US9598421, Example 82	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 56.5							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285612	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285612&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875379	378169251							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913766	Clc1ccc(cc1Cl)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H12Cl2N4O/c17-11-5-4-10(9-12(11)18)15-14(16(23)21-7-2-8-21)20-13-3-1-6-19-22(13)15/h1,3-6,9H,2,7-8H2	VGRIHMHLBGLHHB-UHFFFAOYSA-N	285613	US10077269, Example 83::US10669279, Example 83::US9598421, Example 83::azetidin-1-yl[3-(3,4-dichloro-phenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 6.21							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285613	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285613&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			125474324	378169252							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913767	Clc1ccc(cc1Cl)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H12Cl2N4O/c17-11-5-4-10(9-12(11)18)15-14(16(23)21-7-2-8-21)20-13-3-1-6-19-22(13)15/h1,3-6,9H,2,7-8H2	VGRIHMHLBGLHHB-UHFFFAOYSA-N	285613	US10077269, Example 83::US10669279, Example 83::US9598421, Example 83::azetidin-1-yl[3-(3,4-dichloro-phenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 5.39							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285613	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285613&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			125474324	378169252							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913768	Clc1ccc(cc1Cl)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H12Cl2N4O/c17-11-5-4-10(9-12(11)18)15-14(16(23)21-7-2-8-21)20-13-3-1-6-19-22(13)15/h1,3-6,9H,2,7-8H2	VGRIHMHLBGLHHB-UHFFFAOYSA-N	285613	US10077269, Example 83::US10669279, Example 83::US9598421, Example 83::azetidin-1-yl[3-(3,4-dichloro-phenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 40.0							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285613	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285613&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			125474324	378169252							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913769	Clc1ccc(cc1Cl)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H12Cl2N4O/c17-11-5-4-10(9-12(11)18)15-14(16(23)21-7-2-8-21)20-13-3-1-6-19-22(13)15/h1,3-6,9H,2,7-8H2	VGRIHMHLBGLHHB-UHFFFAOYSA-N	285613	US10077269, Example 83::US10669279, Example 83::US9598421, Example 83::azetidin-1-yl[3-(3,4-dichloro-phenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 495							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285613	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285613&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			125474324	378169252							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913770	Clc1cccc(c1)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H13ClN4O/c17-12-5-1-4-11(10-12)15-14(16(22)20-8-3-9-20)19-13-6-2-7-18-21(13)15/h1-2,4-7,10H,3,8-9H2	LLKDXLOAXVIBRW-UHFFFAOYSA-N	285614	US10077269, Example 84::US10669279, Example 84::US9598421, Example 84::azetidin-1-yl[3-(3-chloro-phenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 16.7							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285614	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285614&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118875397	378169253							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913771	Clc1cccc(c1)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H13ClN4O/c17-12-5-1-4-11(10-12)15-14(16(22)20-8-3-9-20)19-13-6-2-7-18-21(13)15/h1-2,4-7,10H,3,8-9H2	LLKDXLOAXVIBRW-UHFFFAOYSA-N	285614	US10077269, Example 84::US10669279, Example 84::US9598421, Example 84::azetidin-1-yl[3-(3-chloro-phenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 7.84							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285614	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285614&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875397	378169253							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913772	Clc1cccc(c1)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H13ClN4O/c17-12-5-1-4-11(10-12)15-14(16(22)20-8-3-9-20)19-13-6-2-7-18-21(13)15/h1-2,4-7,10H,3,8-9H2	LLKDXLOAXVIBRW-UHFFFAOYSA-N	285614	US10077269, Example 84::US10669279, Example 84::US9598421, Example 84::azetidin-1-yl[3-(3-chloro-phenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 44.4							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285614	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285614&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118875397	378169253							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913773	Clc1cccc(c1)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H13ClN4O/c17-12-5-1-4-11(10-12)15-14(16(22)20-8-3-9-20)19-13-6-2-7-18-21(13)15/h1-2,4-7,10H,3,8-9H2	LLKDXLOAXVIBRW-UHFFFAOYSA-N	285614	US10077269, Example 84::US10669279, Example 84::US9598421, Example 84::azetidin-1-yl[3-(3-chloro-phenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 977							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285614	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285614&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875397	378169253							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913774	CCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C15H13ClN4O/c1-2-17-15(21)13-14(10-5-7-11(16)8-6-10)20-12(19-13)4-3-9-18-20/h3-9H,2H2,1H3,(H,17,21)	SNPDIBMAAUTAIH-UHFFFAOYSA-N	285615	3-(4-chlorophenyl)-N-ethylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 85::US10669279, Example 85::US9598421, Example 85	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 25.6							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285615	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285615&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118875373	378169254							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913775	CCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C15H13ClN4O/c1-2-17-15(21)13-14(10-5-7-11(16)8-6-10)20-12(19-13)4-3-9-18-20/h3-9H,2H2,1H3,(H,17,21)	SNPDIBMAAUTAIH-UHFFFAOYSA-N	285615	3-(4-chlorophenyl)-N-ethylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 85::US10669279, Example 85::US9598421, Example 85	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 87.3							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285615	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285615&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875373	378169254							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913776	CCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C15H13ClN4O/c1-2-17-15(21)13-14(10-5-7-11(16)8-6-10)20-12(19-13)4-3-9-18-20/h3-9H,2H2,1H3,(H,17,21)	SNPDIBMAAUTAIH-UHFFFAOYSA-N	285615	3-(4-chlorophenyl)-N-ethylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 85::US10669279, Example 85::US9598421, Example 85	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 47.2							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285615	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285615&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118875373	378169254							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913777	CCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C15H13ClN4O/c1-2-17-15(21)13-14(10-5-7-11(16)8-6-10)20-12(19-13)4-3-9-18-20/h3-9H,2H2,1H3,(H,17,21)	SNPDIBMAAUTAIH-UHFFFAOYSA-N	285615	3-(4-chlorophenyl)-N-ethylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 85::US10669279, Example 85::US9598421, Example 85	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 6700							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285615	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285615&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875373	378169254							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913778	FC1(F)Oc2ccc(cc2O1)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H12F2N4O3/c18-17(19)25-11-5-4-10(9-12(11)26-17)15-14(16(24)22-7-2-8-22)21-13-3-1-6-20-23(13)15/h1,3-6,9H,2,7-8H2	CIMWFDZKHUKERW-UHFFFAOYSA-N	285616	US10077269, Example 86::US10669279, Example 86::US9598421, Example 86::azetidin-1-yl[3-(2,2-difluoro-1,3-benzodioxol-5-yl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 5.83							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285616	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285616&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118875409	378169255							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913779	FC1(F)Oc2ccc(cc2O1)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H12F2N4O3/c18-17(19)25-11-5-4-10(9-12(11)26-17)15-14(16(24)22-7-2-8-22)21-13-3-1-6-20-23(13)15/h1,3-6,9H,2,7-8H2	CIMWFDZKHUKERW-UHFFFAOYSA-N	285616	US10077269, Example 86::US10669279, Example 86::US9598421, Example 86::azetidin-1-yl[3-(2,2-difluoro-1,3-benzodioxol-5-yl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 7.72							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285616	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285616&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875409	378169255							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913780	FC1(F)Oc2ccc(cc2O1)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H12F2N4O3/c18-17(19)25-11-5-4-10(9-12(11)26-17)15-14(16(24)22-7-2-8-22)21-13-3-1-6-20-23(13)15/h1,3-6,9H,2,7-8H2	CIMWFDZKHUKERW-UHFFFAOYSA-N	285616	US10077269, Example 86::US10669279, Example 86::US9598421, Example 86::azetidin-1-yl[3-(2,2-difluoro-1,3-benzodioxol-5-yl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 25.0							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285616	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285616&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118875409	378169255							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913781	FC1(F)Oc2ccc(cc2O1)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H12F2N4O3/c18-17(19)25-11-5-4-10(9-12(11)26-17)15-14(16(24)22-7-2-8-22)21-13-3-1-6-20-23(13)15/h1,3-6,9H,2,7-8H2	CIMWFDZKHUKERW-UHFFFAOYSA-N	285616	US10077269, Example 86::US10669279, Example 86::US9598421, Example 86::azetidin-1-yl[3-(2,2-difluoro-1,3-benzodioxol-5-yl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 179							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285616	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285616&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875409	378169255							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913782	FC(F)Oc1ccc(cn1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H13F2N5O2/c17-16(18)25-12-6-3-9(8-19-12)14-13(15(24)21-10-4-5-10)22-11-2-1-7-20-23(11)14/h1-3,6-8,10,16H,4-5H2,(H,21,24)	YCEYKGZVRQVUNW-UHFFFAOYSA-N	285617	N-cyclopropyl-3-[6-(difluoromethoxy)pyridin-3-yl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 87::US10669279, Example 87::US9598421, Example 87	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 240							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285617	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285617&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118875385	378169256							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913783	FC(F)Oc1ccc(cn1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H13F2N5O2/c17-16(18)25-12-6-3-9(8-19-12)14-13(15(24)21-10-4-5-10)22-11-2-1-7-20-23(11)14/h1-3,6-8,10,16H,4-5H2,(H,21,24)	YCEYKGZVRQVUNW-UHFFFAOYSA-N	285617	N-cyclopropyl-3-[6-(difluoromethoxy)pyridin-3-yl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 87::US10669279, Example 87::US9598421, Example 87	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 173							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285617	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285617&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875385	378169256							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913784	FC(F)Oc1ccc(cn1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H13F2N5O2/c17-16(18)25-12-6-3-9(8-19-12)14-13(15(24)21-10-4-5-10)22-11-2-1-7-20-23(11)14/h1-3,6-8,10,16H,4-5H2,(H,21,24)	YCEYKGZVRQVUNW-UHFFFAOYSA-N	285617	N-cyclopropyl-3-[6-(difluoromethoxy)pyridin-3-yl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 87::US10669279, Example 87::US9598421, Example 87	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 397							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285617	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285617&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118875385	378169256							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913785	FC(F)Oc1ccc(cn1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H13F2N5O2/c17-16(18)25-12-6-3-9(8-19-12)14-13(15(24)21-10-4-5-10)22-11-2-1-7-20-23(11)14/h1-3,6-8,10,16H,4-5H2,(H,21,24)	YCEYKGZVRQVUNW-UHFFFAOYSA-N	285617	N-cyclopropyl-3-[6-(difluoromethoxy)pyridin-3-yl]imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 87::US10669279, Example 87::US9598421, Example 87	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 6790							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285617	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285617&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875385	378169256							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913786	O=C(NC1CC1)c1nc2cccnn2c1-c1ccc2ncoc2c1	InChI=1S/C17H13N5O2/c23-17(20-11-4-5-11)15-16(22-14(21-15)2-1-7-19-22)10-3-6-12-13(8-10)24-9-18-12/h1-3,6-9,11H,4-5H2,(H,20,23)	QCUHKLBHHWHXAM-UHFFFAOYSA-N	285618	3-(1,3-benzoxazol-6-yl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 88::US10669279, Example 88::US9598421, Example 88	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 45.0							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285618	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285618&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			126700202	378169257							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913787	O=C(NC1CC1)c1nc2cccnn2c1-c1ccc2ncoc2c1	InChI=1S/C17H13N5O2/c23-17(20-11-4-5-11)15-16(22-14(21-15)2-1-7-19-22)10-3-6-12-13(8-10)24-9-18-12/h1-3,6-9,11H,4-5H2,(H,20,23)	QCUHKLBHHWHXAM-UHFFFAOYSA-N	285618	3-(1,3-benzoxazol-6-yl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 88::US10669279, Example 88::US9598421, Example 88	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 39.2							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285618	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285618&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700202	378169257							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913788	O=C(NC1CC1)c1nc2cccnn2c1-c1ccc2ncoc2c1	InChI=1S/C17H13N5O2/c23-17(20-11-4-5-11)15-16(22-14(21-15)2-1-7-19-22)10-3-6-12-13(8-10)24-9-18-12/h1-3,6-9,11H,4-5H2,(H,20,23)	QCUHKLBHHWHXAM-UHFFFAOYSA-N	285618	3-(1,3-benzoxazol-6-yl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 88::US10669279, Example 88::US9598421, Example 88	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 136							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285618	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285618&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			126700202	378169257							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913789	O=C(NC1CC1)c1nc2cccnn2c1-c1ccc2ncoc2c1	InChI=1S/C17H13N5O2/c23-17(20-11-4-5-11)15-16(22-14(21-15)2-1-7-19-22)10-3-6-12-13(8-10)24-9-18-12/h1-3,6-9,11H,4-5H2,(H,20,23)	QCUHKLBHHWHXAM-UHFFFAOYSA-N	285618	3-(1,3-benzoxazol-6-yl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 88::US10669279, Example 88::US9598421, Example 88	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 10400							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285618	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285618&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700202	378169257							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913790	Cc1cc2ncnn2cc1-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C17H15N7O/c1-10-7-14-18-9-20-23(14)8-12(10)16-15(17(25)21-11-4-5-11)22-13-3-2-6-19-24(13)16/h2-3,6-9,11H,4-5H2,1H3,(H,21,25)	HWZASUIHFDZUSF-UHFFFAOYSA-N	285619	N-cyclopropyl-3-(7-methyl[1,2,4]triazolo[1,5-a]pyridin-6-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 89::US10669279, Example 89::US9598421, Example 89	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 829							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285619	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285619&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118875367	378169258							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913791	Cc1cc2ncnn2cc1-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C17H15N7O/c1-10-7-14-18-9-20-23(14)8-12(10)16-15(17(25)21-11-4-5-11)22-13-3-2-6-19-24(13)16/h2-3,6-9,11H,4-5H2,1H3,(H,21,25)	HWZASUIHFDZUSF-UHFFFAOYSA-N	285619	N-cyclopropyl-3-(7-methyl[1,2,4]triazolo[1,5-a]pyridin-6-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 89::US10669279, Example 89::US9598421, Example 89	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 333							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285619	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285619&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875367	378169258							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913792	Cc1cc2ncnn2cc1-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C17H15N7O/c1-10-7-14-18-9-20-23(14)8-12(10)16-15(17(25)21-11-4-5-11)22-13-3-2-6-19-24(13)16/h2-3,6-9,11H,4-5H2,1H3,(H,21,25)	HWZASUIHFDZUSF-UHFFFAOYSA-N	285619	N-cyclopropyl-3-(7-methyl[1,2,4]triazolo[1,5-a]pyridin-6-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 89::US10669279, Example 89::US9598421, Example 89	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 3760							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285619	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285619&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118875367	378169258							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913793	Cc1cc2ncnn2cc1-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C17H15N7O/c1-10-7-14-18-9-20-23(14)8-12(10)16-15(17(25)21-11-4-5-11)22-13-3-2-6-19-24(13)16/h2-3,6-9,11H,4-5H2,1H3,(H,21,25)	HWZASUIHFDZUSF-UHFFFAOYSA-N	285619	N-cyclopropyl-3-(7-methyl[1,2,4]triazolo[1,5-a]pyridin-6-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 89::US10669279, Example 89::US9598421, Example 89	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		>17200							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285619	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285619&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875367	378169258							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913794	Fc1cc(ccc1C#N)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C17H12FN5O/c18-13-8-10(3-4-11(13)9-19)16-15(17(24)21-12-5-6-12)22-14-2-1-7-20-23(14)16/h1-4,7-8,12H,5-6H2,(H,21,24)	VOILLODEUKMPEX-UHFFFAOYSA-N	285620	3-(4-cyano-3-fluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 90::US10669279, Example 90::US9598421, Example 90	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 21.4							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285620	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285620&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118875402	378169259							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913795	Fc1cc(ccc1C#N)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C17H12FN5O/c18-13-8-10(3-4-11(13)9-19)16-15(17(24)21-12-5-6-12)22-14-2-1-7-20-23(14)16/h1-4,7-8,12H,5-6H2,(H,21,24)	VOILLODEUKMPEX-UHFFFAOYSA-N	285620	3-(4-cyano-3-fluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 90::US10669279, Example 90::US9598421, Example 90	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 43.7							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285620	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285620&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875402	378169259							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913796	Fc1cc(ccc1C#N)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C17H12FN5O/c18-13-8-10(3-4-11(13)9-19)16-15(17(24)21-12-5-6-12)22-14-2-1-7-20-23(14)16/h1-4,7-8,12H,5-6H2,(H,21,24)	VOILLODEUKMPEX-UHFFFAOYSA-N	285620	3-(4-cyano-3-fluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 90::US10669279, Example 90::US9598421, Example 90	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 25.5							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285620	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285620&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118875402	378169259							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913797	Fc1cc(ccc1C#N)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C17H12FN5O/c18-13-8-10(3-4-11(13)9-19)16-15(17(24)21-12-5-6-12)22-14-2-1-7-20-23(14)16/h1-4,7-8,12H,5-6H2,(H,21,24)	VOILLODEUKMPEX-UHFFFAOYSA-N	285620	3-(4-cyano-3-fluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 90::US10669279, Example 90::US9598421, Example 90	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 2620							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285620	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285620&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875402	378169259							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913798	Fc1cc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)cc1Cl	InChI=1S/C16H11ClF2N4O/c17-10-8-11(18)9(7-12(10)19)15-14(16(24)22-5-2-6-22)21-13-3-1-4-20-23(13)15/h1,3-4,7-8H,2,5-6H2	PAISFAPTLJTHAX-UHFFFAOYSA-N	285621	US10077269, Example 91::US10669279, Example 91::US9598421, Example 91::azetidin-1-yl[3-(4-chloro-2,5-difluorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 12.6							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285621	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285621&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			126700204	378169260							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913799	Fc1cc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)cc1Cl	InChI=1S/C16H11ClF2N4O/c17-10-8-11(18)9(7-12(10)19)15-14(16(24)22-5-2-6-22)21-13-3-1-4-20-23(13)15/h1,3-4,7-8H,2,5-6H2	PAISFAPTLJTHAX-UHFFFAOYSA-N	285621	US10077269, Example 91::US10669279, Example 91::US9598421, Example 91::azetidin-1-yl[3-(4-chloro-2,5-difluorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 36.9							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285621	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285621&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700204	378169260							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913800	Fc1cc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)cc1Cl	InChI=1S/C16H11ClF2N4O/c17-10-8-11(18)9(7-12(10)19)15-14(16(24)22-5-2-6-22)21-13-3-1-4-20-23(13)15/h1,3-4,7-8H,2,5-6H2	PAISFAPTLJTHAX-UHFFFAOYSA-N	285621	US10077269, Example 91::US10669279, Example 91::US9598421, Example 91::azetidin-1-yl[3-(4-chloro-2,5-difluorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 80.0							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285621	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285621&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			126700204	378169260							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913801	Fc1cc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)cc1Cl	InChI=1S/C16H11ClF2N4O/c17-10-8-11(18)9(7-12(10)19)15-14(16(24)22-5-2-6-22)21-13-3-1-4-20-23(13)15/h1,3-4,7-8H,2,5-6H2	PAISFAPTLJTHAX-UHFFFAOYSA-N	285621	US10077269, Example 91::US10669279, Example 91::US9598421, Example 91::azetidin-1-yl[3-(4-chloro-2,5-difluorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 2250							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285621	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285621&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700204	378169260							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913802	Fc1cc(-c2c(nc3cccnn23)C(=O)NC2CC2)c(F)cc1C#N	InChI=1S/C17H11F2N5O/c18-12-7-11(13(19)6-9(12)8-20)16-15(17(25)22-10-3-4-10)23-14-2-1-5-21-24(14)16/h1-2,5-7,10H,3-4H2,(H,22,25)	RESYBSJMKXZFCE-UHFFFAOYSA-N	285622	3-(4-cyano-2,5-difluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 92::US10669279, Example 92::US9598421, Example 92	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 5.52							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285622	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285622&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118875378	378169261							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913803	Fc1cc(-c2c(nc3cccnn23)C(=O)NC2CC2)c(F)cc1C#N	InChI=1S/C17H11F2N5O/c18-12-7-11(13(19)6-9(12)8-20)16-15(17(25)22-10-3-4-10)23-14-2-1-5-21-24(14)16/h1-2,5-7,10H,3-4H2,(H,22,25)	RESYBSJMKXZFCE-UHFFFAOYSA-N	285622	3-(4-cyano-2,5-difluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 92::US10669279, Example 92::US9598421, Example 92	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 21.0							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285622	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285622&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875378	378169261							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913804	Fc1cc(-c2c(nc3cccnn23)C(=O)NC2CC2)c(F)cc1C#N	InChI=1S/C17H11F2N5O/c18-12-7-11(13(19)6-9(12)8-20)16-15(17(25)22-10-3-4-10)23-14-2-1-5-21-24(14)16/h1-2,5-7,10H,3-4H2,(H,22,25)	RESYBSJMKXZFCE-UHFFFAOYSA-N	285622	3-(4-cyano-2,5-difluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 92::US10669279, Example 92::US9598421, Example 92	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 42.5							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285622	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285622&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118875378	378169261							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913805	Fc1cc(-c2c(nc3cccnn23)C(=O)NC2CC2)c(F)cc1C#N	InChI=1S/C17H11F2N5O/c18-12-7-11(13(19)6-9(12)8-20)16-15(17(25)22-10-3-4-10)23-14-2-1-5-21-24(14)16/h1-2,5-7,10H,3-4H2,(H,22,25)	RESYBSJMKXZFCE-UHFFFAOYSA-N	285622	3-(4-cyano-2,5-difluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 92::US10669279, Example 92::US9598421, Example 92	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		>1440							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285622	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285622&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875378	378169261							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913806	CNC(=O)c1nc2cccnn2c1-c1cc(F)c(Cl)cc1F	InChI=1S/C14H9ClF2N4O/c1-18-14(22)12-13(21-11(20-12)3-2-4-19-21)7-5-10(17)8(15)6-9(7)16/h2-6H,1H3,(H,18,22)	LVRAFMJECWTOEO-UHFFFAOYSA-N	285623	3-(4-chloro-2,5-difluorophenyl)-N-methylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 93::US10669279, Example 93::US9598421, Example 93	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 62.9							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285623	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285623&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118875371	378169262							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913807	CNC(=O)c1nc2cccnn2c1-c1cc(F)c(Cl)cc1F	InChI=1S/C14H9ClF2N4O/c1-18-14(22)12-13(21-11(20-12)3-2-4-19-21)7-5-10(17)8(15)6-9(7)16/h2-6H,1H3,(H,18,22)	LVRAFMJECWTOEO-UHFFFAOYSA-N	285623	3-(4-chloro-2,5-difluorophenyl)-N-methylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 93::US10669279, Example 93::US9598421, Example 93	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 276							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285623	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285623&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875371	378169262							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913808	CNC(=O)c1nc2cccnn2c1-c1cc(F)c(Cl)cc1F	InChI=1S/C14H9ClF2N4O/c1-18-14(22)12-13(21-11(20-12)3-2-4-19-21)7-5-10(17)8(15)6-9(7)16/h2-6H,1H3,(H,18,22)	LVRAFMJECWTOEO-UHFFFAOYSA-N	285623	3-(4-chloro-2,5-difluorophenyl)-N-methylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 93::US10669279, Example 93::US9598421, Example 93	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 134							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285623	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285623&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118875371	378169262							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913809	CNC(=O)c1nc2cccnn2c1-c1cc(F)c(Cl)cc1F	InChI=1S/C14H9ClF2N4O/c1-18-14(22)12-13(21-11(20-12)3-2-4-19-21)7-5-10(17)8(15)6-9(7)16/h2-6H,1H3,(H,18,22)	LVRAFMJECWTOEO-UHFFFAOYSA-N	285623	3-(4-chloro-2,5-difluorophenyl)-N-methylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 93::US10669279, Example 93::US9598421, Example 93	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 4110							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285623	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285623&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875371	378169262							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913810	CNC(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1	InChI=1S/C14H10ClFN4O/c1-17-14(21)12-13(8-4-5-9(15)10(16)7-8)20-11(19-12)3-2-6-18-20/h2-7H,1H3,(H,17,21)	XVPMLCYXSAROSC-UHFFFAOYSA-N	285624	3-(4-chloro-3-fluorophenyl)-N-methylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 94::US10669279, Example 94::US9598421, Example 94	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 24.9							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285624	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285624&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118875407	378169263							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913811	CNC(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1	InChI=1S/C14H10ClFN4O/c1-17-14(21)12-13(8-4-5-9(15)10(16)7-8)20-11(19-12)3-2-6-18-20/h2-7H,1H3,(H,17,21)	XVPMLCYXSAROSC-UHFFFAOYSA-N	285624	3-(4-chloro-3-fluorophenyl)-N-methylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 94::US10669279, Example 94::US9598421, Example 94	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 253							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285624	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285624&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875407	378169263							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913812	CNC(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1	InChI=1S/C14H10ClFN4O/c1-17-14(21)12-13(8-4-5-9(15)10(16)7-8)20-11(19-12)3-2-6-18-20/h2-7H,1H3,(H,17,21)	XVPMLCYXSAROSC-UHFFFAOYSA-N	285624	3-(4-chloro-3-fluorophenyl)-N-methylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 94::US10669279, Example 94::US9598421, Example 94	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 65.0							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285624	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285624&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118875407	378169263							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913813	CNC(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1	InChI=1S/C14H10ClFN4O/c1-17-14(21)12-13(8-4-5-9(15)10(16)7-8)20-11(19-12)3-2-6-18-20/h2-7H,1H3,(H,17,21)	XVPMLCYXSAROSC-UHFFFAOYSA-N	285624	3-(4-chloro-3-fluorophenyl)-N-methylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 94::US10669279, Example 94::US9598421, Example 94	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 5380							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285624	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285624&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875407	378169263							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913814	CCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1C	InChI=1S/C16H15ClN4O/c1-3-18-16(22)14-15(12-7-6-11(17)9-10(12)2)21-13(20-14)5-4-8-19-21/h4-9H,3H2,1-2H3,(H,18,22)	HRLMOSFOSQNGMI-UHFFFAOYSA-N	285625	3-(4-chloro-2-methylphenyl)-N-ethylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 95::US10669279, Example 95::US9598421, Example 95	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 306							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285625	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285625&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875368	378169264							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913815	CCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1C	InChI=1S/C16H15ClN4O/c1-3-18-16(22)14-15(12-7-6-11(17)9-10(12)2)21-13(20-14)5-4-8-19-21/h4-9H,3H2,1-2H3,(H,18,22)	HRLMOSFOSQNGMI-UHFFFAOYSA-N	285625	3-(4-chloro-2-methylphenyl)-N-ethylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 95::US10669279, Example 95::US9598421, Example 95	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 14800							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285625	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285625&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875368	378169264							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913816	CCNC(=O)c1nc2cccnn2c1-c1cc(F)c(Cl)cc1F	InChI=1S/C15H11ClF2N4O/c1-2-19-15(23)13-14(22-12(21-13)4-3-5-20-22)8-6-11(18)9(16)7-10(8)17/h3-7H,2H2,1H3,(H,19,23)	IMOBPVDSTURWHO-UHFFFAOYSA-N	285626	3-(4-chloro-2,5-difluoro-phenyl)-N-ethylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 96::US10669279, Example 96::US9598421, Example 96	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 4.58							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285626	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285626&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118875399	378169265							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913817	CCNC(=O)c1nc2cccnn2c1-c1cc(F)c(Cl)cc1F	InChI=1S/C15H11ClF2N4O/c1-2-19-15(23)13-14(22-12(21-13)4-3-5-20-22)8-6-11(18)9(16)7-10(8)17/h3-7H,2H2,1H3,(H,19,23)	IMOBPVDSTURWHO-UHFFFAOYSA-N	285626	3-(4-chloro-2,5-difluoro-phenyl)-N-ethylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 96::US10669279, Example 96::US9598421, Example 96	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 33.2							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285626	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285626&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875399	378169265							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913818	CCNC(=O)c1nc2cccnn2c1-c1cc(F)c(Cl)cc1F	InChI=1S/C15H11ClF2N4O/c1-2-19-15(23)13-14(22-12(21-13)4-3-5-20-22)8-6-11(18)9(16)7-10(8)17/h3-7H,2H2,1H3,(H,19,23)	IMOBPVDSTURWHO-UHFFFAOYSA-N	285626	3-(4-chloro-2,5-difluoro-phenyl)-N-ethylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 96::US10669279, Example 96::US9598421, Example 96	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 29.2							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285626	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285626&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118875399	378169265							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913819	CCNC(=O)c1nc2cccnn2c1-c1cc(F)c(Cl)cc1F	InChI=1S/C15H11ClF2N4O/c1-2-19-15(23)13-14(22-12(21-13)4-3-5-20-22)8-6-11(18)9(16)7-10(8)17/h3-7H,2H2,1H3,(H,19,23)	IMOBPVDSTURWHO-UHFFFAOYSA-N	285626	3-(4-chloro-2,5-difluoro-phenyl)-N-ethylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 96::US10669279, Example 96::US9598421, Example 96	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 908							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285626	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285626&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875399	378169265							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913820	CC(C)NC(=O)c1nc2cccnn2c1-c1cc(F)c(Cl)cc1C	InChI=1S/C17H16ClFN4O/c1-9(2)21-17(24)15-16(23-14(22-15)5-4-6-20-23)11-8-13(19)12(18)7-10(11)3/h4-9H,1-3H3,(H,21,24)	VJEYWPJLEFUOTH-UHFFFAOYSA-N	285627	3-(4-chloro-5-fluoro-2-methylphenyl)-N-(propan-2-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 97::US10669279, Example 97::US9598421, Example 97	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 5.48							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285627	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285627&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			126700205	378169266							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913821	CC(C)NC(=O)c1nc2cccnn2c1-c1cc(F)c(Cl)cc1C	InChI=1S/C17H16ClFN4O/c1-9(2)21-17(24)15-16(23-14(22-15)5-4-6-20-23)11-8-13(19)12(18)7-10(11)3/h4-9H,1-3H3,(H,21,24)	VJEYWPJLEFUOTH-UHFFFAOYSA-N	285627	3-(4-chloro-5-fluoro-2-methylphenyl)-N-(propan-2-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 97::US10669279, Example 97::US9598421, Example 97	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 23.3							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285627	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285627&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700205	378169266							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913822	CC(C)NC(=O)c1nc2cccnn2c1-c1cc(F)c(Cl)cc1C	InChI=1S/C17H16ClFN4O/c1-9(2)21-17(24)15-16(23-14(22-15)5-4-6-20-23)11-8-13(19)12(18)7-10(11)3/h4-9H,1-3H3,(H,21,24)	VJEYWPJLEFUOTH-UHFFFAOYSA-N	285627	3-(4-chloro-5-fluoro-2-methylphenyl)-N-(propan-2-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 97::US10669279, Example 97::US9598421, Example 97	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 20.0							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285627	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285627&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			126700205	378169266							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913823	CC(C)NC(=O)c1nc2cccnn2c1-c1cc(F)c(Cl)cc1C	InChI=1S/C17H16ClFN4O/c1-9(2)21-17(24)15-16(23-14(22-15)5-4-6-20-23)11-8-13(19)12(18)7-10(11)3/h4-9H,1-3H3,(H,21,24)	VJEYWPJLEFUOTH-UHFFFAOYSA-N	285627	3-(4-chloro-5-fluoro-2-methylphenyl)-N-(propan-2-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 97::US10669279, Example 97::US9598421, Example 97	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		>1850							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285627	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285627&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700205	378169266							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913824	CCNC(=O)c1nc2cccnn2c1-c1cc(F)c(cc1C)C#N	InChI=1S/C17H14FN5O/c1-3-20-17(24)15-16(23-14(22-15)5-4-6-21-23)12-8-13(18)11(9-19)7-10(12)2/h4-8H,3H2,1-2H3,(H,20,24)	FKAXUOKPFFFYTF-UHFFFAOYSA-N	285628	3-(4-cyano-5-fluoro-2-methyl-phenyl)-N-ethylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 98::US10669279, Example 98::US9598421, Example 98	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 26.6							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285628	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285628&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			126700206	378169267							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913825	CCNC(=O)c1nc2cccnn2c1-c1cc(F)c(cc1C)C#N	InChI=1S/C17H14FN5O/c1-3-20-17(24)15-16(23-14(22-15)5-4-6-21-23)12-8-13(18)11(9-19)7-10(12)2/h4-8H,3H2,1-2H3,(H,20,24)	FKAXUOKPFFFYTF-UHFFFAOYSA-N	285628	3-(4-cyano-5-fluoro-2-methyl-phenyl)-N-ethylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 98::US10669279, Example 98::US9598421, Example 98	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 62.7							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285628	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285628&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700206	378169267							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913826	CCNC(=O)c1nc2cccnn2c1-c1cc(F)c(cc1C)C#N	InChI=1S/C17H14FN5O/c1-3-20-17(24)15-16(23-14(22-15)5-4-6-21-23)12-8-13(18)11(9-19)7-10(12)2/h4-8H,3H2,1-2H3,(H,20,24)	FKAXUOKPFFFYTF-UHFFFAOYSA-N	285628	3-(4-cyano-5-fluoro-2-methyl-phenyl)-N-ethylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 98::US10669279, Example 98::US9598421, Example 98	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 107							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285628	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285628&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			126700206	378169267							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913827	CCNC(=O)c1nc2cccnn2c1-c1cc(F)c(cc1C)C#N	InChI=1S/C17H14FN5O/c1-3-20-17(24)15-16(23-14(22-15)5-4-6-21-23)12-8-13(18)11(9-19)7-10(12)2/h4-8H,3H2,1-2H3,(H,20,24)	FKAXUOKPFFFYTF-UHFFFAOYSA-N	285628	3-(4-cyano-5-fluoro-2-methyl-phenyl)-N-ethylimidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 98::US10669279, Example 98::US9598421, Example 98	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 3320							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285628	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285628&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700206	378169267							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913828	CC(C)NC(=O)c1nc2cccnn2c1-c1cc(F)c(cc1C)C#N	InChI=1S/C18H16FN5O/c1-10(2)22-18(25)16-17(24-15(23-16)5-4-6-21-24)13-8-14(19)12(9-20)7-11(13)3/h4-8,10H,1-3H3,(H,22,25)	LCTMXACJLVAYNA-UHFFFAOYSA-N	285629	3-(4-cyano-5-fluoro-2-methylphenyl)-N-(propan-2-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 99::US10669279, Example 99::US9598421, Example 99	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 19.8							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285629	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285629&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118875366	378169268							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913829	CC(C)NC(=O)c1nc2cccnn2c1-c1cc(F)c(cc1C)C#N	InChI=1S/C18H16FN5O/c1-10(2)22-18(25)16-17(24-15(23-16)5-4-6-21-24)13-8-14(19)12(9-20)7-11(13)3/h4-8,10H,1-3H3,(H,22,25)	LCTMXACJLVAYNA-UHFFFAOYSA-N	285629	3-(4-cyano-5-fluoro-2-methylphenyl)-N-(propan-2-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 99::US10669279, Example 99::US9598421, Example 99	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 36.2							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285629	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285629&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875366	378169268							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913830	CC(C)NC(=O)c1nc2cccnn2c1-c1cc(F)c(cc1C)C#N	InChI=1S/C18H16FN5O/c1-10(2)22-18(25)16-17(24-15(23-16)5-4-6-21-24)13-8-14(19)12(9-20)7-11(13)3/h4-8,10H,1-3H3,(H,22,25)	LCTMXACJLVAYNA-UHFFFAOYSA-N	285629	3-(4-cyano-5-fluoro-2-methylphenyl)-N-(propan-2-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 99::US10669279, Example 99::US9598421, Example 99	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 138							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285629	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285629&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118875366	378169268							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913831	CC(C)NC(=O)c1nc2cccnn2c1-c1cc(F)c(cc1C)C#N	InChI=1S/C18H16FN5O/c1-10(2)22-18(25)16-17(24-15(23-16)5-4-6-21-24)13-8-14(19)12(9-20)7-11(13)3/h4-8,10H,1-3H3,(H,22,25)	LCTMXACJLVAYNA-UHFFFAOYSA-N	285629	3-(4-cyano-5-fluoro-2-methylphenyl)-N-(propan-2-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 99::US10669279, Example 99::US9598421, Example 99	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 1550							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285629	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285629&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875366	378169268							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913832	CC(C)NC(=O)c1nc2cccnn2c1-c1cc(F)c(Cl)cc1F	InChI=1S/C16H13ClF2N4O/c1-8(2)21-16(24)14-15(23-13(22-14)4-3-5-20-23)9-6-12(19)10(17)7-11(9)18/h3-8H,1-2H3,(H,21,24)	JMTGAAJHYHUEQI-UHFFFAOYSA-N	285630	3-(4-chloro-2,5-difluoro-phenyl)-N-(propan-2-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 100::US10669279, Example 100::US9598421, Example 100	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 49.1							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285630	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285630&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700207	378169269							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913833	CC(C)NC(=O)c1nc2cccnn2c1-c1cc(F)c(Cl)cc1F	InChI=1S/C16H13ClF2N4O/c1-8(2)21-16(24)14-15(23-13(22-14)4-3-5-20-23)9-6-12(19)10(17)7-11(9)18/h3-8H,1-2H3,(H,21,24)	JMTGAAJHYHUEQI-UHFFFAOYSA-N	285630	3-(4-chloro-2,5-difluoro-phenyl)-N-(propan-2-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 100::US10669279, Example 100::US9598421, Example 100	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 766							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285630	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285630&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700207	378169269							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913834	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)Nc1ncccn1	InChI=1S/C17H11ClN6O/c18-12-6-4-11(5-7-12)15-14(22-13-3-1-10-21-24(13)15)16(25)23-17-19-8-2-9-20-17/h1-10H,(H,19,20,23,25)	LHIGSNUVLANYIO-UHFFFAOYSA-N	285631	3-(4-chlorophenyl)-N-(pyrimidin-2-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 101::US10669279, Example 101::US9598421, Example 101	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 268							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285631	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285631&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118875390	378169270							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913835	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)Nc1ncccn1	InChI=1S/C17H11ClN6O/c18-12-6-4-11(5-7-12)15-14(22-13-3-1-10-21-24(13)15)16(25)23-17-19-8-2-9-20-17/h1-10H,(H,19,20,23,25)	LHIGSNUVLANYIO-UHFFFAOYSA-N	285631	3-(4-chlorophenyl)-N-(pyrimidin-2-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 101::US10669279, Example 101::US9598421, Example 101	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 861							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285631	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285631&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875390	378169270							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913836	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)Nc1ncccn1	InChI=1S/C17H11ClN6O/c18-12-6-4-11(5-7-12)15-14(22-13-3-1-10-21-24(13)15)16(25)23-17-19-8-2-9-20-17/h1-10H,(H,19,20,23,25)	LHIGSNUVLANYIO-UHFFFAOYSA-N	285631	3-(4-chlorophenyl)-N-(pyrimidin-2-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 101::US10669279, Example 101::US9598421, Example 101	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 1179							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285631	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285631&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118875390	378169270							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913837	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)Nc1ncccn1	InChI=1S/C17H11ClN6O/c18-12-6-4-11(5-7-12)15-14(22-13-3-1-10-21-24(13)15)16(25)23-17-19-8-2-9-20-17/h1-10H,(H,19,20,23,25)	LHIGSNUVLANYIO-UHFFFAOYSA-N	285631	3-(4-chlorophenyl)-N-(pyrimidin-2-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 101::US10669279, Example 101::US9598421, Example 101	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		>25900							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285631	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285631&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875390	378169270							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913838	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)NCC1CC1	InChI=1S/C17H15ClN4O/c18-13-7-5-12(6-8-13)16-15(17(23)19-10-11-3-4-11)21-14-2-1-9-20-22(14)16/h1-2,5-9,11H,3-4,10H2,(H,19,23)	VFBYVKMGLDMLTI-UHFFFAOYSA-N	285632	3-(4-chlorophenyl)-N-(cyclo-propylmethyl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 102::US10669279, Example 102::US9598421, Example 102	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 59.9							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285632	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285632&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			126700208	378169271							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913839	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)NCC1CC1	InChI=1S/C17H15ClN4O/c18-13-7-5-12(6-8-13)16-15(17(23)19-10-11-3-4-11)21-14-2-1-9-20-22(14)16/h1-2,5-9,11H,3-4,10H2,(H,19,23)	VFBYVKMGLDMLTI-UHFFFAOYSA-N	285632	3-(4-chlorophenyl)-N-(cyclo-propylmethyl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 102::US10669279, Example 102::US9598421, Example 102	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 103							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285632	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285632&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700208	378169271							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913840	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)NCC1CC1	InChI=1S/C17H15ClN4O/c18-13-7-5-12(6-8-13)16-15(17(23)19-10-11-3-4-11)21-14-2-1-9-20-22(14)16/h1-2,5-9,11H,3-4,10H2,(H,19,23)	VFBYVKMGLDMLTI-UHFFFAOYSA-N	285632	3-(4-chlorophenyl)-N-(cyclo-propylmethyl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 102::US10669279, Example 102::US9598421, Example 102	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 76.0							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285632	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285632&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			126700208	378169271							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913841	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)NCC1CC1	InChI=1S/C17H15ClN4O/c18-13-7-5-12(6-8-13)16-15(17(23)19-10-11-3-4-11)21-14-2-1-9-20-22(14)16/h1-2,5-9,11H,3-4,10H2,(H,19,23)	VFBYVKMGLDMLTI-UHFFFAOYSA-N	285632	3-(4-chlorophenyl)-N-(cyclo-propylmethyl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 102::US10669279, Example 102::US9598421, Example 102	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 5010							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285632	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285632&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700208	378169271							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913842	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)Nc1ccn[nH]1	InChI=1S/C16H11ClN6O/c17-11-5-3-10(4-6-11)15-14(16(24)20-12-7-9-18-22-12)21-13-2-1-8-19-23(13)15/h1-9H,(H2,18,20,22,24)	XMHPQZNHOIRAHG-UHFFFAOYSA-N	285633	3-(4-chlorophenyl)-N-(1H-pyrazol-5-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 103::US10669279, Example 103::US9598421, Example 103	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		 62.7							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285633	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285633&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			126703955	378169272							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913843	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)Nc1ccn[nH]1	InChI=1S/C16H11ClN6O/c17-11-5-3-10(4-6-11)15-14(16(24)20-12-7-9-18-22-12)21-13-2-1-8-19-23(13)15/h1-9H,(H2,18,20,22,24)	XMHPQZNHOIRAHG-UHFFFAOYSA-N	285633	3-(4-chlorophenyl)-N-(1H-pyrazol-5-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 103::US10669279, Example 103::US9598421, Example 103	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 249							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285633	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285633&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126703955	378169272							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913844	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)Nc1ccn[nH]1	InChI=1S/C16H11ClN6O/c17-11-5-3-10(4-6-11)15-14(16(24)20-12-7-9-18-22-12)21-13-2-1-8-19-23(13)15/h1-9H,(H2,18,20,22,24)	XMHPQZNHOIRAHG-UHFFFAOYSA-N	285633	3-(4-chlorophenyl)-N-(1H-pyrazol-5-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 103::US10669279, Example 103::US9598421, Example 103	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 203							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285633	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285633&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			126703955	378169272							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913845	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)Nc1ccn[nH]1	InChI=1S/C16H11ClN6O/c17-11-5-3-10(4-6-11)15-14(16(24)20-12-7-9-18-22-12)21-13-2-1-8-19-23(13)15/h1-9H,(H2,18,20,22,24)	XMHPQZNHOIRAHG-UHFFFAOYSA-N	285633	3-(4-chlorophenyl)-N-(1H-pyrazol-5-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 103::US10669279, Example 103::US9598421, Example 103	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 1550							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285633	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285633&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126703955	378169272							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913846	Fc1cc(cc(F)c1Cl)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H11ClF2N4O/c17-13-10(18)6-8(7-11(13)19)15-14(16(24)21-9-3-4-9)22-12-2-1-5-20-23(12)15/h1-2,5-7,9H,3-4H2,(H,21,24)	GYZISZRYVGZYRR-UHFFFAOYSA-N	285634	3-(4-chloro-3,5-difluoro-phenyl)-N-cyclopropyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 104::US10669279, Example 104::US9598421, Example 104	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens		<0.488							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285634	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285634&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118875388	378169273							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	2QYK,3I8V,3TVX	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913847	Fc1cc(cc(F)c1Cl)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H11ClF2N4O/c17-13-10(18)6-8(7-11(13)19)15-14(16(24)21-9-3-4-9)22-12-2-1-5-20-23(12)15/h1-2,5-7,9H,3-4H2,(H,21,24)	GYZISZRYVGZYRR-UHFFFAOYSA-N	285634	3-(4-chloro-3,5-difluoro-phenyl)-N-cyclopropyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 104::US10669279, Example 104::US9598421, Example 104	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 1.59							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285634	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285634&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875388	378169273							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913848	Fc1cc(cc(F)c1Cl)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H11ClF2N4O/c17-13-10(18)6-8(7-11(13)19)15-14(16(24)21-9-3-4-9)22-12-2-1-5-20-23(12)15/h1-2,5-7,9H,3-4H2,(H,21,24)	GYZISZRYVGZYRR-UHFFFAOYSA-N	285634	3-(4-chloro-3,5-difluoro-phenyl)-N-cyclopropyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 104::US10669279, Example 104::US9598421, Example 104	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 4.69							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285634	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285634&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118875388	378169273							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2PW3,2QYM,5K32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
913849	Fc1cc(cc(F)c1Cl)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H11ClF2N4O/c17-13-10(18)6-8(7-11(13)19)15-14(16(24)21-9-3-4-9)22-12-2-1-5-20-23(12)15/h1-2,5-7,9H,3-4H2,(H,21,24)	GYZISZRYVGZYRR-UHFFFAOYSA-N	285634	3-(4-chloro-3,5-difluoro-phenyl)-N-cyclopropyl-imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 104::US10669279, Example 104::US9598421, Example 104	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 145							US Patent		10.7270/Q2765JC9		aid1804488	US10669279	Chappie, TA; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM; Verhoest, PR	6/2/2020	2/21/2021	Pfizer Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285634	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285634&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875388	378169273							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7